syndrome	score	normalized_score
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	100.0
SALT-AND-PEPPER SYNDROME	0.70075643	70.075643
TUBEROUS SCLEROSIS COMPLEX	0.533857934	53.385793400000004
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3	0.525641	52.5641
NEUROFIBROMATOSIS, TYPE I	0.524374215	52.437421500000006
OSTEOPATHIA STRIATA-PIGMENTARY DERMOPATHY-WHITE FORELOCK SYNDROME	0.5	50.0
TUBEROUS SCLEROSIS-1	0.348563834	34.8563834
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.33870933999999997	33.870934
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.33474131999999995	33.474132
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.33398489	33.398489
CARNEY COMPLEX	0.3272059	32.72059
PALLISTER-HALL SYNDROME	0.281479824	28.1479824
AMERICAN TRYPANOSOMIASIS	0.25537634	25.537633999999997
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.25227638899999993	25.227638899999995
NON-DISTAL MONOSOMY 20Q	0.25227387999999995	25.227387999999994
TEMPLE SYNDROME	0.25164691499999997	25.164691499999996
TERMINAL OSSEOUS DYSPLASIA; TOD	0.25162338	25.162338000000002
SECKEL SYNDROME 2; SCKL2	0.25140831999999996	25.140831999999996
HYPERTRICHOSIS CUBITI	0.25128136399999995	25.128136399999995
TUFTED ANGIOMA	0.25	25.0
CONGENITAL ENTEROVIRUS INFECTION	0.25	25.0
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.25	25.0
WEST SYNDROME	0.25	25.0
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	0.25	25.0
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.25	25.0
TETANUS	0.25	25.0
ACQUIRED PURPURA FULMINANS	0.21666670000000002	21.666670000000003
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	0.2147059	21.47059
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.20342466	20.342466
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.20342466	20.342466
KIKUCHI-FUJIMOTO DISEASE	0.2	20.0
MULTIPLE ENDOCRINE NEOPLASIA TYPE 4	0.2	20.0
CUTANEOUS NEUROENDOCRINE CARCINOMA	0.2	20.0
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1	0.2	20.0
DYSCHROMATOSIS SYMMETRICA HEREDITARIA 1	0.2	20.0
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.2	20.0
HEREDITARY PROGRESSIVE MUCINOUS HISTIOCYTOSIS	0.2	20.0
%615674 DOWLING-DEGOS DISEASE 3; DDD3	0.2	20.0
GENERALIZED ERUPTIVE HISTIOCYTOSIS	0.2	20.0
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.125524934	12.552493400000001
ANAPLASTIC THYROID CARCINOMA	0.125	12.5
MEDULLARY THYROID CARCINOMA	0.125	12.5
SAPHO SYNDROME	0.125	12.5
LYNCH SYNDROME	0.125	12.5
FAMILIAL COLORECTAL CANCER TYPE X	0.125	12.5
ADENOCARCINOMA OF THE ANAL CANAL	0.125	12.5
SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL	0.125	12.5
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.11387068	11.387068
HURLER SYNDROME	0.102694274	10.2694274
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.102694274	10.2694274
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.10075643000000001	10.075643000000001
MUCOPOLYSACCHARIDOSIS TYPE 2	0.10065189000000001	10.065189
DDOST-CDG	0.10065189000000001	10.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.1	10.0
LEPTIN DEFICIENCY OR DYSFUNCTION	0.1	10.0
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.1	10.0
CARDIOFACIOCUTANEOUS SYNDROME	0.096327719	9.6327719
GASTROCUTANEOUS SYNDROME	0.08865196	8.865196000000001
ESOPHAGEAL ATRESIA	0.08443885500000001	8.4438855
GASTROCUTANEOUS SYNDROME	0.0772059	7.72059
HYPERPIGMENTATION, FAMILIAL PROGRESSIVE	0.0772059	7.72059
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.065194274	6.5194274
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.064146915	6.4146915
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.06315189	6.315189
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.0625	6.25
PIGMENTED VILLONODULAR SYNOVITIS	0.0625	6.25
PEUTZ-JEGHERS SYNDROME	0.0625	6.25
NEUROFIBROMATOSIS TYPE 1	0.061571005	6.157100499999999
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.059758359	5.9758359
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.058858305	5.8858305
CUTANEOUS MASTOCYTOSIS	0.058406639999999996	5.840663999999999
COWDEN SYNDROME	0.056719598999999996	5.671959899999999
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.056694955000000005	5.669495500000001
FEMORAL-FACIAL SYNDROME	0.056694955000000005	5.669495500000001
GITELMAN SYNDROME	0.05537634	5.537634000000001
MICROFORM HOLOPROSENCEPHALY	0.054551659	5.4551659
LIMB-MAMMARY SYNDROME	0.053030299999999995	5.30303
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.052800204	5.280020400000001
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.052275270000000006	5.227527
SYMBRACHYDACTYLY OF HANDS AND FEET	0.050995025	5.0995025
CAUDAL REGRESSION SEQUENCE	0.050995025	5.0995025
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.05053764	5.053764
ULBRIGHT-HODES SYNDROME	0.05	5.0
HYPOPLASTIC LEFT HEART SYNDROME	0.05	5.0
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.05	5.0
MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	0.05	5.0
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.05	5.0
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.05	5.0
PENILE AGENESIS	0.05	5.0
DIABETES MELLITUS, TRANSIENT NEONATAL, 3	0.05	5.0
FOIX-CHAVANY-MARIE SYNDROME	0.05	5.0
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.05	5.0
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.045993085	4.5993085
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.044804543999999995	4.480454399999999
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.043931889	4.3931889
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.042307700000000004	4.230770000000001
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.04085495	4.085495
WOLF-HIRSCHHORN SYNDROME	0.040847855	4.084785500000001
RECOMBINANT 8 SYNDROME	0.040616359000000005	4.061635900000001
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.040346900000000005	4.03469
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.040346900000000005	4.03469
ATAXIA-TELANGIECTASIA	0.04004589	4.004589
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.039889555	3.9889555
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.039271835	3.9271835
BOHRING-OPITZ SYNDROME	0.039000080000000006	3.9000080000000006
RELAPSING POLYCHONDRITIS	0.038998649999999996	3.8998649999999997
LYMPHANGIOLEIOMYOMATOSIS	0.038998649999999996	3.8998649999999997
IMMUNOGLOBULIN A VASCULITIS	0.038998649999999996	3.8998649999999997
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.038515404999999996	3.8515404999999996
HENNEKAM-BEEMER SYNDROME	0.036655939	3.6655938999999997
OROFACIODIGITAL SYNDROME XIV; OFD14	0.03610747	3.6107470000000004
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.03595557	3.595557
TYPHOID	0.03567934	3.5679339999999997
EBOLA HEMORRHAGIC FEVER	0.03567934	3.5679339999999997
SCRUB TYPHUS	0.03567934	3.5679339999999997
MYHRE SYNDROME	0.035377084	3.5377084000000005
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.034379549999999995	3.4379549999999997
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.034329725	3.4329725
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.033827719	3.3827719
OCULOAURICULOFRONTONASAL SYNDROME	0.033677834999999996	3.3677835
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.033573294999999996	3.3573294999999996
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.033443829999999994	3.344382999999999
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.033443829999999994	3.344382999999999
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0333347	3.33347
1P36 DELETION SYNDROME	0.033231279	3.3231279000000002
MEHMO SYNDROME; MEHMO	0.033207744	3.3207744
PIEBALDISM	0.03310181399999999	3.3101813999999994
FOCAL DERMAL HYPOPLASIA	0.032815475	3.2815475
CHROMOSOME 1P36 DELETION SYNDROME	0.032728049	3.2728049
HOLOPROSENCEPHALY 11	0.03268281	3.268281
JOUBERT SYNDROME 26	0.03257827	3.257827
CONGENITAL TOXOPLASMOSIS	0.032576879999999996	3.2576879999999995
ZECHI-CEIDE SYNDROME	0.032451313999999995	3.2451313999999996
CHROMOSOME 15Q14 DELETION SYNDROME	0.032451313999999995	3.2451313999999996
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.03243459	3.243459
TEMPI SYNDROME	0.03240334	3.2403340000000003
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.032236254	3.2236254
FANCONI ANEMIA	0.032221069000000005	3.2221069000000004
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.03192638	3.1926379999999996
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.03192638	3.1926379999999996
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.03192638	3.1926379999999996
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.03192638	3.1926379999999996
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.03192638	3.1926379999999996
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.03192638	3.1926379999999996
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.03167816	3.1678159999999997
HOLOPROSENCEPHALY 3; HPE3	0.031584364	3.1584364
KID SYNDROME	0.031479824	3.1479823999999996
PHEOCHROMOCYTOMA	0.0313726	3.13726
HEART AND BRAIN MALFORMATION SYNDROME	0.031059429999999996	3.1059429999999995
HYPER-IGD SYNDROME	0.031017340000000004	3.1017340000000004
CUTANEOUS MASTOCYTOMA	0.031017340000000004	3.1017340000000004
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.031017340000000004	3.1017340000000004
VASCULAR EHLERS-DANLOS SYNDROME	0.030954889999999995	3.0954889999999997
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.030935094	3.0935094
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.030827933999999998	3.0827934
CRI-DU-CHAT SYNDROME	0.030820839	3.0820838999999998
SCHNITZLER SYNDROME	0.030302999999999997	3.0302999999999995
ANGIOMA SERPIGINOSUM	0.030302999999999997	3.0302999999999995
DERMATITIS HERPETIFORMIS	0.030302999999999997	3.0302999999999995
TOXIC EPIDERMAL NECROLYSIS	0.030302999999999997	3.0302999999999995
STEVENS-JOHNSON SYNDROME	0.030302999999999997	3.0302999999999995
DYSCHROMATOSIS SYMMETRICA HEREDITARIA	0.030302999999999997	3.0302999999999995
OROFACIAL CLEFT 11; OFC11	0.030302999999999997	3.0302999999999995
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.030302999999999997	3.0302999999999995
MASTOCYTOSIS	0.030302999999999997	3.0302999999999995
EOSINOPHILIC FASCIITIS	0.030302999999999997	3.0302999999999995
SPINOCEREBELLAR ATAXIA TYPE 34	0.030302999999999997	3.0302999999999995
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.030302999999999997	3.0302999999999995
BULLOUS PEMPHIGOID	0.030302999999999997	3.0302999999999995
ACRAL PEELING SKIN SYNDROME	0.030302999999999997	3.0302999999999995
RHEUMATIC FEVER	0.030302999999999997	3.0302999999999995
BIFID UVULA	0.030302999999999997	3.0302999999999995
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.030302999999999997	3.0302999999999995
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.030302999999999997	3.0302999999999995
MOWAT-WILSON SYNDROME; MOWS	0.030058699999999997	3.00587
CIRCUMVALLATE PLACENTA SYNDROME	0.029979	2.9979
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.029654849	2.9654849
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.029420843999999998	2.9420843999999997
CHROMOSOME 16P13.3 DELETION SYNDROME	0.029303389	2.9303388999999997
THANATOPHORIC DYSPLASIA TYPE 2	0.029196339999999998	2.919634
ERYTHROKERATODERMIA VARIABILIS	0.029091704000000003	2.9091704000000003
BARDET-BIEDL SYNDROME 1; BBS1	0.029069384	2.9069384
DYSKERATOSIS CONGENITA	0.028805365000000003	2.8805365000000003
FETAL HYDANTOIN SYNDROME	0.028626969999999998	2.862697
THANATOPHORIC DYSPLASIA TYPE 1	0.02854445	2.854445
THANATOPHORIC DYSPLASIA	0.02854445	2.854445
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.028203824	2.8203823999999997
LINEAR VERRUCOUS NEVUS SYNDROME	0.028022025	2.8022025
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.027914880000000003	2.791488
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.027801384	2.7801384
9Q33.3Q34.11 MICRODELETION SYNDROME	0.027783429999999998	2.7783429999999996
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0277778	2.77778
MUENKE SYNDROME	0.027683384000000005	2.7683384000000006
PRIMARY HYPEROXALURIA TYPE 1	0.02756355	2.756355
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.027551934	2.7551934
FAMILIAL MULTIPLE NEVI FLAMMEI	0.027160959000000005	2.7160959000000005
XERODERMA PIGMENTOSUM	0.027049320000000005	2.7049320000000003
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.027027	2.7027
NIPPLES, SUPERNUMERARY	0.027027	2.7027
CONGENITAL TRACHEAL STENOSIS	0.027027	2.7027
7P22.1 MICRODUPLICATION SYNDROME	0.027027	2.7027
BARDET-BIEDL SYNDROME 11; BBS11	0.027027	2.7027
WAARDENBURG SYNDROME TYPE 2	0.027027	2.7027
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.027027	2.7027
INFANTILE MYOFIBROMATOSIS	0.027027	2.7027
TRANSALDOLASE DEFICIENCY	0.027027	2.7027
BARDET-BIEDL SYNDROME 12; BBS12	0.027027	2.7027
POLYARTERITIS NODOSA	0.027027	2.7027
LIPOSARCOMA	0.027027	2.7027
BECKER NEVUS SYNDROME	0.026636025000000004	2.6636025000000005
AMISH INFANTILE EPILEPSY SYNDROME	0.026397430000000003	2.639743
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.026292890000000003	2.6292890000000004
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.026292890000000003	2.6292890000000004
PERIODONTAL EHLERS-DANLOS SYNDROME	0.026292890000000003	2.6292890000000004
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.026165934000000005	2.6165934000000006
MOEBIUS SYNDROME	0.02586813	2.586813
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.025764709	2.5764709
LENTIGINOSIS, INHERITED PATTERNED	0.025641000000000004	2.5641000000000003
CHRONIC GRANULOMATOUS DISEASE	0.025641000000000004	2.5641000000000003
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.025641000000000004	2.5641000000000003
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.025641000000000004	2.5641000000000003
PROGRESSIVE OSSEOUS HETEROPLASIA	0.025641000000000004	2.5641000000000003
HAIRY PALMS AND SOLES	0.025641000000000004	2.5641000000000003
KAPOSI SARCOMA	0.025641000000000004	2.5641000000000003
PEUTZ-JEGHERS SYNDROME	0.025641000000000004	2.5641000000000003
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.025641000000000004	2.5641000000000003
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.025641000000000004	2.5641000000000003
RARE CUTANEOUS LUPUS ERYTHEMATOSUS	0.025641000000000004	2.5641000000000003
DARIER-WHITE DISEASE; DAR	0.025641000000000004	2.5641000000000003
HEREDITARY COPROPORPHYRIA	0.025641000000000004	2.5641000000000003
DARIER DISEASE	0.025641000000000004	2.5641000000000003
PSEUDOXANTHOMA ELASTICUM; PXE	0.025641000000000004	2.5641000000000003
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.025641000000000004	2.5641000000000003
MASTOCYTOSIS, CUTANEOUS; MASTC	0.025641000000000004	2.5641000000000003
JOHNSON NEUROECTODERMAL SYNDROME	0.025632043999999996	2.5632043999999996
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.025345705	2.5345705
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.02504279	2.504279
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.024899149	2.4899149
16P11.2P12.2 MICRODELETION SYNDROME	0.024896639999999998	2.489664
FACIAL DYSMORPHISM-ANOREXIA-CACHEXIA-EYE AND SKIN ANOMALIES SYNDROME	0.024374214999999998	2.4374214999999997
PROTEUS SYNDROME	0.024247259	2.4247259
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.024135619999999997	2.4135619999999998
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.024063083999999995	2.4063083999999995
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.02388408	2.3884079999999996
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.023722325	2.3722325
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.023722325	2.3722325
LEGIUS SYNDROME	0.023634469999999998	2.363447
WATSON SYNDROME	0.023379189999999998	2.337919
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.023379189999999998	2.337919
MCCUNE-ALBRIGHT SYNDROME	0.0227273	2.2727299999999997
JUVENILE XANTHOGRANULOMA	0.0227273	2.2727299999999997
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.0227273	2.2727299999999997
NEUROFIBROMATOSIS TYPE 6	0.0227273	2.2727299999999997
HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME	0.0227273	2.2727299999999997
114030 CAFE-AU-LAIT SPOTS, MULTIPLE	0.0227273	2.2727299999999997
PEELING SKIN SYNDROME	0.0227273	2.2727299999999997
EPIDERMODYSPLASIA VERRUCIFORMIS	0.0227273	2.2727299999999997
MAN1B1-CDG	0.0227273	2.2727299999999997
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.0227273	2.2727299999999997
NEUROFIBROMATOSIS TYPE 2	0.0227273	2.2727299999999997
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.0227273	2.2727299999999997
WITTEVEEN-KOLK SYNDROME	0.022576288999999996	2.2576288999999994
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.02204304	2.204304
NIJMEGEN BREAKAGE SYNDROME	0.021687193999999996	2.1687193999999996
NEUROFIBROMATOSIS, TYPE II	0.021599689999999998	2.159969
TURCOT SYNDROME WITH POLYPOSIS	0.021599689999999998	2.159969
7Q11.23 MICRODUPLICATION SYNDROME	0.021526399999999998	2.15264
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.021321034	2.1321034
MICROPHTHALMIA, SYNDROMIC 4	0.021016214000000002	2.1016214
KABUKI SYNDROME 1	0.020775008999999997	2.0775008999999995
MEGAEPIPHYSEAL DWARFISM	0.02049128	2.049128
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.02049128	2.049128
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	2.038535
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.020223334	2.0223334
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.01962433	1.9624329999999999
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.019592469999999997	1.9592469999999997
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019392834	1.9392834
VAN DEN BOSCH SYNDROME	0.019392834	1.9392834
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019392834	1.9392834
AASE-SMITH SYNDROME	0.019285105	1.9285105
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	1.88679
VESICOURETERAL REFLUX 1	0.0188679	1.88679
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	1.88679
PUBIC BONE DYSPLASIA	0.0188679	1.88679
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	1.88679
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	1.88679
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	1.88679
RAYNAUD DISEASE	0.0188679	1.88679
BAND HETEROTOPIA; BH	0.0188679	1.88679
PACHYDERMODACTYLY, FAMILIAL	0.0188679	1.88679
LETTERER-SIWE DISEASE	0.0188679	1.88679
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	1.88679
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	1.88679
THROMBOCYTOPENIA 3	0.0188679	1.88679
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	1.88679
SPINAL ARACHNOIDITIS	0.0188679	1.88679
DOUBLE NAIL FOR FIFTH TOE	0.0188679	1.88679
THUMBS, CONGENITAL CLASPED	0.0188679	1.88679
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	1.88679
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	1.88679
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	1.88679
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	1.88679
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	1.88679
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	1.88679
TOE, MISSHAPEN	0.0188679	1.88679
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	1.88679
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	1.88679
CARPAL DISPLACEMENT	0.0188679	1.88679
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	1.88679
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	1.88679
THALIDOMIDE SUSCEPTIBILITY	0.0188679	1.88679
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	1.88679
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	1.88679
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	1.88679
MONOPHALANGY OF GREAT TOE	0.0188679	1.88679
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	1.88679
TRACHEOBRONCHOMEGALY	0.0188679	1.88679
HHHH SYNDROME	0.0188679	1.88679
NEPHROSIALIDOSIS	0.0188679	1.88679
KNUCKLE PADS	0.0188679	1.88679
N SYNDROME	0.018709084	1.8709084
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.018655493999999998	1.8655494
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.018603159999999997	1.8603159999999996
HOYERAAL-HREIDARSSON SYNDROME	0.018599954	1.8599953999999999
GORLIN SYNDROME	0.018186659	1.8186659
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.018156603999999996	1.8156603999999996
FANCONI ANEMIA	0.018156603999999996	1.8156603999999996
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.01813056	1.813056
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.017843524	1.7843524
TRISOMY 8P	0.01776082	1.776082
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017743309	1.7743308999999998
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.017661725	1.7661725
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.01763167	1.763167
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.017631669999999995	1.7631669999999995
ROBERTS SYNDROME; RBS	0.017610643999999998	1.7610643999999998
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.017440504	1.7440504
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.01742313	1.7423129999999998
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.01742313	1.7423129999999998
X-LINKED AGAMMAGLOBULINEMIA	0.01731859	1.7318589999999998
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.01731859	1.7318589999999998
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.01731859	1.7318589999999998
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.017191634	1.7191634
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.016798959	1.6798958999999998
MONOSOMY X	0.016744095	1.6744095
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.016744095	1.6744095
MOSAIC MONOSOMY X	0.016744095	1.6744095
TURNER SYNDROME	0.016744095	1.6744095
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	1.6666699999999999
PAGET DISEASE, EXTRAMAMMARY	0.0166667	1.6666699999999999
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	1.6666699999999999
PITYRIASIS RUBRA PILARIS	0.0166667	1.6666699999999999
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.0166667	1.6666699999999999
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	1.6666699999999999
117600 CEREBRAL SARCOMA	0.0166667	1.6666699999999999
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	1.6666699999999999
NASOPHARYNGEAL CARCINOMA	0.0166667	1.6666699999999999
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	1.6666699999999999
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	1.6666699999999999
PRIMARY PERITONEAL CARCINOMA	0.0166667	1.6666699999999999
THYMOMA, FAMILIAL	0.0166667	1.6666699999999999
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.0166667	1.6666699999999999
ANTISYNTHETASE SYNDROME	0.0166667	1.6666699999999999
HEPATOCELLULAR CARCINOMA	0.0166667	1.6666699999999999
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0166667	1.6666699999999999
INTESTINAL LYMPHANGIECTASIA	0.0166667	1.6666699999999999
CHYLOUS ASCITES	0.0166667	1.6666699999999999
ADAMANTINOMA OF LONG BONES	0.0166667	1.6666699999999999
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	1.6666699999999999
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	1.6666699999999999
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	1.6666699999999999
ANDROGEN INSENSITIVITY SYNDROME	0.0166667	1.6666699999999999
TRIGEMINAL NEURALGIA	0.0166667	1.6666699999999999
ONCOCYTOMA	0.0166667	1.6666699999999999
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	1.6666699999999999
ICHTHYOSIS, X-LINKED	0.0166667	1.6666699999999999
HURIEZ SYNDROME; HRZ	0.0166667	1.6666699999999999
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	1.6666699999999999
JOHANSON-BLIZZARD SYNDROME; JBS	0.016639153999999996	1.6639153999999996
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.016639153999999996	1.6639153999999996
SILVER-RUSSELL SYNDROME	0.016352814999999996	1.6352814999999996
9P13 MICRODELETION SYNDROME	0.016352814999999996	1.6352814999999996
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.016329279999999998	1.6329279999999997
MONOSOMY 9P	0.016252999	1.6252999000000001
BRANCHIOOCULOFACIAL SYNDROME	0.01625049	1.625049
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016225859	1.6225858999999998
RING CHROMOSOME 7 SYNDROME	0.01611422	1.611422
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.01611422	1.611422
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.01611422	1.611422
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.01611422	1.611422
FONTAINE PROGEROID SYNDROME; FPS	0.015983075	1.5983075
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.015882723999999997	1.5882723999999997
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.015856119	1.5856118999999997
BARAITSER-WINTER SYNDROME 1; BRWS1	0.015512984	1.5512984
RING CHROMOSOME 13 SYNDROME	0.01546233	1.546233
BLOOM SYNDROME	0.01546233	1.546233
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.01535779	1.535779
NOONAN SYNDROME 6; NS6	0.01535779	1.535779
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.01535779	1.535779
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.01535779	1.535779
SYNDROMIC DIARRHEA	0.01535779	1.535779
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.015230833999999999	1.5230834
19P13.13 MICRODELETION SYNDROME	0.015230833999999999	1.5230834
NF1-MICRODELETION SYNDROME	0.015230833999999999	1.5230834
SMITH-KINGSMORE SYNDROME; SKS	0.015230833999999999	1.5230834
TUBEROUS SCLEROSIS 2; TSC2	0.015230833999999999	1.5230834
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.015230833999999999	1.5230834
TRISOMY 17P	0.014997679000000002	1.4997679000000002
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.014904939	1.4904939000000001
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.014861094	1.4861094
2Q23.1 MICRODUPLICATION SYNDROME	0.0147059	1.4705899999999998
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.0147059	1.4705899999999998
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0147059	1.4705899999999998
CENTRAL PRECOCIOUS PUBERTY	0.0147059	1.4705899999999998
RUSSELL-SILVER SYNDROME, X-LINKED	0.0147059	1.4705899999999998
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0147059	1.4705899999999998
SILVER-RUSSELL SYNDROME; SRS	0.0147059	1.4705899999999998
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.0147059	1.4705899999999998
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.014629619000000002	1.4629619000000003
AICARDI SYNDROME; AIC	0.014485935000000002	1.4485935
OCULOCEREBRORENAL SYNDROME OF LOWE	0.014292158999999999	1.4292159
CHROMOSOME 10Q26 DELETION SYNDROME	0.014286484	1.4286484
SAY SYNDROME	0.0141428	1.41428
ALPORT SYNDROME	0.01407199	1.4071989999999999
MARBURG HEMORRHAGIC FEVER	0.01407199	1.4071989999999999
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.01407199	1.4071989999999999
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.01407199	1.4071989999999999
GRANULOMATOSIS WITH POLYANGIITIS	0.01407199	1.4071989999999999
GIANT CELL ARTERITIS	0.01407199	1.4071989999999999
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01407199	1.4071989999999999
RELAPSING FEVER	0.01407199	1.4071989999999999
RHABDOID TUMOR	0.01407199	1.4071989999999999
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.013873189000000001	1.3873189000000001
INTELLECTUAL DISABILITY, WOLFF TYPE	0.013348255	1.3348255
TRISOMY 20P	0.013348255	1.3348255
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.013348255	1.3348255
ISOLATED KLIPPEL-FEIL SYNDROME	0.013064425000000001	1.3064425000000002
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.012955295	1.2955295
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.012758015000000001	1.2758015
LATERAL MENINGOCELE SYNDROME	0.012758015000000001	1.2758015
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.012758015000000001	1.2758015
GM1 GANGLIOSIDOSIS	0.012758015000000001	1.2758015
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.012734480000000001	1.2734480000000001
TRIOPIA	0.012734480000000001	1.2734480000000001
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.012734480000000001	1.2734480000000001
CEREBROFACIOTHORACIC DYSPLASIA	0.012723799000000001	1.2723799
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.01262855	1.262855
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.012594334	1.2594334
MONOSOMY 18P	0.012485204000000001	1.2485204
CORNELIA DE LANGE SYNDROME 1	0.012485204000000001	1.2485204
CAMOS SYNDROME	0.012392464	1.2392464
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.012392464	1.2392464
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.012379274000000001	1.2379274
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.01235323	1.235323
DISTAL TRISOMY 17Q	0.012303405000000002	1.2303405
POLYVALVULAR HEART DISEASE SYNDROME	0.012287924	1.2287924000000001
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.012198865	1.2198864999999999
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.012198865	1.2198864999999999
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.012106125	1.2106125
MARFANOID HYPERMOBILITY SYNDROME	0.012106125	1.2106125
45,X/46,XY MIXED GONADAL DYSGENESIS	0.012092935	1.2092935
OCULOSKELETODENTAL SYNDROME; OCSKD	0.012092935	1.2092935
RECOMBINANT CHROMOSOME 8 SYNDROME	0.011965979	1.1965979
NAIL-PATELLA SYNDROME	0.011965945	1.1965945
CORNELIA DE LANGE SYNDROME	0.01196027	1.196027
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.011856849000000001	1.1856849
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.011856849000000001	1.1856849
MUCOPOLYSACCHARIDOSIS TYPE IX	0.011762990000000001	1.1762990000000002
PYCNODYSOSTOSIS	0.011762990000000001	1.1762990000000002
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.011762990000000001	1.1762990000000002
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.011636034	1.1636034
TYROSINE TRANSAMINASE DEFICIENCY	0.011636034	1.1636034
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.011636034	1.1636034
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.011622844	1.1622844
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.011546975000000001	1.1546975000000002
KAPUR-TORIELLO SYNDROME	0.011546975000000001	1.1546975000000002
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.011546975000000001	1.1546975000000002
DUANE RETRACTION SYNDROME	0.011308380000000002	1.1308380000000002
CRANIOFRONTONASAL DYSPLASIA	0.011204959	1.1204959
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.011204959	1.1204959
CRANIOFRONTONASAL SYNDROME; CFNS	0.01120384	1.120384
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.011113228999999999	1.1113228999999998
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0111111	1.11111
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.0111111	1.11111
COMEDONES, FAMILIAL DYSKERATOTIC	0.0111111	1.11111
ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL	0.0111111	1.11111
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0111111	1.11111
CAROTENEMIA, FAMILIAL	0.0111111	1.11111
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0111111	1.11111
SYRINGOMAS, MULTIPLE	0.0111111	1.11111
LENTIGINES	0.0111111	1.11111
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0111111	1.11111
SCALP-EAR-NIPPLE SYNDROME	0.0111111	1.11111
LICHEN PLANUS, FAMILIAL	0.0111111	1.11111
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0111111	1.11111
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.0111111	1.11111
KYRLE DISEASE	0.0111111	1.11111
HYPOPLASMINOGENEMIA	0.0111111	1.11111
CALLOSITIES, HEREDITARY PAINFUL	0.0111111	1.11111
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0111111	1.11111
KERATOSIS, FAMILIAL ACTINIC	0.0111111	1.11111
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0111111	1.11111
INSECT STINGS, HYPERSENSITIVITY TO	0.0111111	1.11111
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.0111111	1.11111
SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE	0.0111111	1.11111
FASCIAL DYSTROPHY, CONGENITAL	0.0111111	1.11111
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.0111111	1.11111
PAPILLOMATOSIS, FLORID, OF NIPPLE	0.0111111	1.11111
PRENATAL BOWING	0.0111111	1.11111
PATELLA APLASIA-HYPOPLASIA	0.0111111	1.11111
NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES	0.0111111	1.11111
DERMAL RIDGES, PATTERNLESS	0.0111111	1.11111
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0111111	1.11111
PERIODONTITIS, AGGRESSIVE, 1	0.0111111	1.11111
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.0111111	1.11111
EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL	0.0111111	1.11111
TRICHILEMMAL CYST 1	0.0111111	1.11111
DERMATOSIS PAPULOSA NIGRA	0.0111111	1.11111
ACROMIAL DIMPLES	0.0111111	1.11111
131600 EPIDERMOID CYSTS	0.0111111	1.11111
PIGMENTED PURPURIC ERUPTION	0.0111111	1.11111
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0111111	1.11111
PILONIDAL SINUS	0.0111111	1.11111
PSEUDOATROPHODERMA COLLI	0.0111111	1.11111
AMYLOIDOSIS, CUTANEOUS BULLOUS	0.0111111	1.11111
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0111111	1.11111
METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA	0.0111111	1.11111
TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1; HFTC1	0.0111111	1.11111
PARANA HARD-SKIN SYNDROME	0.0111111	1.11111
SHORT SYNDROME	0.0111111	1.11111
FUTCHER LINE	0.0111111	1.11111
SIMOSA CRANIOFACIAL SYNDROME	0.0111111	1.11111
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0111111	1.11111
URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	0.0111111	1.11111
GLOMUVENOUS MALFORMATIONS	0.0111111	1.11111
TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL	0.0111111	1.11111
CURRY-JONES SYNDROME	0.0111111	1.11111
NIJMEGEN BREAKAGE SYNDROME	0.011107520000000001	1.1107520000000002
BOHRING-OPITZ SYNDROME	0.011107520000000001	1.1107520000000002
NOONAN SYNDROME 7; NS7	0.011100419	1.1100419000000001
PELVISCAPULAR DYSPLASIA	0.01109791	1.109791
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.01109791	1.109791
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.011004099	1.1004099
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.01100159	1.100159
RUVALCABA SYNDROME	0.010972039	1.0972039
GAUCHER DISEASE	0.01086499	1.0864989999999999
KBG SYNDROME	0.010861824	1.0861824
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.010843964	1.0843964
POLAND SYNDROME	0.010680025000000001	1.0680025000000002
NOONAN SYNDROME	0.010575485	1.0575485
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.010575485	1.0575485
RITSCHER-SCHINZEL SYNDROME 1	0.010551950000000001	1.055195
WIEACKER-WOLFF SYNDROME	0.010479165	1.0479165000000001
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.010448529	1.0448529
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.010447105	1.0447105
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.010336890000000001	1.033689
RING CHROMOSOME 6 SYNDROME	0.010336890000000001	1.033689
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.010336890000000001	1.033689
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.01024516	1.024516
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.010224134	1.0224134
NAIL-PATELLA SYNDROME	0.0102131	1.02131
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0102131	1.02131
JUNG SYNDROME	0.010209934	1.0209934
ACROOSTEOLYSIS DOMINANT TYPE	0.010164085	1.0164085
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.010009074	1.0009074
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.009977014	0.9977014
KLIPPEL-TRÉNAUNAY SYNDROME	0.009977014	0.9977014
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.009923595	0.9923595000000001
MALAN OVERGROWTH SYNDROME	0.009923595	0.9923595000000001
LATERAL MENINGOCELE SYNDROME	0.009923595	0.9923595000000001
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.009923595	0.9923595000000001
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.009725244000000001	0.9725244000000001
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0096992	0.96992
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.009685000000000001	0.9685000000000001
BARATELA-SCOTT SYNDROME	0.009685000000000001	0.9685000000000001
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00958046	0.9580460000000001
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00958046	0.9580460000000001
FLOATING-HARBOR SYNDROME	0.00958046	0.9580460000000001
SPONDYLOOCULAR SYNDROME; SOS	0.00958046	0.9580460000000001
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00958046	0.9580460000000001
RENPENNING SYNDROME 1; RENS1	0.009493769	0.9493769000000001
MICROTRIPLICATION 11Q24.1	0.009493769	0.9493769000000001
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.009484139999999999	0.9484139999999999
RING CHROMOSOME 8 SYNDROME	0.009453504	0.9453503999999999
HEART-HAND SYNDROME TYPE 2	0.009453504	0.9453503999999999
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.009453504	0.9453503999999999
SPONDYLO-OCULAR SYNDROME	0.009453504	0.9453503999999999
EDINBURGH MALFORMATION SYNDROME	0.009453504	0.9453503999999999
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.009453504	0.9453503999999999
SCARF SYNDROME	0.009453504	0.9453503999999999
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.009453504	0.9453503999999999
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.00945208	0.9452079999999999
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.009357184	0.9357184
FABRY DISEASE	0.00934754	0.934754
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.009220583999999999	0.9220583999999998
DEAFNESS AND MYOPIA; DFNMYP	0.009220583999999999	0.9220583999999998
DUPLICATION OF THE PITUITARY GLAND	0.00920031	0.9200309999999999
EMERY-NELSON SYNDROME	0.00892857	0.892857
SCARF SYNDROME	0.00892857	0.892857
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.892857
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.892857
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00892857	0.892857
HAMAMY SYNDROME; HMMS	0.00892857	0.892857
THORACOMELIC DYSPLASIA	0.00892857	0.892857
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00892857	0.892857
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00892857	0.892857
X SMALL RINGS	0.00892857	0.892857
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00892857	0.892857
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00892857	0.892857
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00892857	0.892857
WILDERVANCK SYNDROME	0.00892857	0.892857
PTERYGIUM COLLI, ISOLATED	0.00892857	0.892857
EMANUEL SYNDROME	0.008841879	0.8841879
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00883225	0.8832249999999999
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.00872771	0.872771
ACUTE PROMYELOCYTIC LEUKEMIA	0.00869565	0.8695649999999999
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00869565	0.8695649999999999
LESCH-NYHAN SYNDROME	0.00869565	0.8695649999999999
CONGENITAL MEGACALYCOSIS	0.00869565	0.8695649999999999
SICKLE CELL ANEMIA	0.00869565	0.8695649999999999
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00869565	0.8695649999999999
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.00869565	0.8695649999999999
NEPHROBLASTOMA	0.00869565	0.8695649999999999
DENT DISEASE	0.00869565	0.8695649999999999
ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE	0.00869565	0.8695649999999999
ALAGILLE SYNDROME 2	0.00869565	0.8695649999999999
DRUG-INDUCED LUPUS ERYTHEMATOSUS	0.00869565	0.8695649999999999
CYSTINURIA	0.00869565	0.8695649999999999
CHRONIC GRAFT VERSUS HOST DISEASE	0.00869565	0.8695649999999999
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00869565	0.8695649999999999
ACQUIRED VON WILLEBRAND SYNDROME	0.00869565	0.8695649999999999
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00869565	0.8695649999999999
AL AMYLOIDOSIS	0.00869565	0.8695649999999999
MALAKOPLAKIA	0.00869565	0.8695649999999999
LEGIONELLOSIS	0.00869565	0.8695649999999999
NEPHROTIC SYNDROME, TYPE 12	0.00869565	0.8695649999999999
COMPLEMENT FACTOR H DEFICIENCY	0.00869565	0.8695649999999999
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.00869565	0.8695649999999999
NEPHROTIC SYNDROME, TYPE 16; NPHS16	0.00869565	0.8695649999999999
CONGENITAL FACTOR V DEFICIENCY	0.00869565	0.8695649999999999
CONGENITAL FACTOR X DEFICIENCY	0.00869565	0.8695649999999999
OROTIC ACIDURIA	0.00869565	0.8695649999999999
HEMOPHILIA B	0.00869565	0.8695649999999999
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00869565	0.8695649999999999
CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY	0.00869565	0.8695649999999999
LCAT DEFICIENCY	0.00869565	0.8695649999999999
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.00869565	0.8695649999999999
HYPEROXALURIA, PRIMARY, TYPE II; HP2	0.00869565	0.8695649999999999
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00869565	0.8695649999999999
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00869565	0.8695649999999999
ATYPICAL HEMOLYTIC UREMIC SYNDROME	0.00869565	0.8695649999999999
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.00869565	0.8695649999999999
CASTLEMAN DISEASE	0.00869565	0.8695649999999999
ACQUIRED HEMOPHILIA	0.00869565	0.8695649999999999
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00869565	0.8695649999999999
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00869565	0.8695649999999999
109820 BLADDER DIVERTICULUM	0.00869565	0.8695649999999999
JUNCTIONAL EPIDERMOLYSIS BULLOSA-PYLORIC ATRESIA SYNDROME	0.00869565	0.8695649999999999
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00869565	0.8695649999999999
NON-FUNCTIONING PARAGANGLIOMA	0.00869565	0.8695649999999999
MEDULLARY SPONGE KIDNEY	0.00869565	0.8695649999999999
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00869565	0.8695649999999999
PRIMARY HYPEROXALURIA	0.00869565	0.8695649999999999
GOODPASTURE SYNDROME	0.00869565	0.8695649999999999
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00869565	0.8695649999999999
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00869565	0.8695649999999999
FECHTNER SYNDROME	0.00869565	0.8695649999999999
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00869565	0.8695649999999999
GAUCHER DISEASE TYPE 1	0.00869565	0.8695649999999999
GAUCHER DISEASE TYPE 3	0.00869565	0.8695649999999999
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.00869565	0.8695649999999999
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00869565	0.8695649999999999
CRYOGLOBULINEMIC VASCULITIS	0.00869565	0.8695649999999999
CONGENITAL ALPHA2-ANTIPLASMIN DEFICIENCY	0.00869565	0.8695649999999999
SMALL CELL CARCINOMA OF THE BLADDER	0.00869565	0.8695649999999999
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00869565	0.8695649999999999
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00869565	0.8695649999999999
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.00869565	0.8695649999999999
MICROSCOPIC POLYANGIITIS	0.00869565	0.8695649999999999
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.00869565	0.8695649999999999
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00869565	0.8695649999999999
HEMOGLOBIN--BETA LOCUS	0.00869565	0.8695649999999999
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00869565	0.8695649999999999
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00869565	0.8695649999999999
HANAC SYNDROME	0.00869565	0.8695649999999999
SCLERODERMA	0.00869565	0.8695649999999999
PRIMARY HYPEROXALURIA TYPE 3	0.00869565	0.8695649999999999
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.00869565	0.8695649999999999
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00869565	0.8695649999999999
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.008677885	0.8677885
PMM2-CDG	0.008600753999999999	0.8600753999999998
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.008571955000000001	0.8571955000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.008571955000000001	0.8571955000000001
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.008550929	0.8550929
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00854842	0.8548419999999999
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.008446389	0.8446389000000001
ALG11-CDG	0.008444999	0.8444999
PETERS-PLUS SYNDROME; PTRPLS	0.008316945000000001	0.8316945000000001
DIAMOND-BLACKFAN ANEMIA 1	0.008207794000000001	0.8207794
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00807582	0.8075819999999999
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.008025995	0.8025994999999999
KOOLEN-DE VRIES SYNDROME; KDVS	0.007976319	0.7976319000000001
SMITH-MAGENIS SYNDROME	0.007976319	0.7976319000000001
KOOLEN-DE VRIES SYNDROME	0.007976319	0.7976319000000001
DISTAL MONOSOMY 15Q	0.00797381	0.797381
2P15P16.1 MICRODELETION SYNDROME	0.007920065	0.7920065000000001
CAMURATI-ENGELMANN DISEASE	0.007888815	0.7888815
CHIARI MALFORMATION TYPE I	0.007888815	0.7888815
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.007846854	0.7846854000000001
BOR SYNDROME	0.0077919899999999995	0.779199
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.007779685000000001	0.7779685000000001
AICARDI-GOUTIÈRES SYNDROME	0.007779685000000001	0.7779685000000001
MARSHALL-SMITH SYNDROME; MRSHSS	0.007688568999999999	0.7688569
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00768286	0.768286
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.00757693	0.757693
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.007560514999999999	0.7560515
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.007555904	0.7555904
NARP SYNDROME	0.007545680000000001	0.7545680000000001
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.007545680000000001	0.7545680000000001
22Q11.2 DELETION SYNDROME	0.0074513850000000005	0.7451385
COFFIN-SIRIS SYNDROME 6; CSS6	0.007451364	0.7451364
19Q13.11 MICRODELETION SYNDROME	0.007449973999999999	0.7449973999999999
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.007449973999999999	0.7449973999999999
EAR-PATELLA-SHORT STATURE SYNDROME	0.007449973999999999	0.7449973999999999
CRANIOPHARYNGIOMA	0.007418724	0.7418724
WYBURN-MASON SYNDROME	0.007418724	0.7418724
KLEEFSTRA SYNDROME	0.007345455	0.7345455
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007345434	0.7345434
MOSAIC TRISOMY 9	0.0073244289999999995	0.7324428999999999
SMITH-LEMLI-OPITZ SYNDROME	0.0073244289999999995	0.7324428999999999
MARFAN SYNDROME	0.0072695649999999995	0.7269565
LOEYS-DIETZ SYNDROME 3; LDS3	0.0072695649999999995	0.7269565
49,XXXXY SYNDROME	0.007219889	0.7219889
AYMÉ-GRIPP SYNDROME	0.007219889	0.7219889
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.007218499	0.7218498999999999
CHIME SYNDROME	0.007090424	0.7090424
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.007090424	0.7090424
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.007030969999999999	0.703097
LOWRY-MACLEAN SYNDROME	0.007030969999999999	0.703097
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.007023255000000001	0.7023255
PARIETAL FORAMINA	0.00699972	0.699972
C SYNDROME	0.006981294	0.6981294
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.006981294	0.6981294
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.006981294	0.6981294
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.006981294	0.6981294
DISTAL MONOSOMY 10Q	0.006981294	0.6981294
SHPRINTZEN-GOLDBERG SYNDROME	0.006927548999999999	0.6927549
MARDEN-WALKER SYNDROME	0.006927548999999999	0.6927549
PITUITARY CARCINOMA	0.00689379	0.6893790000000001
LASSA FEVER	0.00689379	0.6893790000000001
SCLEROSTEOSIS 1; SOST1	0.00689379	0.6893790000000001
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00689379	0.6893790000000001
PLAGUE	0.00689379	0.6893790000000001
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00689379	0.6893790000000001
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.006875363999999999	0.6875363999999999
CHROMOSOME 17Q12 DELETION SYNDROME	0.006823009	0.6823009
SCHAAF-YANG SYNDROME; SHFYNG	0.006823009	0.6823009
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.006823009	0.6823009
OROFACIODIGITAL SYNDROME XVII	0.0068205	0.68205
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.006799494999999999	0.6799494999999999
BAMFORTH-LAZARUS SYNDROME	0.006799474	0.6799474
RIDDLE SYNDROME	0.0067846600000000005	0.678466
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.006693543999999999	0.6693543999999999
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.006657704	0.6657704
SECKEL SYNDROME 5; SCKL5	0.006584413999999999	0.6584414
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.006584413999999999	0.6584414
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.006584413999999999	0.6584414
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.006584413999999999	0.6584414
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.006584413999999999	0.6584414
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.006584413999999999	0.6584414
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.006584413999999999	0.6584414
BANGSTAD SYNDROME	0.006584413999999999	0.6584414
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.006584413999999999	0.6584414
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.006584413999999999	0.6584414
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.006584413999999999	0.6584414
VELOCARDIOFACIAL SYNDROME	0.006584413999999999	0.6584414
48,XXYY SYNDROME	0.006567999	0.6567999
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.006462069	0.6462069
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.006462069	0.6462069
6Q25 MICRODELETION SYNDROME	0.00645636	0.645636
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00645636	0.645636
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00645636	0.645636
DISTAL MONOSOMY 7Q36	0.00645636	0.645636
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0064026149999999995	0.6402614999999999
NEU-LAXOVA SYNDROME	0.0064026149999999995	0.6402614999999999
15Q OVERGROWTH SYNDROME	0.006371365	0.6371365
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.006371365	0.6371365
PRIMARY CILIARY DYSKINESIA	0.006371365	0.6371365
GANGLIOCYTOMA	0.006371365	0.6371365
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.006352939	0.6352939
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.006352939	0.6352939
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.006352938999999999	0.6352939
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.006352938999999999	0.6352939
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.006329404	0.6329404000000001
RENPENNING SYNDROME	0.006329403999999999	0.6329404
OROFACIODIGITAL SYNDROME TYPE 14	0.006329403999999999	0.6329404
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.006329403999999999	0.6329404
PETERS PLUS SYNDROME	0.006329403999999999	0.6329404
ODONTOCHONDRODYSPLASIA	0.006298075	0.6298075000000001
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.006298075	0.6298075000000001
OROFACIODIGITAL SYNDROME X	0.0062745399999999995	0.627454
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0062745399999999995	0.627454
MESOMELIC LIMB SHORTENING AND BOWING	0.0062745399999999995	0.627454
TREACHER-COLLINS SYNDROME	0.0062745399999999995	0.627454
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0062745399999999995	0.627454
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.0062745399999999995	0.627454
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.006224864	0.6224864
MEND SYNDROME	0.006224864	0.6224864
FEINGOLD SYNDROME 1; FGLDS1	0.006223474	0.6223474
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.006171118999999999	0.6171118999999999
WEAVER SYNDROME	0.006171118999999999	0.6171118999999999
MARSHALL-SMITH SYNDROME	0.006171118999999999	0.6171118999999999
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.006171118999999999	0.6171118999999999
COHEN-GIBSON SYNDROME; COGIS	0.006171118999999999	0.6171118999999999
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.006171118999999999	0.6171118999999999
SHASHI-PENA SYNDROME; SHAPNS	0.006171118999999999	0.6171118999999999
WEAVER SYNDROME	0.006171118999999999	0.6171118999999999
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.006171118999999999	0.6171118999999999
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00616861	0.616861
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00613277	0.613277
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00613277	0.613277
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0061189339999999995	0.6118933999999999
AYME-GRIPP SYNDROME; AYGRP	0.0061189339999999995	0.6118933999999999
SIFRIM-HITZ-WEISS SYNDROME	0.0061189339999999995	0.6118933999999999
CHARGE SYNDROME	0.0060691090000000005	0.6069109
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0060691090000000005	0.6069109
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.0060691090000000005	0.6069109
COFFIN-SIRIS SYNDROME 1; CSS1	0.0060691090000000005	0.6069109
COFFIN-SIRIS SYNDROME	0.0060691090000000005	0.6069109
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00605948	0.605948
COG5-CDG	0.00605948	0.605948
SECKEL SYNDROME 4	0.00605948	0.605948
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00605948	0.605948
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.00605948	0.605948
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.006043065	0.6043065000000001
48,XXXY SYNDROME	0.006043064999999999	0.6043065
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.006043064999999999	0.6043065
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.006028230000000001	0.6028230000000001
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.006028230000000001	0.6028230000000001
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.005937135	0.5937135
16Q24.3 MICRODELETION SYNDROME	0.005937135	0.5937135
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.005932524	0.5932524
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.005932524	0.5932524
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.005932524	0.5932524
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.005932524	0.5932524
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.005932524	0.5932524
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.005932524	0.5932524
OROFACIODIGITAL SYNDROME TYPE 4	0.005932524	0.5932524
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.005932524	0.5932524
DESMOSTEROLOSIS	0.005932524	0.5932524
MONOSOMY 22	0.005932524	0.5932524
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.005901274000000001	0.5901274000000001
L1 SYNDROME	0.005901274000000001	0.5901274000000001
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.005901274000000001	0.5901274000000001
HYDROXYKYNURENINURIA	0.005901274000000001	0.5901274000000001
X-LINKED ADRENOLEUKODYSTROPHY	0.005901274000000001	0.5901274000000001
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.005901274000000001	0.5901274000000001
BRUNNER SYNDROME; BRNRS	0.005901274000000001	0.5901274000000001
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.005901274000000001	0.5901274000000001
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.005901274000000001	0.5901274000000001
C SYNDROME	0.005828005	0.5828004999999999
1Q44 MICRODELETION SYNDROME	0.005828005	0.5828004999999999
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005828005	0.5828004999999999
19P13.3 MICRODUPLICATION SYNDROME	0.00580447	0.580447
ISOTRETINOIN-LIKE SYNDROME	0.00580447	0.580447
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.005701049	0.5701049
OCULOMAXILLOFACIAL DYSOSTOSIS	0.005699930000000001	0.5699930000000001
260150 PALANT CLEFT PALATE SYNDROME	0.005699930000000001	0.5699930000000001
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.005699930000000001	0.5699930000000001
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005699930000000001	0.5699930000000001
KLEEFSTRA SYNDROME	0.005698539999999999	0.569854
YUNIS-VARON SYNDROME	0.005698539999999999	0.569854
8P INVERTED DUPLICATION/DELETION SYNDROME	0.005646185	0.5646185
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.005646185	0.5646185
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.005646185	0.5646185
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.005646185	0.5646185
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.005646185	0.5646185
NEMALINE MYOPATHY 3; NEM3	0.005646185	0.5646185
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.005646185	0.5646185
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.005646185	0.5646185
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.005646185	0.5646185
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.005646185	0.5646185
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0055965089999999995	0.5596509
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.005594	0.5594
YUNIS-VARON SYNDROME	0.005594	0.5594
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.005572974	0.5572973999999999
DISTAL MONOSOMY 9P	0.005572974	0.5572973999999999
OCULODENTODIGITAL DYSPLASIA	0.005572974	0.5572973999999999
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.005544174999999999	0.5544174999999999
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.005467044	0.5467044
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.005467044	0.5467044
22Q11.2 MICRODUPLICATION SYNDROME	0.005417219	0.5417219
MENTAL RETARDATION, X-LINKED 102	0.005417219	0.5417219
TRICHOTHIODYSTROPHY	0.0054075899999999994	0.540759
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0054075899999999994	0.540759
DISTAL 17P13.1 MICRODELETION SYNDROME	0.0054075899999999994	0.540759
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0054075899999999994	0.540759
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.0054075899999999994	0.540759
GAUCHER DISEASE, PERINATAL LETHAL	0.0054075899999999994	0.540759
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0054075899999999994	0.540759
LAMBOTTE SYNDROME	0.0054075899999999994	0.540759
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.0054075899999999994	0.540759
20Q11.2 MICRODUPLICATION SYNDROME	0.0054075899999999994	0.540759
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0054075899999999994	0.540759
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0054075899999999994	0.540759
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0054075899999999994	0.540759
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0054075899999999994	0.540759
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0054075899999999994	0.540759
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.5376340000000001
LUJO HEMORRHAGIC FEVER	0.00537634	0.5376340000000001
PREECLAMPSIA	0.00537634	0.5376340000000001
CENTRAL DIABETES INSIPIDUS	0.00537634	0.5376340000000001
PROLACTINOMA	0.00537634	0.5376340000000001
CENTRAL NEUROCYTOMA	0.00537634	0.5376340000000001
ENCEPHALITIS LETHARGICA	0.00537634	0.5376340000000001
CROUZON DISEASE	0.00537634	0.5376340000000001
PARATHYROID CARCINOMA	0.00537634	0.5376340000000001
SECONDARY POLYCYTHEMIA	0.00537634	0.5376340000000001
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.5376340000000001
HUGHES-STOVIN SYNDROME	0.00537634	0.5376340000000001
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.5376340000000001
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.5376340000000001
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00537634	0.5376340000000001
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00537634	0.5376340000000001
POSTORGASMIC ILLNESS SYNDROME	0.00537634	0.5376340000000001
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00537634	0.5376340000000001
BENIGN OCCIPITAL EPILEPSY	0.00537634	0.5376340000000001
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.5376340000000001
CARNEY TRIAD	0.00537634	0.5376340000000001
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.5376340000000001
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.00537634	0.5376340000000001
SYSTEMIC MASTOCYTOSIS	0.00537634	0.5376340000000001
NOCARDIOSIS	0.00537634	0.5376340000000001
RAT-BITE FEVER	0.00537634	0.5376340000000001
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00537634	0.5376340000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.5376340000000001
EPISODIC ATAXIA TYPE 1	0.00537634	0.5376340000000001
ADIPOSIS DOLOROSA	0.00537634	0.5376340000000001
SOLAR URTICARIA	0.00537634	0.5376340000000001
HELLP SYNDROME	0.00537634	0.5376340000000001
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.00537634	0.5376340000000001
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00537634	0.5376340000000001
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.5376340000000001
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00537634	0.5376340000000001
MARSILI SYNDROME; MARSIS	0.00537634	0.5376340000000001
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00537634	0.5376340000000001
GLIOBLASTOMA	0.00537634	0.5376340000000001
POSTENCEPHALITIC PARKINSONISM	0.00537634	0.5376340000000001
PONTIAC FEVER	0.00537634	0.5376340000000001
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.5376340000000001
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.5376340000000001
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.5376340000000001
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.5376340000000001
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.5376340000000001
COLD AGGLUTININ DISEASE	0.00537634	0.5376340000000001
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00537634	0.5376340000000001
HODGKIN LYMPHOMA	0.00537634	0.5376340000000001
INTERNAL CAROTID AGENESIS	0.00537634	0.5376340000000001
PRIMARY PARATHYROID HYPERPLASIA	0.00537634	0.5376340000000001
POLYCYTHEMIA VERA	0.00537634	0.5376340000000001
DENGUE FEVER	0.00537634	0.5376340000000001
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00537634	0.5376340000000001
MEDULLOBLASTOMA	0.00537634	0.5376340000000001
MAJEED SYNDROME	0.00537634	0.5376340000000001
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.5376340000000001
YELLOW FEVER	0.00537634	0.5376340000000001
PARKES WEBER SYNDROME	0.00537634	0.5376340000000001
IDIOPATHIC PANUVEITIS	0.00537634	0.5376340000000001
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.5376340000000001
MENINGIOMA	0.00537634	0.5376340000000001
ACQUIRED METHEMOGLOBINEMIA	0.00537634	0.5376340000000001
NIPAH VIRUS DISEASE	0.00537634	0.5376340000000001
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.5376340000000001
CUSHING DISEASE	0.00537634	0.5376340000000001
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.5376340000000001
LHERMITTE-DUCLOS DISEASE	0.00537634	0.5376340000000001
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.5376340000000001
EPISODIC ATAXIA, TYPE 3	0.00537634	0.5376340000000001
SEVERE HEMOPHILIA A	0.00537634	0.5376340000000001
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00537634	0.5376340000000001
LYME DISEASE	0.00537634	0.5376340000000001
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.5376340000000001
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.5376340000000001
LEPTOSPIROSIS	0.00537634	0.5376340000000001
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.5376340000000001
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.5376340000000001
PINEOCYTOMA	0.00537634	0.5376340000000001
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.5376340000000001
FAMILIAL THROMBOCYTOSIS	0.00537634	0.5376340000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.5376340000000001
PITUICYTOMA	0.00537634	0.5376340000000001
CRANIOSYNOSTOSIS 2	0.00537634	0.5376340000000001
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.5376340000000001
CRYPTOCOCCOSIS	0.00537634	0.5376340000000001
MANGANESE POISONING	0.00537634	0.5376340000000001
RIFT VALLEY FEVER	0.00537634	0.5376340000000001
THYMIC TUMOR	0.00537634	0.5376340000000001
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.5376340000000001
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00537634	0.5376340000000001
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.5376340000000001
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00537634	0.5376340000000001
SUSAC SYNDROME	0.00537634	0.5376340000000001
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00537634	0.5376340000000001
PANHYPOPHYSITIS	0.00537634	0.5376340000000001
ADENOHYPOPHYSITIS	0.00537634	0.5376340000000001
OPTIC PATHWAY GLIOMA	0.00537634	0.5376340000000001
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.5376340000000001
BABESIOSIS	0.00537634	0.5376340000000001
SYDENHAM CHOREA	0.00537634	0.5376340000000001
PINEOBLASTOMA	0.00537634	0.5376340000000001
ROSAÏ-DORFMAN DISEASE	0.00537634	0.5376340000000001
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.00537634	0.5376340000000001
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00537634	0.5376340000000001
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.5376340000000001
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00537634	0.5376340000000001
PERINEURAL CYST	0.00537634	0.5376340000000001
LAFORA DISEASE	0.00537634	0.5376340000000001
FAMILIAL COLD URTICARIA	0.00537634	0.5376340000000001
MALARIA	0.00537634	0.5376340000000001
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.5376340000000001
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00537634	0.5376340000000001
SNEDDON SYNDROME	0.00537634	0.5376340000000001
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.5376340000000001
HEMANGIOBLASTOMA	0.00537634	0.5376340000000001
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.005357914	0.5357914
PENTASOMY X	0.005357913999999999	0.5357913999999999
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.005357913999999999	0.5357913999999999
2Q37 MICRODELETION SYNDROME	0.005357913999999999	0.5357913999999999
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.005357913999999999	0.5357913999999999
8P11.2 DELETION SYNDROME	0.005357913999999999	0.5357913999999999
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.005357913999999999	0.5357913999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.005357913999999999	0.5357913999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.005357913999999999	0.5357913999999999
GOLDENHAR SYNDROME	0.005312679000000001	0.5312679
LOEYS-DIETZ SYNDROME 5	0.00530305	0.530305
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00530305	0.530305
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.005176114999999999	0.5176114999999999
PITT-HOPKINS SYNDROME	0.005176114999999999	0.5176114999999999
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.005176114999999999	0.5176114999999999
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.005176114999999999	0.5176114999999999
HOLOPROSENCEPHALY	0.005176114999999999	0.5176114999999999
HENNEKAM SYNDROME	0.005176094	0.5176094
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.005176094	0.5176094
MICROPHTHALMIA, SYNDROMIC 12	0.005176094	0.5176094
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005176094	0.5176094
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.005176094	0.5176094
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.005176094	0.5176094
VACTERL WITH HYDROCEPHALUS	0.005176094	0.5176094
PERLMAN SYNDROME	0.005176094	0.5176094
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.005176094	0.5176094
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.005176094	0.5176094
JAWAD SYNDROME	0.005176094	0.5176094
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005176094	0.5176094
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.005176094	0.5176094
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.005176094	0.5176094
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.005176094	0.5176094
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.005176094	0.5176094
OROFACIODIGITAL SYNDROME I; OFD1	0.005074084	0.5074084000000001
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.005074084	0.5074084000000001
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.005074084	0.5074084000000001
DISTAL MONOSOMY 10P	0.005074084	0.5074084000000001
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.005071575	0.5071575
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.005071575	0.5071575
AREDYLD SYNDROME	0.005071575	0.5071575
PRADER-WILLI SYNDROME; PWS	0.005071575	0.5071575
HUNTER-MACDONALD SYNDROME	0.005071575	0.5071575
TRISOMY 8Q	0.00504804	0.504804
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00504804	0.504804
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.004944619	0.4944619
HAREL-YOON SYNDROME; HAYOS	0.004944619	0.4944619
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004944619	0.4944619
CHROMOSOME 9P DELETION SYNDROME	0.004944619	0.4944619
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.004944619	0.4944619
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.004944619	0.4944619
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.004944619	0.4944619
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004944619	0.4944619
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.004944619	0.4944619
PALLISTER-KILLIAN SYNDROME	0.0049421099999999996	0.49421099999999996
BETA-THALASSEMIA MAJOR	0.0049421099999999996	0.49421099999999996
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0049421099999999996	0.49421099999999996
BRESEK SYNDROME	0.004892285	0.48922849999999996
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.004832980000000001	0.48329800000000006
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.00483298	0.48329799999999995
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00483298	0.48329799999999995
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00483298	0.48329799999999995
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00483298	0.48329799999999995
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00483298	0.48329799999999995
DISTAL MONOSOMY 17Q	0.00483298	0.48329799999999995
8P23.1 MICRODELETION SYNDROME	0.00483298	0.48329799999999995
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00483298	0.48329799999999995
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00483298	0.48329799999999995
TRISOMY 18P	0.00483298	0.48329799999999995
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.00483298	0.48329799999999995
ZELLWEGER SYNDROME	0.00483298	0.48329799999999995
SAY-BARBER-MILLER SYNDROME	0.00483298	0.48329799999999995
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00483298	0.48329799999999995
GORDON SYNDROME	0.004787745	0.47877450000000005
CAMPOMELIC DYSPLASIA	0.0047877449999999995	0.47877449999999994
MOSAIC TRISOMY 8	0.0047877449999999995	0.47877449999999994
MEIER-GORLIN SYNDROME 7	0.0047877449999999995	0.47877449999999994
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0047877449999999995	0.47877449999999994
CLEIDOCRANIAL DYSPLASIA	0.0047877449999999995	0.47877449999999994
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004706024	0.4706024
LIG4 SYNDROME	0.004706024	0.4706024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.004706024	0.4706024
HOLOPROSENCEPHALY 5; HPE5	0.004706024	0.4706024
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004706024	0.4706024
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004706024	0.4706024
EMANUEL SYNDROME	0.004706024	0.4706024
FRONTONASAL DYSPLASIA 2; FND2	0.004706024	0.4706024
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.004706024	0.4706024
10Q22.3Q23.3 MICRODELETION SYNDROME	0.004706024	0.4706024
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.004706024	0.4706024
CK SYNDROME	0.004706024	0.4706024
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.004706024	0.4706024
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.004706024	0.4706024
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004706024	0.4706024
OTOPALATODIGITAL SYNDROME TYPE 2	0.004660789	0.4660789
TARP SYNDROME	0.004660789	0.4660789
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.004660789	0.4660789
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.004660789	0.4660789
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.00465116	0.465116
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00465116	0.465116
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00465116	0.465116
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00465116	0.465116
16P12.1P12.3 TRIPLICATION SYNDROME	0.00465116	0.465116
HYDROLETHALUS	0.00465116	0.465116
%613857 OROFACIAL CLEFT 13; OFC13	0.00465116	0.465116
HYPOTONIA-CYSTINURIA SYNDROME	0.00465116	0.465116
MYOPATHY, CENTRONUCLEAR, 5	0.00465116	0.465116
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00465116	0.465116
PEHO-LIKE SYNDROME; PEHOL	0.00465116	0.465116
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00465116	0.465116
WEBB-DATTANI SYNDROME; WEDAS	0.00465116	0.465116
PEHO SYNDROME; PEHO	0.00465116	0.465116
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00465116	0.465116
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.00465116	0.465116
HYPOGLOSSIA-HYPODACTYLIA	0.00465116	0.465116
OROFACIODIGITAL SYNDROME TYPE 10	0.00465116	0.465116
POSTERIOR URETHRAL VALVE	0.00465116	0.465116
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00465116	0.465116
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00465116	0.465116
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00465116	0.465116
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.00465116	0.465116
MARFAN SYNDROME; MFS	0.00465116	0.465116
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00465116	0.465116
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00465116	0.465116
LETHAL CONGENITAL CONTRACTURE SYNDROME 11; LCCS11	0.00465116	0.465116
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00465116	0.465116
RADIO-RENAL SYNDROME	0.00465116	0.465116
WT LIMB-BLOOD SYNDROME	0.00465116	0.465116
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00465116	0.465116
SCHINZEL-GIEDION SYNDROME	0.00465116	0.465116
GABA-TRANSAMINASE DEFICIENCY	0.00465116	0.465116
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00465116	0.465116
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00465116	0.465116
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00465116	0.465116
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.00465116	0.465116
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.00465116	0.465116
CRANIOSYNOSTOSIS 4; CRS4	0.00465116	0.465116
KAGAMI-OGATA SYNDROME	0.00465116	0.465116
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.00465116	0.465116
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0046014839999999994	0.46014839999999996
1Q41Q42 MICRODELETION SYNDROME	0.0046014839999999994	0.46014839999999996
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.0046014839999999994	0.46014839999999996
URBAN-ROGERS-MEYER SYNDROME	0.0046014839999999994	0.46014839999999996
MCDONOUGH SYNDROME	0.0046014839999999994	0.46014839999999996
15Q14 MICRODELETION SYNDROME	0.0045516590000000004	0.45516590000000007
2Q31.1 MICRODELETION SYNDROME	0.0045516590000000004	0.45516590000000007
SCHWARTZ-JAMPEL SYNDROME	0.0045516590000000004	0.45516590000000007
CAREY-FINEMAN-ZITER SYNDROME	0.0045516590000000004	0.45516590000000007
FOCAL DERMAL HYPOPLASIA; FDH	0.0045516590000000004	0.45516590000000007
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0045516590000000004	0.45516590000000007
DISTAL MONOSOMY 3P	0.00454915	0.454915
PELIZAEUS-MERZBACHER DISEASE	0.004445729	0.4445729
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.004445729	0.4445729
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.004445729	0.4445729
COFFIN-SIRIS SYNDROME 4; CSS4	0.004445729	0.4445729
15Q24 MICRODELETION SYNDROME	0.004445729	0.4445729
COFFIN-SIRIS SYNDROME 3; CSS3	0.004445729	0.4445729
MICROPHTHALMIA, LENZ TYPE	0.004445729	0.4445729
PIERPONT SYNDROME	0.004445729	0.4445729
DUBOWITZ SYNDROME	0.004445729	0.4445729
16P13.2 MICRODELETION SYNDROME	0.004445729	0.4445729
3Q29 MICRODUPLICATION SYNDROME	0.004422194	0.4422194
MEIER-GORLIN SYNDROME 1; MGORS1	0.004422194	0.4422194
ALLAN-HERNDON-DUDLEY SYNDROME	0.004419685	0.4419685
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004419685	0.4419685
LERI PLEONOSTEOSIS	0.004419685	0.4419685
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.004419685	0.4419685
CORNELIA DE LANGE SYNDROME 3	0.004317654000000001	0.4317654000000001
3MC SYNDROME 3	0.004317654000000001	0.4317654000000001
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00418109	0.418109
PITT-HOPKINS SYNDROME	0.00418109	0.418109
PYRUVATE DEHYDROGENASE DEFICIENCY	0.00418109	0.418109
VERVERI-BRADY SYNDROME; VERBRAS	0.00418109	0.418109
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00418109	0.418109
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00418109	0.418109
PSEUDOTRISOMY 13 SYNDROME	0.00418109	0.418109
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00418109	0.418109
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00418109	0.418109
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004135855	0.4135855
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.004135855	0.4135855
KNIEST DYSPLASIA	0.004135855	0.4135855
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.004135855	0.4135855
CLEIDOCRANIAL DYSPLASIA; CCD	0.004135855	0.4135855
DIASTROPHIC DWARFISM	0.004135855	0.4135855
TETRASOMY 12P	0.00407655	0.407655
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.00407655	0.407655
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00407655	0.407655
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00407655	0.407655
HYPERTELORISM, TEEBI TYPE; TBHS	0.00407655	0.407655
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00407655	0.407655
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.00407655	0.407655
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00407655	0.407655
BRANCHIO-OCULO-FACIAL SYNDROME	0.00407655	0.407655
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00407655	0.407655
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00407655	0.407655
KABUKI SYNDROME	0.004026725	0.4026725
KBG SYNDROME	0.004026725	0.4026725
MENTAL RETARDATION, X-LINKED 90	0.003949594	0.39495939999999996
XIA-GIBBS SYNDROME	0.003949594	0.39495939999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.003949594	0.39495939999999996
MENTAL RETARDATION, X-LINKED 107; MRX107	0.003949594	0.39495939999999996
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.003949594	0.39495939999999996
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.003949594	0.39495939999999996
CEREBROOCULONASAL SYNDROME	0.003949594	0.39495939999999996
LELIS SYNDROME	0.003949594	0.39495939999999996
RAMOS-ARROYO SYNDROME	0.003949594	0.39495939999999996
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.003949594	0.39495939999999996
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.003949594	0.39495939999999996
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.003949594	0.39495939999999996
IMMUNODEFICIENCY 49; IMD49	0.003949594	0.39495939999999996
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.003949594	0.39495939999999996
20Q13.33 MICRODELETION SYNDROME	0.003949594	0.39495939999999996
DOWN SYNDROME	0.003949594	0.39495939999999996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.003949594	0.39495939999999996
XP22.13P22.2 DUPLICATION SYNDROME	0.003920795	0.3920795
17Q23.1Q23.2 MICRODELETION SYNDROME	0.003920795	0.3920795
17P11.2 MICRODUPLICATION SYNDROME	0.003920795	0.3920795
POTOCKI-LUPSKI SYNDROME	0.003920795	0.3920795
MARDEN-WALKER SYNDROME	0.003899769	0.3899769
CHARGE SYNDROME	0.003899769	0.3899769
SECKEL SYNDROME 1; SCKL1	0.003899769	0.3899769
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.00389726	0.389726
DIABETIC EMBRYOPATHY	0.0038972599999999996	0.38972599999999996
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0038972599999999996	0.38972599999999996
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0038972599999999996	0.38972599999999996
LARSEN SYNDROME	0.0037952290000000002	0.3795229
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.0037952290000000002	0.3795229
ZTTK SYNDROME; ZTTKS	0.0037952290000000002	0.3795229
3C SYNDROME	0.0037952290000000002	0.3795229
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0037938390000000002	0.3793839
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.0037938390000000002	0.3793839
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0037938390000000002	0.3793839
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0037938390000000002	0.3793839
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0037938390000000002	0.3793839
RAPADILINO SYNDROME	0.0037927200000000003	0.37927200000000005
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0037927200000000003	0.37927200000000005
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0037927200000000003	0.37927200000000005
CHARGE-LIKE SYNDROME, X-LINKED	0.0037927200000000003	0.37927200000000005
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00379272	0.379272
SMITH-MAGENIS SYNDROME; SMS	0.003689299	0.36892990000000003
HURLER SYNDROME	0.003689299	0.36892990000000003
RAMON SYNDROME	0.003689299	0.36892990000000003
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.003689299	0.36892990000000003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.003689299	0.36892990000000003
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.003689299	0.36892990000000003
3MC SYNDROME 2	0.003665764	0.3665764
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.003665764	0.3665764
OROFACIODIGITAL SYNDROME TYPE 1	0.003665764	0.3665764
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.003665764	0.3665764
ACROCALLOSAL SYNDROME; ACLS	0.003665764	0.3665764
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.003665764	0.3665764
PFEIFFER SYNDROME TYPE 3	0.003665764	0.3665764
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.003665764	0.3665764
CEREBROCOSTOMANDIBULAR SYNDROME	0.0035566340000000004	0.3556634
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0035566340000000004	0.3556634
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0035566340000000004	0.3556634
OCULOPALATOCEREBRAL SYNDROME	0.0035566340000000004	0.3556634
OCULO-PALATO-CEREBRAL SYNDROME	0.0035566340000000004	0.3556634
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0035566340000000004	0.3556634
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.0035566340000000004	0.3556634
GLASS SYNDROME	0.0035566340000000004	0.3556634
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0035566340000000004	0.3556634
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.0035566340000000004	0.3556634
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0035566340000000004	0.3556634
FETAL ALCOHOL SYNDROME	0.0035566340000000004	0.3556634
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0034507039999999998	0.3450704
PELIZAEUS-MERZBACHER DISEASE	0.0034507039999999998	0.3450704
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0034507039999999998	0.3450704
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0034507039999999998	0.3450704
CHROMOSOME 1P35 DELETION SYNDROME	0.0034507039999999998	0.3450704
GENITOPATELLAR SYNDROME	0.0034507039999999998	0.3450704
RUBINSTEIN-TAYBI SYNDROME	0.0034507039999999998	0.3450704
GROWTH HORMONE INSENSITIVITY SYNDROME	0.0034507039999999998	0.3450704
OPTIC ATROPHY 11; OPA11	0.0034507039999999998	0.3450704
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0034507039999999998	0.3450704
5Q14.3 MICRODELETION SYNDROME	0.00342466	0.342466
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.00342466	0.342466
OROFACIAL CLEFT 15	0.00342466	0.342466
TETRASOMY X	0.00342466	0.342466
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00342466	0.342466
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.00342466	0.342466
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00342466	0.342466
TETRASOMY 5P	0.00342466	0.342466
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00342466	0.342466
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00342466	0.342466
DEAFNESS-CRANIOFACIAL SYNDROME	0.00342466	0.342466
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00342466	0.342466
BENCZE SYNDROME	0.00342466	0.342466
FRONTOOCULAR SYNDROME	0.00342466	0.342466
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00342466	0.342466
CHROMOSOME 16Q22 DELETION SYNDROME	0.00342466	0.342466
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00342466	0.342466
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00342466	0.342466
8Q24.3 MICRODELETION SYNDROME	0.00342466	0.342466
HOLOPROSENCEPHALY 7	0.00342466	0.342466
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00342466	0.342466
CROSSED POLYSYNDACTYLY	0.00342466	0.342466
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00342466	0.342466
SCHOLTE SYNDROME; SHLTS	0.00342466	0.342466
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00342466	0.342466
OTOONYCHOPERONEAL SYNDROME	0.00342466	0.342466
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00342466	0.342466
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00342466	0.342466
THAKKER-DONNAI SYNDROME	0.00342466	0.342466
1P21.3 MICRODELETION SYNDROME	0.00342466	0.342466
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00342466	0.342466
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00342466	0.342466
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00342466	0.342466
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00342466	0.342466
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00342466	0.342466
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00342466	0.342466
ALAGILLE SYNDROME 1; ALGS1	0.00342466	0.342466
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00342466	0.342466
MENTAL RETARDATION, X-LINKED 21	0.00342466	0.342466
NON-DISTAL MONOSOMY 10Q	0.00342466	0.342466
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00342466	0.342466
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00342466	0.342466
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00342466	0.342466
TRISOMY X	0.00342466	0.342466
CZEIZEL-LOSONCI SYNDROME	0.00342466	0.342466
NEU-LAXOVA SYNDROME 2; NLS2	0.003374835	0.3374835
GENITOPALATOCARDIAC SYNDROME	0.0033748349999999996	0.33748349999999994
OKAMOTO SYNDROME	0.0033748349999999996	0.33748349999999994
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0033748349999999996	0.33748349999999994
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.0033748349999999996	0.33748349999999994
19P13.12 MICRODELETION SYNDROME	0.0033748349999999996	0.33748349999999994
AICARDI SYNDROME	0.0033748349999999996	0.33748349999999994
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0032702950000000003	0.32702950000000003
BALLER-GEROLD SYNDROME	0.003270295	0.3270295
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.003270295	0.3270295
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.003270295	0.3270295
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.003270295	0.3270295
SAETHRE-CHOTZEN SYNDROME	0.003270295	0.3270295
AARSKOG-SCOTT SYNDROME	0.003270295	0.3270295
CATEL-MANZKE SYNDROME	0.003270295	0.3270295
STICKLER SYNDROME	0.003270295	0.3270295
XFE PROGEROID SYNDROME; XFEPS	0.003268905	0.3268905
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.003268905	0.3268905
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.003268905	0.3268905
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.003268905	0.3268905
MELNICK-NEEDLES SYNDROME	0.003164365	0.3164365
MUCOPOLYSACCHARIDOSIS TYPE 4	0.003164365	0.3164365
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.003164365	0.3164365
OSTEOGENESIS IMPERFECTA, TYPE IV	0.003164365	0.3164365
FREEMAN-SHELDON SYNDROME	0.003164365	0.3164365
OSTEOGENESIS IMPERFECTA	0.003164365	0.3164365
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.003164365	0.3164365
LYMPHEDEMA, HEREDITARY, III	0.003164365	0.3164365
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.003164365	0.3164365
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.003143339	0.3143339
JOUBERT SYNDROME WITH RENAL DEFECT	0.003143339	0.3143339
AU-KLINE SYNDROME; AUKS	0.003143339	0.3143339
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003143339	0.3143339
BASAL CELL NEVUS SYNDROME	0.003143339	0.3143339
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003143339	0.3143339
OTOPALATODIGITAL SYNDROME TYPE 1	0.00314083	0.314083
SWEENEY-COX SYNDROME; SWCOS	0.00314083	0.314083
HARDIKAR SYNDROME	0.00314083	0.314083
CAMPOMELIC DYSPLASIA	0.00314083	0.314083
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00314083	0.314083
NAGER SYNDROME	0.00314083	0.314083
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00314083	0.314083
TIBIAL HEMIMELIA	0.00314083	0.314083
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.003037409	0.3037409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.003037409	0.3037409
COWDEN SYNDROME 5; CWS5	0.003037409	0.3037409
COWDEN SYNDROME 6; CWS6	0.003037409	0.3037409
3MC SYNDROME	0.003037409	0.3037409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.003037409	0.3037409
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.003037409	0.3037409
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.003037409	0.3037409
ALPHA-MANNOSIDOSIS	0.003037409	0.3037409
TEEBI-SHALTOUT SYNDROME; TBSH	0.0030317	0.30317
TRISOMY 18	0.0030317	0.30317
ACROCRANIOFACIAL DYSOSTOSIS	0.0030317	0.30317
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0030317	0.30317
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0030317	0.30317
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.0030317	0.30317
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0030317	0.30317
RAINE SYNDROME	0.0030317	0.30317
2Q32Q33 MICRODELETION SYNDROME	0.0030317	0.30317
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.0030317	0.30317
16P13.11 MICRODELETION SYNDROME	0.0030317	0.30317
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.0030317	0.30317
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.0030317	0.30317
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0030317	0.30317
XYLT1-CDG	0.0030317	0.30317
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0030317	0.30317
OROFACIODIGITAL SYNDROME IX; OFD9	0.0030317	0.30317
MOWAT-WILSON SYNDROME	0.0030317	0.30317
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.0029282789999999998	0.2928279
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0029282789999999998	0.2928279
1Q21.1 MICRODELETION SYNDROME	0.0029282789999999998	0.2928279
FRYNS-SMEETS-THIRY SYNDROME	0.0029282789999999998	0.2928279
CEREBELLOFACIODENTAL SYNDROME	0.0029282789999999998	0.2928279
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0029282789999999998	0.2928279
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0029282789999999998	0.2928279
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0029282789999999998	0.2928279
12Q14 MICRODELETION SYNDROME	0.0029282789999999998	0.2928279
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0029282789999999998	0.2928279
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.0029282789999999998	0.2928279
WAGR SYNDROME	0.0029282789999999998	0.2928279
WILLIAMS SYNDROME	0.0029282789999999998	0.2928279
COHEN SYNDROME	0.0029282789999999998	0.2928279
CHROMOSOME 18Q DELETION SYNDROME	0.0029282789999999998	0.2928279
MARINESCO-SJOGREN SYNDROME; MSS	0.0029282789999999998	0.2928279
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0029282789999999998	0.2928279
RUVALCABA SYNDROME	0.0029282789999999998	0.2928279
ROTHMUND-THOMSON SYNDROME	0.0029282789999999998	0.2928279
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0029282789999999998	0.2928279
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.0029282789999999998	0.2928279
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.0029282789999999998	0.2928279
SECKEL SYNDROME	0.0029282789999999998	0.2928279
SJÖGREN-LARSSON SYNDROME	0.0029282789999999998	0.2928279
COFFIN-LOWRY SYNDROME	0.0029282789999999998	0.2928279
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0029282789999999998	0.2928279
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.0029282789999999998	0.2928279
ASPARTYLGLUCOSAMINURIA; AGU	0.0029282789999999998	0.2928279
COFFIN-LOWRY SYNDROME; CLS	0.0029282789999999998	0.2928279
RFT1-CDG	0.0029257700000000003	0.29257700000000003
46,XX GONADAL DYSGENESIS	0.0029257700000000003	0.29257700000000003
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0029257700000000003	0.29257700000000003
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0029257700000000003	0.29257700000000003
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0029257700000000003	0.29257700000000003
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0029257700000000003	0.29257700000000003
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0029257700000000003	0.29257700000000003
FETAL METHYLMERCURY SYNDROME	0.0029257700000000003	0.29257700000000003
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0029257700000000003	0.29257700000000003
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.002904744	0.29047439999999997
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.002904744	0.29047439999999997
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.002904744	0.29047439999999997
LOWRY-MACLEAN SYNDROME	0.002904744	0.29047439999999997
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.002904744	0.29047439999999997
OCULODENTODIGITAL DYSPLASIA; ODDD	0.002904744	0.29047439999999997
MEIER-GORLIN SYNDROME 6; MGORS6	0.002904744	0.29047439999999997
ADAMS-OLIVER SYNDROME 1; AOS1	0.002904744	0.29047439999999997
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.002904744	0.29047439999999997
BARTSOCAS-PAPAS SYNDROME	0.002904744	0.29047439999999997
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.002904744	0.29047439999999997
ROBERTS SYNDROME	0.002904744	0.29047439999999997
OTOMANDIBULAR SYNDROME	0.002904744	0.29047439999999997
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.002904744	0.29047439999999997
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.002800204	0.2800204
TRISOMY 12P	0.002800204	0.2800204
OROFACIODIGITAL SYNDROME VI	0.002800204	0.2800204
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.002800204	0.2800204
2Q33.1 DELETION SYNDROME	0.002800204	0.2800204
FRONTONASAL DYSPLASIA	0.002800204	0.2800204
MCKUSICK-KAUFMAN SYNDROME	0.002800204	0.2800204
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.002800204	0.2800204
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.002800204	0.2800204
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.002800204	0.2800204
OROFACIODIGITAL SYNDROME TYPE 6	0.002800204	0.2800204
SMITH-FINEMAN-MYERS SYNDROME	0.002800204	0.2800204
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002800204	0.2800204
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.002800204	0.2800204
EEC SYNDROME	0.002800204	0.2800204
CYCLIC VOMITING SYNDROME	0.002798814	0.2798814
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.002798814	0.2798814
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002798814	0.2798814
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.002798814	0.2798814
WAARDENBURG SYNDROME TYPE 3	0.002798814	0.2798814
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002798814	0.2798814
WARSAW BREAKAGE SYNDROME; WABS	0.002798814	0.2798814
ATYPICAL RETT SYNDROME	0.002798814	0.2798814
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.002798814	0.2798814
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002798814	0.2798814
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.002798814	0.2798814
MICROPHTHALMIA, SYNDROMIC 1	0.002798814	0.2798814
17Q12 MICRODELETION SYNDROME	0.002694274	0.2694274
CHOPS SYNDROME; CHOPS	0.002694274	0.2694274
OHDO SYNDROME	0.002694274	0.2694274
ACRODYSOSTOSIS	0.002694274	0.2694274
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.002694274	0.2694274
DYSOSTEOSCLEROSIS	0.002694274	0.2694274
BARDET-BIEDL SYNDROME	0.002694274	0.2694274
PRIMROSE SYNDROME; PRIMS	0.002694274	0.2694274
COFFIN-SIRIS SYNDROME 7; CSS7	0.002694274	0.2694274
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.002694274	0.2694274
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.002694274	0.2694274
TOWNES-BROCKS SYNDROME	0.002694274	0.2694274
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.002618405	0.2618405
NEMALINE MYOPATHY 2; NEM2	0.002618405	0.2618405
WAARDENBURG SYNDROME TYPE 1	0.002618405	0.2618405
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.002618405	0.2618405
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.002618405	0.2618405
FRONTORHINY	0.002618405	0.2618405
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.002618405	0.2618405
METATROPIC DYSPLASIA	0.002618405	0.2618405
3P25.3 MICRODELETION SYNDROME	0.002618405	0.2618405
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.002618405	0.2618405
BRITTLE CORNEA SYNDROME	0.002618405	0.2618405
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.002618405	0.2618405
FACIOCARDIORENAL SYNDROME	0.002618405	0.2618405
TRISOMY 13	0.002618405	0.2618405
ATELOSTEOGENESIS, TYPE II	0.002618405	0.2618405
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.002618405	0.2618405
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.002618405	0.2618405
PENTALOGY OF CANTRELL	0.002618405	0.2618405
ATELOSTEOGENESIS TYPE I	0.002618405	0.2618405
FETAL AKINESIA DEFORMATION SEQUENCE	0.002618405	0.2618405
STICKLER SYNDROME, TYPE I	0.002618405	0.2618405
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.002618405	0.2618405
MAXILLONASAL DYSPLASIA	0.002618405	0.2618405
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002618405	0.2618405
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002512475	0.2512475
IVIC SYNDROME	0.002512475	0.2512475
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.002512475	0.2512475
MORQUIO SYNDROME A	0.002512475	0.2512475
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.002512475	0.2512475
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.002512475	0.2512475
FRIEDREICH ATAXIA	0.002512475	0.2512475
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.002512475	0.2512475
BRITTLE CORNEA SYNDROME	0.002512475	0.2512475
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.002512475	0.2512475
ZIMMERMANN-LABAND SYNDROME 1	0.002512475	0.2512475
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.002512475	0.2512475
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.002512475	0.2512475
CENANI-LENZ SYNDROME	0.002512475	0.2512475
CAMURATI-ENGELMANN DISEASE	0.002512475	0.2512475
DISTAL MONOSOMY 6P	0.002512475	0.2512475
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.002512475	0.2512475
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.002512475	0.2512475
4Q21 MICRODELETION SYNDROME	0.002512475	0.2512475
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.002512475	0.2512475
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.002512475	0.2512475
IVIC SYNDROME	0.002512475	0.2512475
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.002512475	0.2512475
PITT-HOPKINS-LIKE SYNDROME	0.002512475	0.2512475
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.002512475	0.2512475
FRIED SYNDROME	0.002512475	0.2512475
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.002512475	0.2512475
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.002512475	0.2512475
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.0024033450000000003	0.24033450000000003
HALL-RIGGS SYNDROME	0.0024033450000000003	0.24033450000000003
NON-DISTAL TRISOMY 10Q	0.0024033450000000003	0.24033450000000003
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0024033450000000003	0.24033450000000003
RETT SYNDROME	0.0024033450000000003	0.24033450000000003
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0024033450000000003	0.24033450000000003
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.0024033450000000003	0.24033450000000003
TRISOMY 4P	0.0024033450000000003	0.24033450000000003
MICRO SYNDROME	0.0024033450000000003	0.24033450000000003
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0024033450000000003	0.24033450000000003
DYSOSTOSIS, STANESCU TYPE	0.0024033450000000003	0.24033450000000003
SLC35A2-CDG	0.0024033450000000003	0.24033450000000003
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0024033450000000003	0.24033450000000003
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.0024033450000000003	0.24033450000000003
MONOSOMY 5P	0.0024033450000000003	0.24033450000000003
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0024033450000000003	0.24033450000000003
OGDEN SYNDROME; OGDNS	0.0024033450000000003	0.24033450000000003
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00237981	0.237981
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00237981	0.237981
DOORS SYNDROME	0.00237981	0.237981
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00237981	0.237981
RHIZOMELIC SYNDROME, URBACH TYPE	0.00237981	0.237981
PRIMARY PULMONARY HYPOPLASIA	0.00237981	0.237981
ADDUCTED THUMBS SYNDROME	0.00237981	0.237981
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00237981	0.237981
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00237981	0.237981
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00237981	0.237981
SCHISIS ASSOCIATION	0.00237981	0.237981
MECKEL SYNDROME, TYPE 4; MKS4	0.00237981	0.237981
MECKEL SYNDROME	0.00237981	0.237981
VICI SYNDROME; VICIS	0.00237981	0.237981
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00237981	0.237981
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00237981	0.237981
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00237981	0.237981
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00237981	0.237981
FAMILIAL VISCERAL MYOPATHY	0.00237981	0.237981
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00237981	0.237981
3MC SYNDROME 1	0.00237981	0.237981
WEAVER-WILLIAMS SYNDROME	0.00237981	0.237981
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00237981	0.237981
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.00237981	0.237981
MECKEL SYNDROME, TYPE 1; MKS1	0.00237981	0.237981
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00237981	0.237981
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00237981	0.237981
HARTSFIELD SYNDROME; HRTFDS	0.00237981	0.237981
TETRAPLOIDY	0.00237981	0.237981
STROMME SYNDROME; STROMS	0.00237981	0.237981
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.002276389	0.22763890000000003
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.002276389	0.22763890000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002276389	0.22763890000000003
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.002276389	0.22763890000000003
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.002276389	0.22763890000000003
HARROD SYNDROME	0.002276389	0.22763890000000003
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.002276389	0.22763890000000003
MARINESCO-SJÖGREN SYNDROME	0.002276389	0.22763890000000003
JUBERG-HAYWARD SYNDROME	0.002276389	0.22763890000000003
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.002276389	0.22763890000000003
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.002276389	0.22763890000000003
TRISOMY 9P	0.002276389	0.22763890000000003
HOLOPROSENCEPHALY 2; HPE2	0.002276389	0.22763890000000003
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.002276389	0.22763890000000003
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.002276389	0.22763890000000003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.002276389	0.22763890000000003
HALLERMANN-STREIFF SYNDROME; HSS	0.002276389	0.22763890000000003
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.002276389	0.22763890000000003
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.002276389	0.22763890000000003
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.002276389	0.22763890000000003
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.002276389	0.22763890000000003
JABERI-ELAHI SYNDROME; JABELS	0.002276389	0.22763890000000003
KLEEFSTRA SYNDROME 2; KLEFS2	0.002276389	0.22763890000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.002276389	0.22763890000000003
FETAL TRIMETHADIONE SYNDROME	0.002276389	0.22763890000000003
TETRASOMY 18P	0.002276389	0.22763890000000003
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.002276389	0.22763890000000003
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.002276389	0.22763890000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.002276389	0.22763890000000003
OROFACIODIGITAL SYNDROME TYPE 5	0.002276389	0.22763890000000003
SSR4-CDG	0.002276389	0.22763890000000003
BETA-UREIDOPROPIONASE DEFICIENCY	0.002276389	0.22763890000000003
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.002276389	0.22763890000000003
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.002276389	0.22763890000000003
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.002276389	0.22763890000000003
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0022752700000000002	0.22752700000000003
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0022752700000000002	0.22752700000000003
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.0022752700000000002	0.22752700000000003
ACROCRANIOFACIAL DYSOSTOSIS	0.0022752700000000002	0.22752700000000003
ACROFRONTOFACIONASAL DYSOSTOSIS	0.0022752700000000002	0.22752700000000003
MUCOLIPIDOSIS TYPE III	0.0022752700000000002	0.22752700000000003
BRANCHIOGENIC DEAFNESS SYNDROME	0.0022752700000000002	0.22752700000000003
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0022752700000000002	0.22752700000000003
OROFACIODIGITAL SYNDROME IV; OFD4	0.0022752700000000002	0.22752700000000003
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.0022752700000000002	0.22752700000000003
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0022752700000000002	0.22752700000000003
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0022752700000000002	0.22752700000000003
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0022752700000000002	0.22752700000000003
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.0022752700000000002	0.22752700000000003
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0022752700000000002	0.22752700000000003
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.0022752700000000002	0.22752700000000003
FRONTOFACIONASAL DYSPLASIA	0.0022752700000000002	0.22752700000000003
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.0022752700000000002	0.22752700000000003
NEURALGIC AMYOTROPHY	0.0022752700000000002	0.22752700000000003
MARSHALL SYNDROME	0.0022752700000000002	0.22752700000000003
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.0022752700000000002	0.22752700000000003
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0022752700000000002	0.22752700000000003
CULLER-JONES SYNDROME; CJS	0.0022752700000000002	0.22752700000000003
DIAMOND-BLACKFAN ANEMIA 10	0.0022752700000000002	0.22752700000000003
ABRUZZO-ERICKSON SYNDROME	0.0022752700000000002	0.22752700000000003
CHROMOSOME 15Q25 DELETION SYNDROME	0.0022752700000000002	0.22752700000000003
FIBROCHONDROGENESIS	0.0022752700000000002	0.22752700000000003
TYSHCHENKO SYNDROME	0.0022752700000000002	0.22752700000000003
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.0022752700000000002	0.22752700000000003
BLACKFAN-DIAMOND ANEMIA	0.0022752700000000002	0.22752700000000003
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.0022752700000000002	0.22752700000000003
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0022752700000000002	0.22752700000000003
LARSEN-LIKE SYNDROME	0.0022752700000000002	0.22752700000000003
XYLOSIDASE DEFICIENCY	0.00227388	0.22738799999999998
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00227388	0.22738799999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.00227388	0.22738799999999998
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00227388	0.22738799999999998
YOU-HOOVER-FONG SYNDROME; YHFS	0.00227388	0.22738799999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.00227388	0.22738799999999998
GENITOPATELLAR SYNDROME; GTPTS	0.00227388	0.22738799999999998
PHELAN-MCDERMID SYNDROME	0.00227388	0.22738799999999998
LATHOSTEROLOSIS	0.00227388	0.22738799999999998
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00227388	0.22738799999999998
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00227388	0.22738799999999998
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.00227388	0.22738799999999998
HSD10 DISEASE	0.00227388	0.22738799999999998
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.00227388	0.22738799999999998
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00227388	0.22738799999999998
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00227388	0.22738799999999998
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.00227388	0.22738799999999998
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00227388	0.22738799999999998
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00227388	0.22738799999999998
MUCOLIPIDOSIS III ALPHA/BETA	0.002171849	0.21718490000000001
COOPER-JABS SYNDROME	0.002171849	0.21718490000000001
LOWE OCULOCEREBRORENAL SYNDROME	0.002171849	0.21718490000000001
MCDONOUGH SYNDROME	0.002171849	0.21718490000000001
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.002171849	0.21718490000000001
ACROGERIA	0.002171849	0.21718490000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.002171849	0.21718490000000001
ISOLATED GLYCEROL KINASE DEFICIENCY	0.002171849	0.21718490000000001
SIALIDOSIS TYPE 1	0.002171849	0.21718490000000001
INCONTINENTIA PIGMENTI	0.002171849	0.21718490000000001
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002171849	0.21718490000000001
MUCOPOLYSACCHARIDOSIS TYPE 1	0.002171849	0.21718490000000001
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.002171849	0.21718490000000001
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.002171849	0.21718490000000001
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.002171849	0.21718490000000001
JACOBSEN SYNDROME	0.002171849	0.21718490000000001
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.002171849	0.21718490000000001
FOUNTAIN SYNDROME	0.002171849	0.21718490000000001
SHWACHMAN-DIAMOND SYNDROME	0.002171849	0.21718490000000001
ISOLATED SPINA BIFIDA	0.002171849	0.21718490000000001
CODAS SYNDROME	0.002171849	0.21718490000000001
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00216934	0.21693400000000002
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00216934	0.21693400000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.00216934	0.21693400000000002
THALIDOMIDE EMBRYOPATHY	0.00216934	0.21693400000000002
COXOAURICULAR SYNDROME	0.00216934	0.21693400000000002
SPASTIC PARAPARESIS AND DEAFNESS	0.00216934	0.21693400000000002
DISTAL TRISOMY 14Q	0.00216934	0.21693400000000002
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00216934	0.21693400000000002
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00216934	0.21693400000000002
COXOAURICULAR SYNDROME	0.00216934	0.21693400000000002
SIALIDOSIS TYPE 2	0.00216934	0.21693400000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.00216934	0.21693400000000002
CAT-EYE SYNDROME	0.00216934	0.21693400000000002
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00216934	0.21693400000000002
X-LINKED HYPOPHOSPHATEMIA	0.00216934	0.21693400000000002
13Q12.3 MICRODELETION SYNDROME	0.00216934	0.21693400000000002
JUVENILE PAGET DISEASE	0.00216934	0.21693400000000002
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00216934	0.21693400000000002
KEUTEL SYNDROME	0.00216934	0.21693400000000002
14Q22Q23 MICRODELETION SYNDROME	0.00216934	0.21693400000000002
CONGENITAL HYPOTHYROIDISM	0.00216934	0.21693400000000002
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00216934	0.21693400000000002
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00216934	0.21693400000000002
GAPO SYNDROME	0.00216934	0.21693400000000002
SPINOCEREBELLAR ATAXIA TYPE 13	0.00216934	0.21693400000000002
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.00216934	0.21693400000000002
BUSCHKE-OLLENDORFF SYNDROME	0.00216934	0.21693400000000002
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00216934	0.21693400000000002
H SYNDROME	0.00216934	0.21693400000000002
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002148314	0.2148314
ACROCARDIOFACIAL SYNDROME	0.002148314	0.2148314
OCULOCEREBROCUTANEOUS SYNDROME	0.002148314	0.2148314
HEMIFACIAL MICROSOMIA	0.002148314	0.2148314
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.002148314	0.2148314
MOSAIC TRISOMY 14	0.002148314	0.2148314
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002148314	0.2148314
DISTAL MONOSOMY 19P13.3	0.002148314	0.2148314
17Q12 MICRODUPLICATION SYNDROME	0.002148314	0.2148314
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.002148314	0.2148314
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.002148314	0.2148314
FRYNS SYNDROME	0.002148314	0.2148314
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.002148314	0.2148314
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.002148314	0.2148314
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.002148314	0.2148314
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.002148314	0.2148314
FACIOCARDIORENAL SYNDROME	0.002148314	0.2148314
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002148314	0.2148314
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.002148314	0.2148314
2Q24 MICRODELETION SYNDROME	0.002148314	0.2148314
STICKLER SYNDROME TYPE 1	0.002148314	0.2148314
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.002148314	0.2148314
FRYNS SYNDROME; FRNS	0.002148314	0.2148314
CEREBROOCULONASAL SYNDROME	0.002148314	0.2148314
ZUNICH NEUROECTODERMAL SYNDROME	0.002148314	0.2148314
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.002148314	0.2148314
OROFACIODIGITAL SYNDROME XI; OFD11	0.002148314	0.2148314
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002148314	0.2148314
ZECHI-CEIDE SYNDROME	0.002148314	0.2148314
OPITZ G/BBB SYNDROME	0.002148314	0.2148314
PFEIFFER SYNDROME TYPE 2	0.002148314	0.2148314
ISOLATED PLAGIOCEPHALY	0.002042384	0.2042384
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002042384	0.2042384
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002042384	0.2042384
8P23.1 DUPLICATION SYNDROME	0.002042384	0.2042384
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.002042384	0.2042384
GALACTOSIALIDOSIS	0.002042384	0.2042384
LISSENCEPHALY 5; LIS5	0.002042384	0.2042384
ACQUIRED PARTIAL LIPODYSTROPHY	0.002042384	0.2042384
OCULOCEREBROCUTANEOUS SYNDROME	0.002042384	0.2042384
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.002042384	0.2042384
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.002042384	0.2042384
SEVERE CANAVAN DISEASE	0.002042384	0.2042384
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.002042384	0.2042384
BARBER-SAY SYNDROME; BBRSAY	0.002042384	0.2042384
TRANSIENT NEONATAL DIABETES MELLITUS	0.002042384	0.2042384
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.002042384	0.2042384
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.002042384	0.2042384
BETA-MANNOSIDOSIS	0.002042384	0.2042384
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.002042384	0.2042384
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.002042384	0.2042384
CRIGLER-NAJJAR SYNDROME TYPE 1	0.002042384	0.2042384
DYSOSTEOSCLEROSIS	0.002042384	0.2042384
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.002042384	0.2042384
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.002042384	0.2042384
FETAL IODINE DEFICIENCY DISORDER	0.002042384	0.2042384
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.002042384	0.2042384
SPINOCEREBELLAR ATAXIA 13	0.002042384	0.2042384
BARDET-BIEDL SYNDROME 16; BBS16	0.002042384	0.2042384
PROLIDASE DEFICIENCY	0.002042384	0.2042384
HYDROXYKYNURENINURIA	0.002042384	0.2042384
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002042384	0.2042384
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.002042384	0.2042384
RICHARDS-RUNDLE SYNDROME; RRNS	0.002042384	0.2042384
LEBER CONGENITAL AMAUROSIS	0.002042384	0.2042384
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002042384	0.2042384
CONE-ROD DYSTROPHY 1; CORD1	0.002042384	0.2042384
ISOLATED BRACHYCEPHALY	0.002042384	0.2042384
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.002042384	0.2042384
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002042384	0.2042384
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.002042384	0.2042384
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.002042384	0.2042384
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002042384	0.2042384
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.002042384	0.2042384
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.002042384	0.2042384
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.002042384	0.2042384
COWCHOCK SYNDROME; COWCK	0.002042384	0.2042384
8Q21.11 MICRODELETION SYNDROME	0.002042384	0.2042384
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.002042384	0.2042384
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.002042384	0.2042384
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002042384	0.2042384
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.002042384	0.2042384
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.002042384	0.2042384
MONOSOMY 22Q13.3	0.002042384	0.2042384
OSTEOPETROSIS AND RELATED DISORDERS	0.002042384	0.2042384
MASA SYNDROME	0.0019332540000000001	0.1933254
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0019332540000000001	0.1933254
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.001933254	0.19332539999999998
SANJAD-SAKATI SYNDROME	0.001933254	0.19332539999999998
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001933254	0.19332539999999998
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.001933254	0.19332539999999998
LEUKOCYTE ADHESION DEFICIENCY	0.001933254	0.19332539999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001933254	0.19332539999999998
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.001933254	0.19332539999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001933254	0.19332539999999998
17Q11.2 MICRODUPLICATION SYNDROME	0.001933254	0.19332539999999998
CEDNIK SYNDROME	0.001933254	0.19332539999999998
SECKEL SYNDROME 8; SCKL8	0.001933254	0.19332539999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001933254	0.19332539999999998
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001933254	0.19332539999999998
WARBURG MICRO SYNDROME 1	0.001933254	0.19332539999999998
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001933254	0.19332539999999998
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.001933254	0.19332539999999998
GMS SYNDROME	0.001933254	0.19332539999999998
FEINGOLD SYNDROME 2; FGLDS2	0.001933254	0.19332539999999998
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001933254	0.19332539999999998
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.001933254	0.19332539999999998
CONGENITAL RUBELLA SYNDROME	0.001933254	0.19332539999999998
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.001933254	0.19332539999999998
DISTAL MONOSOMY 12Q	0.001933254	0.19332539999999998
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.001933254	0.19332539999999998
COCKAYNE SYNDROME	0.001933254	0.19332539999999998
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001933254	0.19332539999999998
COHEN SYNDROME	0.001933254	0.19332539999999998
MEVALONIC ACIDURIA	0.001933254	0.19332539999999998
JOHANSON-BLIZZARD SYNDROME	0.001933254	0.19332539999999998
HOLOPROSENCEPHALY 1; HPE1	0.001933254	0.19332539999999998
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001933254	0.19332539999999998
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.001933254	0.19332539999999998
LOWRY-WOOD SYNDROME	0.001933254	0.19332539999999998
15Q24 RECURRENT MICRODELETION SYNDROME	0.001933254	0.19332539999999998
PSEUDOPROGERIA SYNDROME	0.001933254	0.19332539999999998
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.001933254	0.19332539999999998
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001933254	0.19332539999999998
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.001933254	0.19332539999999998
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001933254	0.19332539999999998
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.001933254	0.19332539999999998
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001933254	0.19332539999999998
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.001933254	0.19332539999999998
MENTAL RETARDATION, X-LINKED 12; MRX12	0.001933254	0.19332539999999998
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.001933254	0.19332539999999998
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001933254	0.19332539999999998
MOYNAHAN SYNDROME	0.001933254	0.19332539999999998
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001933254	0.19332539999999998
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001933254	0.19332539999999998
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.001933254	0.19332539999999998
FEINGOLD SYNDROME	0.001933254	0.19332539999999998
21Q22.11Q22.12 MICRODELETION SYNDROME	0.001933254	0.19332539999999998
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001933254	0.19332539999999998
AL KAISSI SYNDROME; ALKAS	0.001933254	0.19332539999999998
ANE SYNDROME	0.001933254	0.19332539999999998
XQ12-Q13.3 DUPLICATION SYNDROME	0.001933254	0.19332539999999998
CROME SYNDROME	0.001933254	0.19332539999999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001933254	0.19332539999999998
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001933254	0.19332539999999998
ALAZAMI-YUAN SYNDROME	0.001933254	0.19332539999999998
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001933254	0.19332539999999998
COFFIN-SIRIS SYNDROME 5	0.001933254	0.19332539999999998
CHROMOSOME XP11.3 DELETION SYNDROME	0.001933254	0.19332539999999998
DISTAL MONOSOMY 1Q	0.001933254	0.19332539999999998
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.001933254	0.19332539999999998
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001933254	0.19332539999999998
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001933254	0.19332539999999998
WOLCOTT-RALLISON SYNDROME	0.001933254	0.19332539999999998
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001933254	0.19332539999999998
MENKES DISEASE	0.001933254	0.19332539999999998
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.001933254	0.19332539999999998
HADZISELIMOVIC SYNDROME	0.001933254	0.19332539999999998
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001933254	0.19332539999999998
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.001933254	0.19332539999999998
5Q35 MICRODUPLICATION SYNDROME	0.001933254	0.19332539999999998
MULTIPLE SULFATASE DEFICIENCY	0.001933254	0.19332539999999998
15Q13.3 MICRODELETION SYNDROME	0.001933254	0.19332539999999998
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001933254	0.19332539999999998
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001933254	0.19332539999999998
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001933254	0.19332539999999998
MONOSOMY 13Q14	0.001933254	0.19332539999999998
WHITE-SUTTON SYNDROME; WHSUS	0.001933254	0.19332539999999998
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.001933254	0.19332539999999998
INCONTINENTIA PIGMENTI; IP	0.001933254	0.19332539999999998
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001933254	0.19332539999999998
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001933254	0.19332539999999998
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.001933254	0.19332539999999998
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001933254	0.19332539999999998
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001933254	0.19332539999999998
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001751455	0.1751455
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001751455	0.1751455
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.001751455	0.1751455
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001751455	0.1751455
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001751455	0.1751455
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.001751455	0.1751455
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001751455	0.1751455
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.001751455	0.1751455
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001751455	0.1751455
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001751455	0.1751455
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.001751455	0.1751455
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001751455	0.1751455
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001751455	0.1751455
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.001751455	0.1751455
CRANIOSYNOSTOSIS 6; CRS6	0.001751455	0.1751455
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.001751455	0.1751455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.001751455	0.1751455
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001751455	0.1751455
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001751455	0.1751455
NORRIE DISEASE	0.001751455	0.1751455
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001751455	0.1751455
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001751455	0.1751455
ALAZAMI SYNDROME; ALAZS	0.001751455	0.1751455
14Q12 MICRODELETION SYNDROME	0.001751455	0.1751455
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.001751455	0.1751455
OLIVER SYNDROME	0.001751455	0.1751455
NEVUS COMEDONICUS SYNDROME	0.001751455	0.1751455
ALLAN-HERNDON-DUDLEY SYNDROME	0.001751455	0.1751455
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.001751455	0.1751455
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.001751455	0.1751455
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.001751455	0.1751455
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001751455	0.1751455
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.001751455	0.1751455
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001751455	0.1751455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001751455	0.1751455
KEPPEN-LUBINSKY SYNDROME	0.001751455	0.1751455
SHELDON-HALL SYNDROME	0.001646915	0.16469150000000002
STÜVE-WIEDEMANN SYNDROME	0.001646915	0.16469150000000002
ALSTROM SYNDROME; ALMS	0.001646915	0.16469150000000002
CLASSIC MULTIMINICORE MYOPATHY	0.001646915	0.16469150000000002
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.001646915	0.16469150000000002
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.001646915	0.16469150000000002
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001646915	0.16469150000000002
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.001646915	0.16469150000000002
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001646915	0.16469150000000002
ENG-STROM SYNDROME	0.001646915	0.16469150000000002
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001646915	0.16469150000000002
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.001646915	0.16469150000000002
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.001646915	0.16469150000000002
SHOX-RELATED SHORT STATURE	0.001646915	0.16469150000000002
MULTIPLE OSTEOCHONDROMAS	0.001646915	0.16469150000000002
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.001646915	0.16469150000000002
BRUCK SYNDROME	0.001646915	0.16469150000000002
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.001646915	0.16469150000000002
HYPOPHOSPHATEMIC RICKETS	0.001646915	0.16469150000000002
CRANIOLENTICULOSUTURAL DYSPLASIA	0.001646915	0.16469150000000002
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.001646915	0.16469150000000002
COLE-CARPENTER SYNDROME 1; CLCRP1	0.001646915	0.16469150000000002
OSTEOGENESIS IMPERFECTA, TYPE X	0.001646915	0.16469150000000002
MACS SYNDROME	0.001646915	0.16469150000000002
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001646915	0.16469150000000002
HURLER-SCHEIE SYNDROME	0.001646915	0.16469150000000002
MULTIMINICORE MYOPATHY	0.001646915	0.16469150000000002
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.001646915	0.16469150000000002
RIGID SPINE MUSCULAR DYSTROPHY 1	0.001646915	0.16469150000000002
MIRAGE SYNDROME; MIRAGE	0.001646915	0.16469150000000002
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.001646915	0.16469150000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001646915	0.16469150000000002
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.001646915	0.16469150000000002
SHPRINTZEN OMPHALOCELE SYNDROME	0.001646915	0.16469150000000002
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.001646915	0.16469150000000002
CRANIOLENTICULOSUTURAL DYSPLASIA	0.001646915	0.16469150000000002
3M SYNDROME	0.001646915	0.16469150000000002
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.001646915	0.16469150000000002
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.001646915	0.16469150000000002
ACROCAPITOFEMORAL DYSPLASIA	0.001646915	0.16469150000000002
PYCNODYSOSTOSIS	0.001646915	0.16469150000000002
STUVE-WIEDEMANN SYNDROME	0.001646915	0.16469150000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.001646915	0.16469150000000002
BRADDOCK SYNDROME	0.001646915	0.16469150000000002
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001646915	0.16469150000000002
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.001646915	0.16469150000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.001646915	0.16469150000000002
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.001646915	0.16469150000000002
MUCOLIPIDOSIS III GAMMA	0.001646915	0.16469150000000002
BRACHYOLMIA, MAROTEAUX TYPE	0.001646915	0.16469150000000002
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.001646915	0.16469150000000002
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001646915	0.16469150000000002
POPOV-CHANG SYNDROME; POPCHAS	0.001646915	0.16469150000000002
CODAS SYNDROME	0.001646915	0.16469150000000002
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.001646915	0.16469150000000002
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.001646915	0.16469150000000002
STEEL SYNDROME; STLS	0.001646915	0.16469150000000002
PRADER-WILLI SYNDROME	0.001646915	0.16469150000000002
COLE-CARPENTER SYNDROME	0.001646915	0.16469150000000002
CUTIS LAXA	0.001646915	0.16469150000000002
MAFFUCCI SYNDROME	0.001646915	0.16469150000000002
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.001646915	0.16469150000000002
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.001646915	0.16469150000000002
CLASSICAL EHLERS-DANLOS SYNDROME	0.001646915	0.16469150000000002
ATKIN-FLAITZ SYNDROME	0.001646915	0.16469150000000002
NOONAN SYNDROME 4; NS4	0.001646915	0.16469150000000002
TRISOMY 5P	0.001646915	0.16469150000000002
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.001646915	0.16469150000000002
DIGEORGE SYNDROME; DGS	0.001646915	0.16469150000000002
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.001646915	0.16469150000000002
RETT SYNDROME; RTT	0.001646915	0.16469150000000002
WEILL-MARCHESANI SYNDROME 1; WMS1	0.001646915	0.16469150000000002
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.001646915	0.16469150000000002
BRACHYDACTYLY TYPE A1	0.001646915	0.16469150000000002
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.001646915	0.16469150000000002
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.001646915	0.16469150000000002
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.001646915	0.16469150000000002
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001646915	0.16469150000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001646915	0.16469150000000002
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.001646915	0.16469150000000002
TEMPLE SYNDROME	0.001646915	0.16469150000000002
HOLZGREVE SYNDROME	0.00162338	0.162338
ISOLATED DANDY-WALKER MALFORMATION	0.00162338	0.162338
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00162338	0.162338
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.00162338	0.162338
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.162338
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00162338	0.162338
CLEFT PALATE	0.00162338	0.162338
CHAND SYNDROME	0.00162338	0.162338
BECKWITH-WIEDEMANN SYNDROME	0.00162338	0.162338
CRANE-HEISE SYNDROME	0.00162338	0.162338
HISTIOCYTOID CARDIOMYOPATHY	0.00162338	0.162338
DIPROSOPUS	0.00162338	0.162338
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00162338	0.162338
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00162338	0.162338
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00162338	0.162338
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM-CLEFT PALATE SYNDROME	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.00162338	0.162338
CAMPOMELIA, CUMMING TYPE	0.00162338	0.162338
RENAL AGENESIS, BILATERAL	0.00162338	0.162338
SHORT RIB-POLYDACTYLY SYNDROME	0.00162338	0.162338
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00162338	0.162338
HARTSFIELD SYNDROME	0.00162338	0.162338
HEMIMELIA	0.00162338	0.162338
MOSAIC TRISOMY 1	0.00162338	0.162338
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00162338	0.162338
CDAGS SYNDROME	0.00162338	0.162338
STICKLER SYNDROME, TYPE III	0.00162338	0.162338
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00162338	0.162338
RETINOBLASTOMA; RB1	0.00162338	0.162338
FIBROCHONDROGENESIS 1; FBCG1	0.00162338	0.162338
RETINOBLASTOMA	0.00162338	0.162338
BRANCHIOOTIC SYNDROME	0.00162338	0.162338
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00162338	0.162338
KERATODERMA HEREDITARIUM MUTILANS	0.00162338	0.162338
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00162338	0.162338
THORACOABDOMINAL SYNDROME	0.00162338	0.162338
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00162338	0.162338
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00162338	0.162338
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00162338	0.162338
PALATOPHARYNGEAL INCOMPETENCE	0.00162338	0.162338
GENITOPALATOCARDIAC SYNDROME	0.00162338	0.162338
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.00162338	0.162338
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00162338	0.162338
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00162338	0.162338
TRISOMY 1Q	0.00162338	0.162338
TARP SYNDROME; TARPS	0.00162338	0.162338
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00162338	0.162338
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00162338	0.162338
HOLZGREVE SYNDROME	0.00162338	0.162338
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00162338	0.162338
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00162338	0.162338
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00162338	0.162338
LYMPHEDEMA, HEREDITARY, II	0.00162338	0.162338
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.00162338	0.162338
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00162338	0.162338
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00162338	0.162338
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00162338	0.162338
KALLMANN SYNDROME	0.00162338	0.162338
ROSSELLI-GULIENETTI SYNDROME	0.00162338	0.162338
PHOCOMELIA, SCHINZEL TYPE	0.00162338	0.162338
PELVIS-SHOULDER DYSPLASIA	0.00162338	0.162338
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00162338	0.162338
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00162338	0.162338
ANTLEY-BIXLER SYNDROME	0.00162338	0.162338
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00162338	0.162338
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00162338	0.162338
MECKEL SYNDROME, TYPE 6; MKS6	0.00162338	0.162338
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00162338	0.162338
KYPHOMELIC DYSPLASIA	0.00162338	0.162338
TREACHER COLLINS SYNDROME 2; TCS2	0.00162338	0.162338
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00162338	0.162338
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00162338	0.162338
BARTSOCAS-PAPAS SYNDROME; BPS	0.00162338	0.162338
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00162338	0.162338
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00162338	0.162338
VACTERL/VATER ASSOCIATION	0.00162338	0.162338
VAN DER WOUDE SYNDROME	0.00162338	0.162338
PARC SYNDROME	0.00162338	0.162338
AGNATHIA-OTOCEPHALY COMPLEX	0.00162338	0.162338
MECKEL SYNDROME, TYPE 5	0.00162338	0.162338
MECKEL SYNDROME, TYPE 10; MKS10	0.00162338	0.162338
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00162338	0.162338
STICKLER SYNDROME TYPE 2	0.00162338	0.162338
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00162338	0.162338
PIERRE ROBIN SYNDROME	0.00162338	0.162338
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00162338	0.162338
HYDROLETHALUS SYNDROME 1	0.00162338	0.162338
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.162338
AASE-SMITH SYNDROME I	0.00162338	0.162338
POPLITEAL PTERYGIUM SYNDROME	0.00162338	0.162338
KNIEST-LIKE DYSPLASIA, LETHAL	0.00162338	0.162338
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.00162338	0.162338
CATEL-MANZKE SYNDROME; CATMANS	0.00162338	0.162338
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00162338	0.162338
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00162338	0.162338
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.162338
TREACHER COLLINS SYNDROME 3; TCS3	0.00162338	0.162338
CONGENITAL LARYNGOMALACIA	0.00162338	0.162338
ATELOSTEOGENESIS, TYPE I; AO1	0.00162338	0.162338
LETHAL KNIEST-LIKE DYSPLASIA	0.00162338	0.162338
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00162338	0.162338
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00162338	0.162338
DYSTONIA, JUVENILE-ONSET	0.00162338	0.162338
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00162338	0.162338
ISOTRETINOIN SYNDROME	0.00162338	0.162338
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.00162338	0.162338
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00162338	0.162338
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00162338	0.162338
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00162338	0.162338
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00162338	0.162338
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00162338	0.162338
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00162338	0.162338
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00162338	0.162338
THOMAS SYNDROME	0.00162338	0.162338
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00162338	0.162338
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.162338
TRIPLOIDY	0.00162338	0.162338
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00162338	0.162338
ACROPECTOROVERTEBRAL DYSPLASIA	0.00162338	0.162338
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.162338
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00162338	0.162338
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00162338	0.162338
ISOLATED PIERRE ROBIN SYNDROME	0.00162338	0.162338
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00162338	0.162338
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00162338	0.162338
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00162338	0.162338
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00162338	0.162338
ACRORENAL SYNDROME	0.00162338	0.162338
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00162338	0.162338
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00162338	0.162338
SPRENGEL DEFORMITY	0.00162338	0.162338
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00162338	0.162338
MELNICK-NEEDLES SYNDROME	0.00162338	0.162338
ACALVARIA	0.00162338	0.162338
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.162338
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00162338	0.162338
611961 STEVENSON-CAREY SYNDROME	0.001519959	0.1519959
DESBUQUOIS DYSPLASIA 1	0.001519959	0.1519959
ARTERIAL TORTUOSITY SYNDROME	0.001519959	0.1519959
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001519959	0.1519959
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001519959	0.1519959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.001519959	0.1519959
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.001519959	0.1519959
ALEXANDER DISEASE	0.001519959	0.1519959
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001519959	0.1519959
MUCOPOLYSACCHARIDOSIS TYPE 7	0.001519959	0.1519959
WEISMANN-NETTER SYNDROME	0.001519959	0.1519959
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.001519959	0.1519959
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.001519959	0.1519959
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.001519959	0.1519959
GAPO SYNDROME; GAPOS	0.001519959	0.1519959
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.001519959	0.1519959
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.001519959	0.1519959
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001519959	0.1519959
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.001519959	0.1519959
GIANT AXONAL NEUROPATHY	0.001519959	0.1519959
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.001519959	0.1519959
VAN MALDERGEM SYNDROME 1; VMLDS1	0.001519959	0.1519959
METAPHYSEAL ACROSCYPHODYSPLASIA	0.001519959	0.1519959
JOUBERT SYNDROME 7	0.001519959	0.1519959
OCCIPITAL HORN SYNDROME	0.001519959	0.1519959
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001519959	0.1519959
LAMB-SHAFFER SYNDROME	0.001519959	0.1519959
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.001519959	0.1519959
SOTOS SYNDROME 2	0.001519959	0.1519959
OROFACIODIGITAL SYNDROME V; OFD5	0.001519959	0.1519959
METAPHYSEAL ACROSCYPHODYSPLASIA	0.001519959	0.1519959
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.001519959	0.1519959
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.001519959	0.1519959
MENTAL RETARDATION, X-LINKED 82	0.001519959	0.1519959
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001519959	0.1519959
MYOCLONIC-ATONIC EPILEPSY	0.001519959	0.1519959
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001519959	0.1519959
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.001519959	0.1519959
VAN MALDERGEM SYNDROME 2; VMLDS2	0.001519959	0.1519959
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.001519959	0.1519959
DESBUQUOIS SYNDROME	0.001519959	0.1519959
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.001519959	0.1519959
JOUBERT SYNDROME	0.001519959	0.1519959
IMMUNODEFICIENCY 23; IMD23	0.001519959	0.1519959
ATYPICAL JUVENILE PARKINSONISM	0.001519959	0.1519959
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.001519959	0.1519959
FRONTOMETAPHYSEAL DYSPLASIA	0.001519959	0.1519959
CLASSIC HOMOCYSTINURIA	0.001519959	0.1519959
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.001519959	0.1519959
HYPERMANGANESEMIA WITH DYSTONIA 2	0.001519959	0.1519959
TENORIO SYNDROME; TNORS	0.001519959	0.1519959
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.001519959	0.1519959
PONTINE TEGMENTAL CAP DYSPLASIA	0.001519959	0.1519959
CLARK-BARAITSER SYNDROME	0.001519959	0.1519959
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.001519959	0.1519959
SOTOS SYNDROME	0.001519959	0.1519959
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.001519959	0.1519959
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.001519959	0.1519959
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.001519959	0.1519959
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.001519959	0.1519959
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.001519959	0.1519959
HYPOCHONDROPLASIA	0.001519959	0.1519959
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001519959	0.1519959
15Q26 OVERGROWTH SYNDROME	0.001519959	0.1519959
49,XYYYY SYNDROME	0.001519959	0.1519959
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.001519959	0.1519959
OCULOFACIOCARDIODENTAL SYNDROME	0.001519959	0.1519959
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001519959	0.1519959
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.001519959	0.1519959
ASPARTYLGLUCOSAMINURIA	0.001519959	0.1519959
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001519959	0.1519959
LEBER OPTIC ATROPHY AND DYSTONIA	0.001519959	0.1519959
OSTEOGLOSPHONIC DYSPLASIA	0.001519959	0.1519959
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001519959	0.1519959
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001519959	0.1519959
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.15174500000000002
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.00151745	0.15174500000000002
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.15174500000000002
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.15174500000000002
CHAR SYNDROME	0.00151745	0.15174500000000002
ADRENOLEUKODYSTROPHY	0.00151745	0.15174500000000002
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.15174500000000002
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.15174500000000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.15174500000000002
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.15174500000000002
CANAVAN DISEASE	0.00151745	0.15174500000000002
TRANSKETOLASE DEFICIENCY	0.00151745	0.15174500000000002
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.00151745	0.15174500000000002
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.15174500000000002
KEARNS-SAYRE SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00151745	0.15174500000000002
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.00151745	0.15174500000000002
SLC39A8-CDG	0.00151745	0.15174500000000002
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.15174500000000002
GRACILE SYNDROME	0.00151745	0.15174500000000002
BROOKE-SPIEGLER SYNDROME	0.00151745	0.15174500000000002
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.15174500000000002
MENIERE DISEASE	0.00151745	0.15174500000000002
DEAFNESS-CRANIOFACIAL SYNDROME	0.00151745	0.15174500000000002
EAR EXOSTOSES	0.00151745	0.15174500000000002
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.00151745	0.15174500000000002
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.15174500000000002
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.15174500000000002
RENAL COLOBOMA SYNDROME	0.00151745	0.15174500000000002
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.15174500000000002
MULTIPLE CARBOXYLASE DEFICIENCY	0.00151745	0.15174500000000002
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00151745	0.15174500000000002
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.15174500000000002
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.15174500000000002
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.15174500000000002
BRANCHIOOTIC SYNDROME 2	0.00151745	0.15174500000000002
PFEIFFER SYNDROME TYPE 1	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 18	0.00151745	0.15174500000000002
RHYNS SYNDROME	0.00151745	0.15174500000000002
RICHARDS-RUNDLE SYNDROME	0.00151745	0.15174500000000002
PERMANENT NEONATAL DIABETES MELLITUS	0.00151745	0.15174500000000002
CANAVAN DISEASE	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00151745	0.15174500000000002
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.00151745	0.15174500000000002
AUROCEPHALOSYNDACTYLY	0.00151745	0.15174500000000002
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.00151745	0.15174500000000002
AURICULOCONDYLAR SYNDROME	0.00151745	0.15174500000000002
DEMENTIA, FAMILIAL DANISH	0.00151745	0.15174500000000002
ARACHNOIDITIS	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.15174500000000002
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00151745	0.15174500000000002
CARNEY-STRATAKIS SYNDROME	0.00151745	0.15174500000000002
BARBER-SAY SYNDROME	0.00151745	0.15174500000000002
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.15174500000000002
NATHALIE SYNDROME	0.00151745	0.15174500000000002
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.15174500000000002
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.15174500000000002
AXENFELD-RIEGER SYNDROME	0.00151745	0.15174500000000002
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.00151745	0.15174500000000002
GLYCOGEN STORAGE DISEASE II	0.00151745	0.15174500000000002
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.15174500000000002
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00151745	0.15174500000000002
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00151745	0.15174500000000002
KEUTEL SYNDROME; KTLS	0.00151745	0.15174500000000002
KRABBE DISEASE	0.00151745	0.15174500000000002
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00151745	0.15174500000000002
MYASTHENIA GRAVIS	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.15174500000000002
BIOTINIDASE DEFICIENCY	0.00151745	0.15174500000000002
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.15174500000000002
RETINAL VENOUS BEADING	0.00151745	0.15174500000000002
ANUS, IMPERFORATE	0.00151745	0.15174500000000002
ABLEPHARON MACROSTOMIA SYNDROME	0.00151745	0.15174500000000002
184705 STEINFELD SYNDROME	0.00151745	0.15174500000000002
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.15174500000000002
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.15174500000000002
TUNE DEAFNESS	0.00151745	0.15174500000000002
WAARDENBURG-SHAH SYNDROME	0.00151745	0.15174500000000002
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00151745	0.15174500000000002
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00151745	0.15174500000000002
AGEL AMYLOIDOSIS	0.00151745	0.15174500000000002
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.15174500000000002
TAY-SACHS DISEASE	0.00151745	0.15174500000000002
SANDHOFF DISEASE	0.00151745	0.15174500000000002
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00151745	0.15174500000000002
20Q11.2 MICRODELETION SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.15174500000000002
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.00151745	0.15174500000000002
SCLEROSTEOSIS 2; SOST2	0.00151745	0.15174500000000002
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.15174500000000002
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.15174500000000002
OTOSCLEROSIS 8; OTSC8	0.00151745	0.15174500000000002
PILI TORTI	0.00151745	0.15174500000000002
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.15174500000000002
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.15174500000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.00151745	0.15174500000000002
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00151745	0.15174500000000002
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.15174500000000002
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.00151745	0.15174500000000002
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.15174500000000002
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00151745	0.15174500000000002
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.15174500000000002
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00151745	0.15174500000000002
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00151745	0.15174500000000002
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.15174500000000002
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.15174500000000002
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.00151745	0.15174500000000002
OTOSCLEROSIS 3; OTSC3	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.15174500000000002
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00151745	0.15174500000000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00151745	0.15174500000000002
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.15174500000000002
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.15174500000000002
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.15174500000000002
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.15174500000000002
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.15174500000000002
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.15174500000000002
6P22 MICRODELETION SYNDROME	0.00151745	0.15174500000000002
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.15174500000000002
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.00151745	0.15174500000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.00151745	0.15174500000000002
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00151745	0.15174500000000002
LOCKED-IN SYNDROME	0.00151745	0.15174500000000002
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.00151745	0.15174500000000002
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.15174500000000002
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.15174500000000002
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.15174500000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00151745	0.15174500000000002
DESANTO-SHINAWI SYNDROME	0.00151745	0.15174500000000002
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.00151745	0.15174500000000002
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.00151745	0.15174500000000002
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.15174500000000002
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00151745	0.15174500000000002
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00151745	0.15174500000000002
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.00151745	0.15174500000000002
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.15174500000000002
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.15174500000000002
PEROXISOME BIOGENESIS DISORDER 11B	0.00151745	0.15174500000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.15174500000000002
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.00151745	0.15174500000000002
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.00151745	0.15174500000000002
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.15174500000000002
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.15174500000000002
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.15174500000000002
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.15174500000000002
SPINOCEREBELLAR ATAXIA TYPE 31	0.00151745	0.15174500000000002
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.15174500000000002
CRIGLER-NAJJAR SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.15174500000000002
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.15174500000000002
FUCOSIDOSIS	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.00151745	0.15174500000000002
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.15174500000000002
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00151745	0.15174500000000002
VIRAL HEMORRHAGIC FEVER	0.00151745	0.15174500000000002
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00151745	0.15174500000000002
GYRATE ATROPHY OF CHOROID AND RETINA	0.00151745	0.15174500000000002
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00151745	0.15174500000000002
WILDERVANCK SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00151745	0.15174500000000002
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.15174500000000002
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.15174500000000002
WALDENSTRÖM MACROGLOBULINEMIA	0.00151745	0.15174500000000002
ABCD SYNDROME	0.00151745	0.15174500000000002
RETICULAR DYSGENESIS	0.00151745	0.15174500000000002
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00151745	0.15174500000000002
TIETZ SYNDROME	0.00151745	0.15174500000000002
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.15174500000000002
USHER SYNDROME, TYPE ID	0.00151745	0.15174500000000002
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.00140832	0.140832
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00140832	0.140832
HOLMES-GANG SYNDROME	0.00140832	0.140832
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.00140832	0.140832
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00140832	0.140832
BOWEN-CONRADI SYNDROME	0.00140832	0.140832
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00140832	0.140832
6Q16 MICRODELETION SYNDROME	0.00140832	0.140832
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00140832	0.140832
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.00140832	0.140832
COFS SYNDROME	0.00140832	0.140832
PERRAULT SYNDROME 3	0.00140832	0.140832
BLOOM SYNDROME	0.00140832	0.140832
BONNEMANN-MEINECKE-REICH SYNDROME	0.00140832	0.140832
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.00140832	0.140832
BRAIN-LUNG-THYROID SYNDROME	0.00140832	0.140832
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.00140832	0.140832
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00140832	0.140832
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00140832	0.140832
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00140832	0.140832
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00140832	0.140832
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00140832	0.140832
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00140832	0.140832
DYSTONIA 28, CHILDHOOD-ONSET	0.00140832	0.140832
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00140832	0.140832
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00140832	0.140832
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00140832	0.140832
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00140832	0.140832
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00140832	0.140832
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00140832	0.140832
PAGOD SYNDROME	0.00140832	0.140832
TEMPLE-BARAITSER SYNDROME	0.00140832	0.140832
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00140832	0.140832
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00140832	0.140832
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00140832	0.140832
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00140832	0.140832
ROIFMAN SYNDROME; RFMN	0.00140832	0.140832
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.00140832	0.140832
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.00140832	0.140832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.00140832	0.140832
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.00140832	0.140832
SECKEL SYNDROME 9; SCKL9	0.00140832	0.140832
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.00140832	0.140832
ERMINE PHENOTYPE	0.00140832	0.140832
2Q23.1 MICRODELETION SYNDROME	0.00140832	0.140832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.00140832	0.140832
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00140832	0.140832
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00140832	0.140832
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00140832	0.140832
DISTAL TRISOMY 5Q	0.00140832	0.140832
N-ACETYLASPARTATE DEFICIENCY; NACED	0.00140832	0.140832
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00140832	0.140832
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00140832	0.140832
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00140832	0.140832
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00140832	0.140832
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00140832	0.140832
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00140832	0.140832
ADNP SYNDROME	0.00140832	0.140832
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00140832	0.140832
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00140832	0.140832
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00140832	0.140832
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.00140832	0.140832
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00140832	0.140832
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00140832	0.140832
KEARNS-SAYRE SYNDROME; KSS	0.00140832	0.140832
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00140832	0.140832
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00140832	0.140832
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00140832	0.140832
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00140832	0.140832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.00140832	0.140832
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00140832	0.140832
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00140832	0.140832
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.00140832	0.140832
MEVALONIC ACIDURIA; MEVA	0.00140832	0.140832
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00140832	0.140832
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.00140832	0.140832
MONOSOMY 18Q	0.00140832	0.140832
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.00140832	0.140832
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.00140832	0.140832
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00140832	0.140832
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00140832	0.140832
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00140832	0.140832
SATOYOSHI SYNDROME	0.00140832	0.140832
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.00140832	0.140832
IMMUNODEFICIENCY 55; IMD55	0.00140832	0.140832
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00140832	0.140832
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00140832	0.140832
CEREBROFACIOARTICULAR SYNDROME	0.00140832	0.140832
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00140832	0.140832
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00140832	0.140832
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00140832	0.140832
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00140832	0.140832
ISOLATED OSTEOPOIKILOSIS	0.00140832	0.140832
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.00140832	0.140832
STIMMLER SYNDROME	0.00140832	0.140832
TOLUENE EMBRYOPATHY	0.00140832	0.140832
MELAS	0.00140832	0.140832
MICROHYDRANENCEPHALY; MHAC	0.00140832	0.140832
DISTAL MONOSOMY 13Q	0.00140832	0.140832
ACROOTOOCULAR SYNDROME	0.00140832	0.140832
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00140832	0.140832
TRIPLE A SYNDROME	0.00140832	0.140832
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00140832	0.140832
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00140832	0.140832
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00140832	0.140832
ROIFMAN SYNDROME	0.00140832	0.140832
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00140832	0.140832
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00140832	0.140832
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00140832	0.140832
FORSYTHE-WAKELING SYNDROME; FWS	0.00140832	0.140832
GALLOWAY-MOWAT SYNDROME	0.00140832	0.140832
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00140832	0.140832
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.00140832	0.140832
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00140832	0.140832
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00140832	0.140832
LEPRECHAUNISM	0.00140832	0.140832
MICROPHTHALMIA, SYNDROMIC 3	0.00140832	0.140832
MARTSOLF SYNDROME	0.00140832	0.140832
LISSENCEPHALY 4	0.00140832	0.140832
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.00140832	0.140832
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00140832	0.140832
PRIMARY CUTIS VERTICIS GYRATA	0.0012813640000000001	0.1281364
20P13 MICRODELETION SYNDROME	0.0012813640000000001	0.1281364
ACHALASIA-MICROCEPHALY SYNDROME	0.0012813640000000001	0.1281364
HALLERMANN-STREIFF SYNDROME	0.0012813640000000001	0.1281364
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0012813640000000001	0.1281364
MUCOLIPIDOSIS TYPE IV	0.0012813640000000001	0.1281364
PHENOBARBITAL EMBRYOPATHY	0.0012813640000000001	0.1281364
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.0012813640000000001	0.1281364
FILIPPI SYNDROME	0.0012813640000000001	0.1281364
DPAGT1-CDG	0.0012813640000000001	0.1281364
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.0012813640000000001	0.1281364
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0012813640000000001	0.1281364
MENKES DISEASE	0.0012813640000000001	0.1281364
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.0012813640000000001	0.1281364
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0012813640000000001	0.1281364
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.0012813640000000001	0.1281364
WALKER-WARBURG SYNDROME	0.0012813640000000001	0.1281364
WIEDEMANN-STEINER SYNDROME	0.0012813640000000001	0.1281364
STT3B-CDG	0.0012813640000000001	0.1281364
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.0012813640000000001	0.1281364
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.0012813640000000001	0.1281364
DISTAL TRISOMY 15Q	0.0012813640000000001	0.1281364
FRASER SYNDROME	0.0012813640000000001	0.1281364
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0012813640000000001	0.1281364
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.0012813640000000001	0.1281364
CONGENITAL VARICELLA SYNDROME	0.0012813640000000001	0.1281364
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.0012813640000000001	0.1281364
17Q21.31 MICRODUPLICATION SYNDROME	0.0012813640000000001	0.1281364
STT3A-CDG	0.0012813640000000001	0.1281364
MIETENS SYNDROME	0.0012813640000000001	0.1281364
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.0012813640000000001	0.1281364
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.0012813640000000001	0.1281364
GALACTOSEMIA	0.0012813640000000001	0.1281364
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.0012813640000000001	0.1281364
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0012813640000000001	0.1281364
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.0012813640000000001	0.1281364
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.0012813640000000001	0.1281364
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.0012813640000000001	0.1281364
MMEP SYNDROME	0.0012813640000000001	0.1281364
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0012813640000000001	0.1281364
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0012813640000000001	0.1281364
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0012813640000000001	0.1281364
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0012813640000000001	0.1281364
TYROSINEMIA TYPE 2	0.0012813640000000001	0.1281364
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.0012813640000000001	0.1281364
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0012813640000000001	0.1281364
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.0012813640000000001	0.1281364
MATERNAL PHENYLKETONURIA	0.0012813640000000001	0.1281364
WOLF-HIRSCHHORN SYNDROME	0.0012813640000000001	0.1281364
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.0012813640000000001	0.1281364
SUPRABULBAR PARESIS, CONGENITAL	0.0012813640000000001	0.1281364
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0012813640000000001	0.1281364
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.0012813640000000001	0.1281364
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.0012813640000000001	0.1281364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0012813640000000001	0.1281364
LISSENCEPHALY 8; LIS8	0.0012813640000000001	0.1281364
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.0012813640000000001	0.1281364
TURNPENNY-FRY SYNDROME; TPFS	0.0012813640000000001	0.1281364
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0012813640000000001	0.1281364
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0012813640000000001	0.1281364
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0012813640000000001	0.1281364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0012813640000000001	0.1281364
GOLDBERG-SHPRINTZEN SYNDROME	0.0012813640000000001	0.1281364
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.0012813640000000001	0.1281364
MICROCEPHALY-CARDIOMYOPATHY	0.0012813640000000001	0.1281364
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0012813640000000001	0.1281364
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0012813640000000001	0.1281364
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0012813640000000001	0.1281364
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.0012813640000000001	0.1281364
BARDET-BIEDL SYNDROME 20	0.0012813640000000001	0.1281364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0012813640000000001	0.1281364
ACHALASIA-MICROCEPHALY SYNDROME	0.0012813640000000001	0.1281364
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.0012813640000000001	0.1281364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0012813640000000001	0.1281364
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.0012813640000000001	0.1281364
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0012813640000000001	0.1281364
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0012813640000000001	0.1281364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0012813640000000001	0.1281364
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0012813640000000001	0.1281364
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.0012813640000000001	0.1281364
COFFIN-SIRIS SYNDROME 10; CSS10	0.0012813640000000001	0.1281364
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.0012813640000000001	0.1281364
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0012813640000000001	0.1281364
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0012813640000000001	0.1281364
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0012813640000000001	0.1281364
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0012813640000000001	0.1281364
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0012813640000000001	0.1281364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0012813640000000001	0.1281364
FILIPPI SYNDROME; FLPIS	0.0012813640000000001	0.1281364
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.0012813640000000001	0.1281364
JACOBSEN SYNDROME	0.0012813640000000001	0.1281364
LARYNGEAL ABDUCTOR PARALYSIS	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0012813640000000001	0.1281364
MUCOLIPIDOSIS IV; ML4	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0012813640000000001	0.1281364
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.0012813640000000001	0.1281364
FACIOCARDIOMELIC SYNDROME	0.0012813640000000001	0.1281364
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.0012813640000000001	0.1281364
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.0012813640000000001	0.1281364
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0012813640000000001	0.1281364
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.0012813640000000001	0.1281364
PHENYLKETONURIA	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0012813640000000001	0.1281364
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0012813640000000001	0.1281364
MENTAL RETARDATION, X-LINKED 63	0.0012813640000000001	0.1281364
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0012813640000000001	0.1281364
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0012813640000000001	0.1281364
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0012813640000000001	0.1281364
DE SANCTIS-CACCHIONE SYNDROME	0.0012813640000000001	0.1281364
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.0012813640000000001	0.1281364
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0012813640000000001	0.1281364
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0012813640000000001	0.1281364
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0012813640000000001	0.1281364
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.0012813640000000001	0.1281364
2P15-16.1 MICRODELETION SYNDROME	0.0012813640000000001	0.1281364
COCKAYNE SYNDROME A; CSA	0.0012813640000000001	0.1281364
TOWNES-BROCKS SYNDROME 1; TBS1	0.0012813640000000001	0.1281364
ENCEPHALOMALACIA, MULTILOCULAR	0.0012813640000000001	0.1281364
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.0012813640000000001	0.1281364
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.0012813640000000001	0.1281364
3Q29 MICRODELETION SYNDROME	0.0012813640000000001	0.1281364
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0012813640000000001	0.1281364
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0012813640000000001	0.1281364
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0012813640000000001	0.1281364
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0012813640000000001	0.1281364
ANGELMAN SYNDROME (TYPE 1)	0.0012813640000000001	0.1281364
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.0012813640000000001	0.1281364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0012813640000000001	0.1281364
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.0012813640000000001	0.1281364
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0012813640000000001	0.1281364
RING CHROMOSOME 14 SYNDROME	0.0012813640000000001	0.1281364
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.0012813640000000001	0.1281364
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0012813640000000001	0.1281364
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.0012813640000000001	0.1281364
ADENYLOSUCCINASE DEFICIENCY	0.0012813640000000001	0.1281364
9Q SUBTELOMERIC DELETION SYNDROME	0.0012813640000000001	0.1281364
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0012813640000000001	0.1281364
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.0012813640000000001	0.1281364
DUBOWITZ SYNDROME	0.0012813640000000001	0.1281364
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0012813640000000001	0.1281364
GERODERMA OSTEODYSPLASTICUM; GO	0.0012813640000000001	0.1281364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0012813640000000001	0.1281364
AICARDI-GOUTIERES SYNDROME 7	0.0012813640000000001	0.1281364
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.0012813640000000001	0.1281364
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.0012813640000000001	0.1281364
207790 ARACHNOID CYSTS, INTRACRANIAL	0.0012813640000000001	0.1281364
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0012813640000000001	0.1281364
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0012813640000000001	0.1281364
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0012813640000000001	0.1281364
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0012813640000000001	0.1281364
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0012813640000000001	0.1281364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0012813640000000001	0.1281364
LATHOSTEROLOSIS	0.0012813640000000001	0.1281364
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0012813640000000001	0.1281364
CRI DU CHAT SYNDROME (5P DELETION)	0.0012813640000000001	0.1281364
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0012813640000000001	0.1281364
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.0012813640000000001	0.1281364
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.0012813640000000001	0.1281364
ANGELMAN SYNDROME (TYPE 2)	0.0012813640000000001	0.1281364
EPILEPSY-TELANGIECTASIA SYNDROME	0.001176824	0.11768239999999999
OTOFACIOCERVICAL SYNDROME	0.001176824	0.11768239999999999
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001176824	0.11768239999999999
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.001176824	0.11768239999999999
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.001176824	0.11768239999999999
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.001176824	0.11768239999999999
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.001176824	0.11768239999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.001176824	0.11768239999999999
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.001176824	0.11768239999999999
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.001176824	0.11768239999999999
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001176824	0.11768239999999999
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.001176824	0.11768239999999999
PFEIFFER-PALM-TELLER SYNDROME	0.001176824	0.11768239999999999
RODRIGUES BLINDNESS	0.001176824	0.11768239999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001176824	0.11768239999999999
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.001176824	0.11768239999999999
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.001176824	0.11768239999999999
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.001176824	0.11768239999999999
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.001176824	0.11768239999999999
DYSSPONDYLOENCHONDROMATOSIS	0.001176824	0.11768239999999999
LAURENCE-MOON SYNDROME	0.001176824	0.11768239999999999
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.001176824	0.11768239999999999
NIEMANN-PICK DISEASE, TYPE A	0.001176824	0.11768239999999999
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.001176824	0.11768239999999999
15Q11Q13 MICRODUPLICATION SYNDROME	0.001176824	0.11768239999999999
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.001176824	0.11768239999999999
ARGININOSUCCINIC ACIDURIA	0.001176824	0.11768239999999999
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.001176824	0.11768239999999999
COSTELLO SYNDROME; CSTLO	0.001176824	0.11768239999999999
LUSCAN-LUMISH SYNDROME; LLS	0.001176824	0.11768239999999999
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.001176824	0.11768239999999999
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.001176824	0.11768239999999999
ALSTRÖM SYNDROME	0.001176824	0.11768239999999999
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.001176824	0.11768239999999999
245800 LAURENCE-MOON SYNDROME	0.001176824	0.11768239999999999
BIEMOND SYNDROME II	0.001176824	0.11768239999999999
HARTNUP DISEASE	0.001176824	0.11768239999999999
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.001176824	0.11768239999999999
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.001176824	0.11768239999999999
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.001176824	0.11768239999999999
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001176824	0.11768239999999999
FOUNTAIN SYNDROME	0.001176824	0.11768239999999999
NEURAMINIDASE DEFICIENCY	0.001176824	0.11768239999999999
THUMB DEFORMITY AND ALOPECIA	0.001176824	0.11768239999999999
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001176824	0.11768239999999999
NOONAN SYNDROME 8; NS8	0.001176824	0.11768239999999999
MOMO SYNDROME	0.001176824	0.11768239999999999
PSEUDOAMINOPTERIN SYNDROME	0.001176824	0.11768239999999999
RABSON-MENDENHALL SYNDROME	0.001176824	0.11768239999999999
WILLIAMS-BEUREN SYNDROME; WBS	0.001176824	0.11768239999999999
HELSMOORTEL-VAN DER AA SYNDROME	0.001176824	0.11768239999999999
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.001176824	0.11768239999999999
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001176824	0.11768239999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001176824	0.11768239999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.001176824	0.11768239999999999
NETHERTON SYNDROME	0.001176824	0.11768239999999999
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.001176824	0.11768239999999999
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001176824	0.11768239999999999
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.001176824	0.11768239999999999
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.001176824	0.11768239999999999
MASA SYNDROME	0.001176824	0.11768239999999999
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.001176824	0.11768239999999999
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001176824	0.11768239999999999
ICF SYNDROME	0.001176824	0.11768239999999999
FLOATING-HARBOR SYNDROME	0.001176824	0.11768239999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001176824	0.11768239999999999
NEUROFACIODIGITORENAL SYNDROME	0.001176824	0.11768239999999999
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.001176824	0.11768239999999999
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.001176824	0.11768239999999999
PRIMARY CONGENITAL HYPOTHYROIDISM	0.001176824	0.11768239999999999
PERMANENT CONGENITAL HYPOTHYROIDISM	0.001176824	0.11768239999999999
COFFIN-SIRIS SYNDROME 2; CSS2	0.001176824	0.11768239999999999
GEMIGNANI SYNDROME	0.001176824	0.11768239999999999
GERMAN SYNDROME	0.001176824	0.11768239999999999
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.001176824	0.11768239999999999
SACCHAROPINURIA	0.001176824	0.11768239999999999
NIEMANN-PICK DISEASE TYPE B	0.001176824	0.11768239999999999
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001176824	0.11768239999999999
MEND SYNDROME; MEND	0.001176824	0.11768239999999999
GLYCEROL KINASE DEFICIENCY; GKD	0.001176824	0.11768239999999999
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001176824	0.11768239999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001176824	0.11768239999999999
PRADER-WILLI-LIKE SYNDROME	0.001176824	0.11768239999999999
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.001176824	0.11768239999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.001176824	0.11768239999999999
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001176824	0.11768239999999999
FRAXE INTELLECTUAL DISABILITY	0.001176824	0.11768239999999999
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.001176824	0.11768239999999999
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001176824	0.11768239999999999
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001176824	0.11768239999999999
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.001176824	0.11768239999999999
HIRSCHSPRUNG DISEASE	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED 99	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED 92	0.001176824	0.11768239999999999
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001176824	0.11768239999999999
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.001176824	0.11768239999999999
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001176824	0.11768239999999999
COSTELLO SYNDROME	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.001176824	0.11768239999999999
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001176824	0.11768239999999999
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED 84	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED 45	0.001176824	0.11768239999999999
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.001176824	0.11768239999999999
GRISCELLI SYNDROME	0.001176824	0.11768239999999999
FAMILIAL THYROID DYSHORMONOGENESIS	0.001176824	0.11768239999999999
SMITH-MAGENIS SYNDROME	0.001176824	0.11768239999999999
BIEMOND SYNDROME TYPE 2	0.001176824	0.11768239999999999
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001176824	0.11768239999999999
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.001176824	0.11768239999999999
WILLIAMS-BEUREN SYNDROME (WBS)	0.001176824	0.11768239999999999
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001176824	0.11768239999999999
WILSON-TURNER SYNDROME	0.001176824	0.11768239999999999
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.001176824	0.11768239999999999
CAT-EYE SYNDROME (TYPE I)	0.001176824	0.11768239999999999
GURRIERI SYNDROME	0.001176824	0.11768239999999999
MYOTONIA PERMANENS	0.001176824	0.11768239999999999
22Q11.2 DISTAL DELETION SYNDROME	0.001176824	0.11768239999999999
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.001176824	0.11768239999999999
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.001176824	0.11768239999999999
VICI SYNDROME	0.001176824	0.11768239999999999
KENNERKNECHT SYNDROME	0.001176824	0.11768239999999999
FARBER DISEASE	0.001176824	0.11768239999999999
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001176824	0.11768239999999999
ATKIN-FLAITZ SYNDROME	0.001176824	0.11768239999999999
CRANIODIAPHYSEAL DYSPLASIA	0.001176824	0.11768239999999999
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.001176824	0.11768239999999999
CHROMOSOME 2Q37 DELETION SYNDROME	0.001176824	0.11768239999999999
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.001176824	0.11768239999999999
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.001176824	0.11768239999999999
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.001176824	0.11768239999999999
XQ25 DUPLICATION SYNDROME	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED 2	0.001176824	0.11768239999999999
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.001176824	0.11768239999999999
NOONAN SYNDROME 5; NS5	0.001176824	0.11768239999999999
LESCH-NYHAN SYNDROME; LNS	0.001176824	0.11768239999999999
SPINOCEREBELLAR ATAXIA 47; SCA47	0.001176824	0.11768239999999999
DYSEQUILIBRIUM SYNDROME	0.001176824	0.11768239999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.001176824	0.11768239999999999
PITUITARY STALK INTERRUPTION SYNDROME	0.001176824	0.11768239999999999
SONODA SYNDROME	0.001176824	0.11768239999999999
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001176824	0.11768239999999999
SJOGREN-LARSSON SYNDROME; SLS	0.001176824	0.11768239999999999
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.001176824	0.11768239999999999
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.001176824	0.11768239999999999
CHROMOSOME 18P DELETION SYNDROME	0.001176824	0.11768239999999999
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.001176824	0.11768239999999999
DUANE-RADIAL RAY SYNDROME; DRRS	0.000995025	0.09950250000000001
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.000995025	0.09950250000000001
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.000995025	0.09950250000000001
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.000995025	0.09950250000000001
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.000995025	0.09950250000000001
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.000995025	0.09950250000000001
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.000995025	0.09950250000000001
17Q24.2 MICRODELETION SYNDROME	0.000995025	0.09950250000000001
RETT SYNDROME, CONGENITAL VARIANT	0.000995025	0.09950250000000001
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.000995025	0.09950250000000001
PETTIGREW SYNDROME	0.000995025	0.09950250000000001
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.000995025	0.09950250000000001
6Q TERMINAL DELETION SYNDROME	0.000995025	0.09950250000000001
HOLT-ORAM SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.000995025	0.09950250000000001
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.000995025	0.09950250000000001
HEMIHYPERPLASIA, ISOLATED	0.000995025	0.09950250000000001
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000995025	0.09950250000000001
ACRODYSPLASIA SCOLIOSIS	0.000995025	0.09950250000000001
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.000995025	0.09950250000000001
231970 GLUTEAL MUSCLES, ABSENCE OF	0.000995025	0.09950250000000001
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000995025	0.09950250000000001
SALIH MYOPATHY; SALMY	0.000995025	0.09950250000000001
SPONDYLOCAMPTODACTYLY	0.000995025	0.09950250000000001
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.000995025	0.09950250000000001
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.000995025	0.09950250000000001
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.000995025	0.09950250000000001
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.000995025	0.09950250000000001
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.000995025	0.09950250000000001
TERMINAL TRANSVERSE LIMB DEFECT	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000995025	0.09950250000000001
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.000995025	0.09950250000000001
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.000995025	0.09950250000000001
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.000995025	0.09950250000000001
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D	0.000995025	0.09950250000000001
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000995025	0.09950250000000001
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.000995025	0.09950250000000001
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.000995025	0.09950250000000001
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.000995025	0.09950250000000001
MADELUNG DEFORMITY	0.000995025	0.09950250000000001
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000995025	0.09950250000000001
PYLE DISEASE; PYL	0.000995025	0.09950250000000001
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.000995025	0.09950250000000001
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.000995025	0.09950250000000001
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000995025	0.09950250000000001
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.000995025	0.09950250000000001
PACHYDERMOPERIOSTOSIS	0.000995025	0.09950250000000001
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.000995025	0.09950250000000001
PSEUDOXANTHOMA ELASTICUM	0.000995025	0.09950250000000001
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.000995025	0.09950250000000001
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.000995025	0.09950250000000001
LOEYS-DIETZ SYNDROME	0.000995025	0.09950250000000001
CARTILAGE-HAIR HYPOPLASIA; CHH	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 13	0.000995025	0.09950250000000001
NEMALINE MYOPATHY 1; NEM1	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.000995025	0.09950250000000001
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.000995025	0.09950250000000001
OGDEN SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.000995025	0.09950250000000001
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000995025	0.09950250000000001
CZECH DYSPLASIA, METATARSAL TYPE	0.000995025	0.09950250000000001
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.000995025	0.09950250000000001
MARFANOID HABITUS WITH SITUS INVERSUS	0.000995025	0.09950250000000001
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.000995025	0.09950250000000001
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.000995025	0.09950250000000001
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.000995025	0.09950250000000001
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.000995025	0.09950250000000001
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000995025	0.09950250000000001
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.000995025	0.09950250000000001
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000995025	0.09950250000000001
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA TYPE 42	0.000995025	0.09950250000000001
ARNOLD-CHIARI MALFORMATION TYPE I	0.000995025	0.09950250000000001
X-LINKED CENTRONUCLEAR MYOPATHY	0.000995025	0.09950250000000001
FRAGILE X MENTAL RETARDATION SYNDROME	0.000995025	0.09950250000000001
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.000995025	0.09950250000000001
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.000995025	0.09950250000000001
LAING EARLY-ONSET DISTAL MYOPATHY	0.000995025	0.09950250000000001
CENTRONUCLEAR MYOPATHY	0.000995025	0.09950250000000001
HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES	0.000995025	0.09950250000000001
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.000995025	0.09950250000000001
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.000995025	0.09950250000000001
CONO-SPONDYLAR DYSPLASIA	0.000995025	0.09950250000000001
GNATHODIAPHYSEAL DYSPLASIA	0.000995025	0.09950250000000001
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.000995025	0.09950250000000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000995025	0.09950250000000001
OPSISMODYSPLASIA; OPSMD	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE IX	0.000995025	0.09950250000000001
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.000995025	0.09950250000000001
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.000995025	0.09950250000000001
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.000995025	0.09950250000000001
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.000995025	0.09950250000000001
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.000995025	0.09950250000000001
PURE MITOCHONDRIAL MYOPATHY	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.000995025	0.09950250000000001
9Q21.13 MICRODELETION SYNDROME	0.000995025	0.09950250000000001
PSEUDOACHONDROPLASIA	0.000995025	0.09950250000000001
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000995025	0.09950250000000001
SPONDYLOCAMPTODACTYLY SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.000995025	0.09950250000000001
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L	0.000995025	0.09950250000000001
PRUNE BELLY SYNDROME	0.000995025	0.09950250000000001
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000995025	0.09950250000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000995025	0.09950250000000001
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000995025	0.09950250000000001
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.000995025	0.09950250000000001
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000995025	0.09950250000000001
OSTEOMESOPYKNOSIS	0.000995025	0.09950250000000001
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.000995025	0.09950250000000001
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000995025	0.09950250000000001
SILLENCE SYNDROME	0.000995025	0.09950250000000001
WEILL-MARCHESANI SYNDROME 2; WMS2	0.000995025	0.09950250000000001
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.000995025	0.09950250000000001
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.000995025	0.09950250000000001
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.000995025	0.09950250000000001
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.000995025	0.09950250000000001
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.000995025	0.09950250000000001
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.000995025	0.09950250000000001
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.000995025	0.09950250000000001
METATROPIC DYSPLASIA	0.000995025	0.09950250000000001
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000995025	0.09950250000000001
SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1	0.000995025	0.09950250000000001
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.000995025	0.09950250000000001
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000995025	0.09950250000000001
DIASTEMATOMYELIA	0.000995025	0.09950250000000001
FRONTOMETAPHYSEAL DYSPLASIA	0.000995025	0.09950250000000001
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000995025	0.09950250000000001
DYSTONIA, DOPA-RESPONSIVE; DRD	0.000995025	0.09950250000000001
RIN2 SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.000995025	0.09950250000000001
FLYNN-AIRD SYNDROME	0.000995025	0.09950250000000001
RIGID SPINE SYNDROME	0.000995025	0.09950250000000001
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.000995025	0.09950250000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.09950250000000001
SPINOCEREBELLAR ATAXIA TYPE 25	0.000995025	0.09950250000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS 5	0.000995025	0.09950250000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.000995025	0.09950250000000001
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.000995025	0.09950250000000001
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.000995025	0.09950250000000001
LERI-WEILL DYSCHONDROSTEOSIS	0.000995025	0.09950250000000001
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.000995025	0.09950250000000001
TOWNES-BROCKS SYNDROME 2; TBS2	0.000995025	0.09950250000000001
COFFIN-SIRIS SYNDROME 8; CSS8	0.000995025	0.09950250000000001
ODONTOCHONDRODYSPLASIA; ODCD	0.000995025	0.09950250000000001
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.000995025	0.09950250000000001
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.000995025	0.09950250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000995025	0.09950250000000001
ACRO-RENAL-MANDIBULAR SYNDROME	0.000995025	0.09950250000000001
ISOLATED HEMIHYPERPLASIA	0.000995025	0.09950250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000995025	0.09950250000000001
SYRINGOMYELIA, ISOLATED	0.000995025	0.09950250000000001
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.000995025	0.09950250000000001
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.000995025	0.09950250000000001
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.000995025	0.09950250000000001
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.000995025	0.09950250000000001
HIP DYSPLASIA, BEUKES TYPE	0.000995025	0.09950250000000001
BAKER-GORDON SYNDROME; BAGOS	0.000995025	0.09950250000000001
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000995025	0.09950250000000001
FAMILIAL DYSAUTONOMIA	0.000995025	0.09950250000000001
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.000995025	0.09950250000000001
THORACOLARYNGOPELVIC DYSPLASIA	0.000995025	0.09950250000000001
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.000995025	0.09950250000000001
SPRENGEL DEFORMITY	0.000995025	0.09950250000000001
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.000995025	0.09950250000000001
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.000995025	0.09950250000000001
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.000995025	0.09950250000000001
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.000995025	0.09950250000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000995025	0.09950250000000001
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.000995025	0.09950250000000001
TIBIAL TORSION, BILATERAL MEDIAL	0.000995025	0.09950250000000001
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.000995025	0.09950250000000001
GERODERMA OSTEODYSPLASTICA	0.000995025	0.09950250000000001
ATAXIA WITH VITAMIN E DEFICIENCY	0.000995025	0.09950250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.000995025	0.09950250000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000995025	0.09950250000000001
TYPICAL NEMALINE MYOPATHY	0.000995025	0.09950250000000001
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.000995025	0.09950250000000001
CARTILAGE-HAIR HYPOPLASIA	0.000995025	0.09950250000000001
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000995025	0.09950250000000001
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.000995025	0.09950250000000001
EPIPHYSEAL DYSPLASIA, MULTIPLE, 7; EDM7	0.000995025	0.09950250000000001
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.000995025	0.09950250000000001
PERIVENTRICULAR NODULAR HETEROTOPIA	0.000995025	0.09950250000000001
DUCHENNE MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA TYPE 7	0.000995025	0.09950250000000001
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000995025	0.09950250000000001
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.000995025	0.09950250000000001
CAFFEY DISEASE	0.000995025	0.09950250000000001
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.000995025	0.09950250000000001
PSEUDODIASTROPHIC DYSPLASIA	0.000995025	0.09950250000000001
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.000995025	0.09950250000000001
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.000995025	0.09950250000000001
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.000995025	0.09950250000000001
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000995025	0.09950250000000001
POSTERIOR COLUMN ATAXIA	0.000995025	0.09950250000000001
ULNAR HEMIMELIA	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA, 'CORNER FRACTURE' TYPE	0.000995025	0.09950250000000001
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.000995025	0.09950250000000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000995025	0.09950250000000001
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.000995025	0.09950250000000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA	0.000995025	0.09950250000000001
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000995025	0.09950250000000001
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.000995025	0.09950250000000001
FRANK-TER HAAR SYNDROME	0.000995025	0.09950250000000001
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.000995025	0.09950250000000001
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.000995025	0.09950250000000001
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.000995025	0.09950250000000001
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000995025	0.09950250000000001
KUSKOKWIM SYNDROME	0.000995025	0.09950250000000001
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.000995025	0.09950250000000001
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.000995025	0.09950250000000001
MYOPATHY, SCAPULOHUMEROPERONEAL	0.000995025	0.09950250000000001
SPONASTRIME DYSPLASIA	0.000995025	0.09950250000000001
DIPHALLIA	0.000995025	0.09950250000000001
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000995025	0.09950250000000001
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.000995025	0.09950250000000001
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.000995025	0.09950250000000001
PSEUDOACHONDROPLASIA	0.000995025	0.09950250000000001
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.000995025	0.09950250000000001
MYOPATHY, DISTAL, 1; MPD1	0.000995025	0.09950250000000001
CRISPONI SYNDROME	0.000995025	0.09950250000000001
ANGELMAN SYNDROME	0.000995025	0.09950250000000001
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000995025	0.09950250000000001
HYPERREFLEXIA	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.00075643	0.075643
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00075643	0.075643
PEHO SYNDROME	0.00075643	0.075643
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.00075643	0.075643
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00075643	0.075643
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.00075643	0.075643
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.075643
8Q22.1 MICRODELETION SYNDROME	0.00075643	0.075643
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.00075643	0.075643
LISSENCEPHALY 3; LIS3	0.00075643	0.075643
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.075643
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.00075643	0.075643
RHIZOMELIC SYNDROME	0.00075643	0.075643
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00075643	0.075643
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.00075643	0.075643
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.075643
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.075643
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.075643
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.075643
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.075643
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00075643	0.075643
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.075643
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.075643
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.075643
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.00075643	0.075643
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.00075643	0.075643
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00075643	0.075643
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00075643	0.075643
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.075643
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.00075643	0.075643
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.075643
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.00075643	0.075643
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.00075643	0.075643
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.075643
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.075643
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.075643
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.075643
3-HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.075643
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.075643
CHROMOSOME 19P13.13 DELETION SYNDROME	0.00075643	0.075643
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00075643	0.075643
AICARDI-GOUTIERES SYNDROME 5	0.00075643	0.075643
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00075643	0.075643
PEDIATRIC-ONSET GRAVES DISEASE	0.00075643	0.075643
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.075643
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00075643	0.075643
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.075643
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00075643	0.075643
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.075643
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.075643
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.075643
CRANIOTELENCEPHALIC DYSPLASIA	0.00075643	0.075643
FUMARASE DEFICIENCY; FMRD	0.00075643	0.075643
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.075643
PAINE SYNDROME	0.00075643	0.075643
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00075643	0.075643
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.075643
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.075643
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.00075643	0.075643
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.075643
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.075643
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.075643
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00075643	0.075643
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.075643
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.075643
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.075643
LIG4 SYNDROME	0.00075643	0.075643
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00075643	0.075643
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.075643
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.075643
ISOLATED CEREBELLAR AGENESIS	0.00075643	0.075643
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.00075643	0.075643
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.075643
WORSTER-DROUGHT SYNDROME	0.00075643	0.075643
XK APROSENCEPHALY SYNDROME	0.00075643	0.075643
RING CHROMOSOME 1 SYNDROME	0.00075643	0.075643
RING CHROMOSOME 12 SYNDROME	0.00075643	0.075643
RING CHROMOSOME 22 SYNDROME	0.00075643	0.075643
XQ28 (MECP2) DUPLICATION	0.00075643	0.075643
DUPLICATION/INVERSION 15Q11	0.00075643	0.075643
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.00075643	0.075643
AMISH LETHAL MICROCEPHALY	0.00075643	0.075643
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.00075643	0.075643
BRANCHIOSKELETOGENITAL SYNDROME	0.00075643	0.075643
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.075643
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.075643
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.00075643	0.075643
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.075643
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.00075643	0.075643
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00075643	0.075643
RENAL TUBULAR DYSGENESIS	0.00075643	0.075643
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.075643
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.00075643	0.075643
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00075643	0.075643
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00075643	0.075643
NON-DISTAL TRISOMY 13Q	0.00075643	0.075643
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.075643
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00075643	0.075643
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00075643	0.075643
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.075643
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.075643
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.075643
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.00075643	0.075643
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.00075643	0.075643
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.075643
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00075643	0.075643
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.075643
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.075643
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.075643
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.075643
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00075643	0.075643
MONOSOMY 13Q34	0.00075643	0.075643
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00075643	0.075643
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.075643
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.00075643	0.075643
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00075643	0.075643
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00075643	0.075643
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00075643	0.075643
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00075643	0.075643
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.075643
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.00075643	0.075643
PHACE SYNDROME	0.00075643	0.075643
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.00075643	0.075643
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.075643
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.00075643	0.075643
ALG1-CDG	0.00075643	0.075643
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.00075643	0.075643
INFANTILE LIVER FAILURE SYNDROME 1	0.00075643	0.075643
ADAMS-OLIVER SYNDROME 3; AOS3	0.00075643	0.075643
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00075643	0.075643
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.00075643	0.075643
DPM1-CDG	0.00075643	0.075643
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.075643
ALG3-CDG	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00075643	0.075643
SECKEL SYNDROME 7; SCKL7	0.00075643	0.075643
BOWEN-CONRADI SYNDROME	0.00075643	0.075643
MEHMO SYNDROME	0.00075643	0.075643
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.075643
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00075643	0.075643
ALPERS-HUTTENLOCHER SYNDROME	0.00075643	0.075643
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.00075643	0.075643
HEREDITARY METHEMOGLOBINEMIA	0.00075643	0.075643
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00075643	0.075643
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.00075643	0.075643
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.075643
COG4-CDG	0.00075643	0.075643
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00075643	0.075643
MECKEL SYNDROME 12; MKS12	0.00075643	0.075643
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00075643	0.075643
CHRISTIANSON SYNDROME	0.00075643	0.075643
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.00075643	0.075643
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.00075643	0.075643
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00075643	0.075643
ANGELMAN SYNDROME	0.00075643	0.075643
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.00075643	0.075643
LISSENCEPHALY 2; LIS2	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.00075643	0.075643
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.00075643	0.075643
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.075643
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.075643
ISOLATED COMPLEX I DEFICIENCY	0.00075643	0.075643
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00075643	0.075643
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.075643
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00075643	0.075643
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.00075643	0.075643
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00075643	0.075643
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00075643	0.075643
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.00075643	0.075643
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.075643
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00075643	0.075643
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.075643
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.075643
MACDERMOT-WINTER SYNDROME	0.00075643	0.075643
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.00075643	0.075643
CLASSIC PHENYLKETONURIA	0.00075643	0.075643
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.075643
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.075643
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.075643
AICARDI-GOUTIERES SYNDROME 6	0.00075643	0.075643
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.075643
SECKEL SYNDROME 10; SCKL10	0.00075643	0.075643
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00075643	0.075643
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.075643
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.00075643	0.075643
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00075643	0.075643
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.075643
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.00075643	0.075643
PSEUDO-TORCH SYNDROME 2	0.00075643	0.075643
ADAMS-OLIVER SYNDROME 2; AOS2	0.00075643	0.075643
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.075643
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00075643	0.075643
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.00075643	0.075643
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00075643	0.075643
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00075643	0.075643
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00075643	0.075643
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00075643	0.075643
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.00075643	0.075643
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00075643	0.075643
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.00075643	0.075643
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00075643	0.075643
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.075643
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00075643	0.075643
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.00075643	0.075643
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00075643	0.075643
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.00075643	0.075643
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.00075643	0.075643
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00075643	0.075643
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.075643
AL-RAQAD SYNDROME; ARS	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.00075643	0.075643
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.00075643	0.075643
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00075643	0.075643
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.00075643	0.075643
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.075643
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.075643
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.00075643	0.075643
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00075643	0.075643
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.075643
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00075643	0.075643
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00075643	0.075643
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.00075643	0.075643
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.00075643	0.075643
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.075643
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00075643	0.075643
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.075643
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.075643
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.00075643	0.075643
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.00075643	0.075643
UNILATERAL POLYMICROGYRIA	0.00075643	0.075643
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00075643	0.075643
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.075643
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.00075643	0.075643
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00075643	0.075643
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.075643
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.075643
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.075643
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00075643	0.075643
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.075643
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00075643	0.075643
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00075643	0.075643
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.00075643	0.075643
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.075643
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.075643
INFANTILE REFSUM DISEASE	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE IA	0.00065189	0.065189
HARTNUP DISORDER	0.00065189	0.065189
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.00065189	0.065189
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.00065189	0.065189
CORNEODERMATOOSSEOUS SYNDROME	0.00065189	0.065189
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00065189	0.065189
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00065189	0.065189
JUVENILE POLYPOSIS OF INFANCY	0.00065189	0.065189
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00065189	0.065189
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00065189	0.065189
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00065189	0.065189
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00065189	0.065189
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00065189	0.065189
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE IB	0.00065189	0.065189
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00065189	0.065189
EIKEN SYNDROME	0.00065189	0.065189
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00065189	0.065189
SATOYOSHI SYNDROME	0.00065189	0.065189
NEUTRAL LIPID STORAGE MYOPATHY	0.00065189	0.065189
600736 VELOFACIOSKELETAL SYNDROME	0.00065189	0.065189
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00065189	0.065189
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.00065189	0.065189
ATYPICAL WERNER SYNDROME	0.00065189	0.065189
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00065189	0.065189
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.00065189	0.065189
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00065189	0.065189
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00065189	0.065189
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00065189	0.065189
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.00065189	0.065189
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.00065189	0.065189
DENTAL ANOMALIES AND SHORT STATURE; DASS	0.00065189	0.065189
SPINAL DYSPLASIA, ANHALT TYPE	0.00065189	0.065189
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00065189	0.065189
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00065189	0.065189
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00065189	0.065189
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00065189	0.065189
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00065189	0.065189
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00065189	0.065189
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.00065189	0.065189
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.00065189	0.065189
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY	0.00065189	0.065189
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00065189	0.065189
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00065189	0.065189
ADRENOMYODYSTROPHY	0.00065189	0.065189
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00065189	0.065189
BRACHYDACTYLY, TYPE A6	0.00065189	0.065189
PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS	0.00065189	0.065189
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.00065189	0.065189
AURICULOOSTEODYSPLASIA	0.00065189	0.065189
TIBIAL HEMIMELIA-POLYSYNDACTYLY-TRIPHALANGEAL THUMB SYNDROME	0.00065189	0.065189
ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00065189	0.065189
211120 BONE DYSPLASIA, LETHAL, HOLMGREN TYPE	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.00065189	0.065189
ACRODERMATITIS ENTEROPATHICA	0.00065189	0.065189
EHLERS-DANLOS SYNDROME, TYPE I	0.00065189	0.065189
EIKEN SYNDROME	0.00065189	0.065189
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00065189	0.065189
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO LIVER GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.00065189	0.065189
TRICHOHEPATOENTERIC SYNDROME 1	0.00065189	0.065189
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.00065189	0.065189
WIDOW'S PEAK SYNDROME	0.00065189	0.065189
HYPOPHOSPHATASIA	0.00065189	0.065189
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00065189	0.065189
SEPTOOPTIC DYSPLASIA	0.00065189	0.065189
MULTIPLE METAPHYSEAL DYSPLASIA	0.00065189	0.065189
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00065189	0.065189
HURLER-SCHEIE SYNDROME	0.00065189	0.065189
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00065189	0.065189
FG SYNDROME TYPE 1	0.00065189	0.065189
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00065189	0.065189
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00065189	0.065189
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.00065189	0.065189
CHUDLEY-LOWRY-HOAR SYNDROME	0.00065189	0.065189
JUBERG-MARSIDI SYNDROME	0.00065189	0.065189
CARPENTER-WAZIRI SYNDROME	0.00065189	0.065189
SCHIZOPHRENIA 1; SCZD1	0.00065189	0.065189
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00065189	0.065189
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.00065189	0.065189
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.00065189	0.065189
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00065189	0.065189
LEGG-CALVE-PERTHES DISEASE	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE	0.00065189	0.065189
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.00065189	0.065189
SPONDYLOPERIPHERAL DYSPLASIA	0.00065189	0.065189
STIFF SKIN SYNDROME	0.00065189	0.065189
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00065189	0.065189
SIX2-RELATED FRONTONASAL DYSPLASIA	0.00065189	0.065189
PALLISTER-HALL SYNDROME	0.00065189	0.065189
HYPOPHOSPHATEMIC BONE DISEASE	0.00065189	0.065189
WERNER SYNDROME; WRN	0.00065189	0.065189
BRACHYDACTYLY TYPE A4	0.00065189	0.065189
MUCOLIPIDOSIS TYPE II	0.00065189	0.065189
NON-ACQUIRED ISOLATED GROWTH HORMONE DEFICIENCY	0.00065189	0.065189
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00065189	0.065189
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00065189	0.065189
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00065189	0.065189
NAVAJO NEUROHEPATOPATHY	0.00065189	0.065189
MERRF	0.00065189	0.065189
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.00065189	0.065189
PELVIS-SHOULDER DYSPLASIA	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.00065189	0.065189
PRECOCIOUS PUBERTY, CENTRAL	0.00065189	0.065189
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.00065189	0.065189
NASODIGITOACOUSTIC SYNDROME	0.00065189	0.065189
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.00065189	0.065189
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00065189	0.065189
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00065189	0.065189
BRACHYDACTYLY TYPE E	0.00065189	0.065189
PFEIFFER-PALM-TELLER SYNDROME	0.00065189	0.065189
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.00065189	0.065189
XQ25 MICRODUPLICATION SYNDROME	0.00065189	0.065189
RADIAL-RENAL SYNDROME	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE IXB	0.00065189	0.065189
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00065189	0.065189
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.00065189	0.065189
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00065189	0.065189
BRACHYDACTYLY TYPE C	0.00065189	0.065189
PYGMY	0.00065189	0.065189
MUCKLE-WELLS SYNDROME	0.00065189	0.065189
STORMORKEN SYNDROME; STRMK	0.00065189	0.065189
HAIRY ELBOWS	0.00065189	0.065189
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00065189	0.065189
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00065189	0.065189
FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION ANDPROPORTIONATE SHORT STATURE	0.00065189	0.065189
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00065189	0.065189
WERNER SYNDROME	0.00065189	0.065189
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00065189	0.065189
PFEIFFER SYNDROME	0.00065189	0.065189
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00065189	0.065189
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00065189	0.065189
INTRAUTERINE GROWTH RESTRICTION-SHORT STATURE-EARLY ADULT-ONSET DIABETES SYNDROME	0.00065189	0.065189
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00065189	0.065189
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00065189	0.065189
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00065189	0.065189
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00065189	0.065189
TRIPHALANGEAL THUMBS AND DISLOCATION OF PATELLA	0.00065189	0.065189
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00065189	0.065189
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00065189	0.065189
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00065189	0.065189
EXOSTOSES, MULTIPLE, TYPE II	0.00065189	0.065189
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00065189	0.065189
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00065189	0.065189
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00065189	0.065189
EXOSTOSES, MULTIPLE, TYPE I	0.00065189	0.065189
X-LINKED EHLERS-DANLOS SYNDROME	0.00065189	0.065189
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00065189	0.065189
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00065189	0.065189
NEONATAL ADRENOLEUKODYSTROPHY	0.00065189	0.065189
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00065189	0.065189
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00065189	0.065189
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.00065189	0.065189
AROMATASE EXCESS SYNDROME	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00065189	0.065189
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00065189	0.065189
JEUNE SYNDROME	0.00065189	0.065189
DENT DISEASE 1	0.00065189	0.065189
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.00065189	0.065189
MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED APPEARANCE	0.00065189	0.065189
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00065189	0.065189
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00065189	0.065189
THYROID ECTOPIA	0.00065189	0.065189
ATHYREOSIS	0.00065189	0.065189
SHORT FIFTH METACARPALS-INSULIN RESISTANCE SYNDROME	0.00065189	0.065189
PGM3-CDG	0.00065189	0.065189
THYROID HYPOPLASIA	0.00065189	0.065189
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.00065189	0.065189
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00065189	0.065189
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00065189	0.065189
HYALURONIDASE DEFICIENCY	0.00065189	0.065189
DYSOSTOSIS WITH BRACHYDACTYLY	0.00065189	0.065189
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00065189	0.065189
HYPOPHOSPHATASIA, CHILDHOOD	0.00065189	0.065189
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE	0.00065189	0.065189
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.00065189	0.065189
THORACOPELVIC DYSOSTOSIS	0.00065189	0.065189
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00065189	0.065189
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00065189	0.065189
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00065189	0.065189
SHORT STATURE DUE TO PARTIAL GHR DEFICIENCY	0.00065189	0.065189
OROFACIODIGITAL SYNDROME TYPE 2	0.00065189	0.065189
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES	0.00065189	0.065189
LEGG-CALVÉ-PERTHES DISEASE	0.00065189	0.065189
SHORT STATURE, BRUSSELS TYPE	0.00065189	0.065189
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00065189	0.065189
PERIPHERAL DYSOSTOSIS	0.00065189	0.065189
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.00065189	0.065189
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00065189	0.065189
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00065189	0.065189
20P12.3 MICRODELETION SYNDROME	0.00065189	0.065189
NAIL-PATELLA-LIKE RENAL DISEASE	0.00065189	0.065189
CONGENITAL LARYNGEAL WEB	0.00065189	0.065189
THREE M SYNDROME 2; 3M2	0.00065189	0.065189
SINGLETON-MERTEN SYNDROME 2; SGMRT2	0.00065189	0.065189
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00065189	0.065189
FRIAS SYNDROME	0.00065189	0.065189
THYROID HORMONE METABOLISM, ABNORMAL; THMA	0.00065189	0.065189
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.00065189	0.065189
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.00065189	0.065189
NOONAN SYNDROME 3; NS3	0.00065189	0.065189
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.00065189	0.065189
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00065189	0.065189
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.00065189	0.065189
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.00065189	0.065189
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00065189	0.065189
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.00065189	0.065189
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00065189	0.065189
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00065189	0.065189
DISTAL TRISOMY 6P	0.00065189	0.065189
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00065189	0.065189
WORMIAN BONE-MULTIPLE FRACTURES-DENTINOGENESIS IMPERFECTA-SKELETAL DYSPLASIA	0.00065189	0.065189
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00065189	0.065189
NATIVE AMERICAN MYOPATHY	0.00065189	0.065189
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00065189	0.065189
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.00065189	0.065189
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00065189	0.065189
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME	0.00065189	0.065189
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00065189	0.065189
OSLAM SYNDROME	0.00065189	0.065189
CRANIOECTODERMAL DYSPLASIA 3	0.00065189	0.065189
ULNAR-MAMMARY SYNDROME	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00065189	0.065189
TRISOMY XQ28	0.00065189	0.065189
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.00065189	0.065189
NEPHROTIC SYNDROME, TYPE 17; NPHS17	0.00065189	0.065189
SAUL-WILSON SYNDROME; SWILS	0.00065189	0.065189
LAMELLAR ICHTHYOSIS	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00065189	0.065189
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00065189	0.065189
RICHIERI COSTA-DA SILVA SYNDROME	0.00065189	0.065189
IMMUNODEFICIENCY 58; IMD58	0.00065189	0.065189
POLYDACTYLY, POSTAXIAL, TYPE A8; PAPA8	0.00065189	0.065189
OXOGLUTARIC ACIDURIA	0.00065189	0.065189
BRUCK SYNDROME 2	0.00065189	0.065189
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00065189	0.065189
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00065189	0.065189
HIDROTIC ECTODERMAL DYSPLASIA	0.00065189	0.065189
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.00065189	0.065189
DE BARSY SYNDROME	0.00065189	0.065189
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.00065189	0.065189
FEMUR-FIBULA-ULNA COMPLEX	0.00065189	0.065189
CONGENITAL SHORT BOWEL SYNDROME	0.00065189	0.065189
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00065189	0.065189
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM	0.00065189	0.065189
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00065189	0.065189
ANAUXETIC DYSPLASIA 2; ANXD2	0.00065189	0.065189
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00065189	0.065189
ISOLATED AGAMMAGLOBULINEMIA	0.00065189	0.065189
NATHALIE SYNDROME	0.00065189	0.065189
KEIPERT SYNDROME	0.00065189	0.065189
NOONAN SYNDROME 10; NS10	0.00065189	0.065189
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 8	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 5	0.00065189	0.065189
GLAUCOMA-ECTOPIA LENTIS-MICROSPHEROPHAKIA-STIFF JOINTS-SHORT STATURE SYNDROME	0.00065189	0.065189
CYSTINOSIS	0.00065189	0.065189
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00065189	0.065189
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 4	0.00065189	0.065189
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00065189	0.065189
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00065189	0.065189
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00065189	0.065189
GRANT SYNDROME	0.00065189	0.065189
PROGEROID SYNDROME, PETTY TYPE	0.00065189	0.065189
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.00065189	0.065189
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00065189	0.065189
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.00065189	0.065189
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00065189	0.065189
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00065189	0.065189
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00065189	0.065189
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00065189	0.065189
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00065189	0.065189
SAGLIKER SYNDROME	0.00065189	0.065189
MIRROR POLYDACTYLY-VERTEBRAL SEGMENTATION-LIMBS DEFECTS SYNDROME	0.00065189	0.065189
XQ27.3Q28 DUPLICATION SYNDROME	0.00065189	0.065189
STICKLER SYNDROME, TYPE V; STL5	0.00065189	0.065189
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00065189	0.065189
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.00065189	0.065189
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00065189	0.065189
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00065189	0.065189
OVARIAN DYSGENESIS 5; ODG5	0.00065189	0.065189
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00065189	0.065189
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00065189	0.065189
OSTEOGENESIS IMPERFECTA, TYPE V	0.00065189	0.065189
RING CHROMOSOME Y SYNDROME	0.00065189	0.065189
CRANIOECTODERMAL DYSPLASIA 4	0.00065189	0.065189
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00065189	0.065189
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00065189	0.065189
CHITAYAT SYNDROME	0.00065189	0.065189
NOONAN SYNDROME 9; NS9	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME 3	0.00065189	0.065189
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00065189	0.065189
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00065189	0.065189
SHORT STATURE DUE TO GHSR DEFICIENCY	0.00065189	0.065189
GRACILE BONE DYSPLASIA; GCLEB	0.00065189	0.065189
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.00065189	0.065189
NOONAN SYNDROME 2; NS2	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00065189	0.065189
LETHAL CONGENITAL CONTRACTURE SYNDROME TYPE 1	0.00065189	0.065189
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.00065189	0.065189
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00065189	0.065189
RHYNS SYNDROME; RHYNS	0.00065189	0.065189
PROPIONIC ACIDEMIA	0.00065189	0.065189
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00065189	0.065189
LARYNX ATRESIA	0.00065189	0.065189
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00065189	0.065189
ATRESIA OF SMALL INTESTINE	0.00065189	0.065189
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00065189	0.065189
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00065189	0.065189
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00065189	0.065189
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.00065189	0.065189
CRANIOFACIAL DYSSYNOSTOSIS	0.00065189	0.065189
VELO-FACIAL-SKELETAL SYNDROME	0.00065189	0.065189
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.00065189	0.065189
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00065189	0.065189
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00065189	0.065189
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00065189	0.065189
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00065189	0.065189
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00065189	0.065189
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00065189	0.065189
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00065189	0.065189
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00065189	0.065189
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00065189	0.065189
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00065189	0.065189
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00065189	0.065189
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00065189	0.065189
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00065189	0.065189
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.065189
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00065189	0.065189
%613678 BRACHYOLMIA TYPE 2;;BRACHYOLMIA, MAROTEAUX TYPE	0.00065189	0.065189
GROWTH HORMONE DEFICIENCY, ISOLATED PARTIAL; GHDP	0.00065189	0.065189
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00065189	0.065189
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00065189	0.065189
FATCO SYNDROME	0.00065189	0.065189
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00065189	0.065189
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.00065189	0.065189
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00065189	0.065189
GROWTH HORMONE INSENSITIVITY, PARTIAL; GHIP	0.00065189	0.065189
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00065189	0.065189
BRACHYDACTYLY, TYPE E2; BDE2	0.00065189	0.065189
PARANA HARD SKIN SYNDROME	0.00065189	0.065189
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00065189	0.065189
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00065189	0.065189
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00065189	0.065189
NEPHROGENIC DIABETES INSIPIDUS	0.00065189	0.065189
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00065189	0.065189
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00065189	0.065189
FAMILIAL BENIGN COPPER DEFICIENCY	0.00065189	0.065189
METAPHYSEAL ANADYSPLASIA	0.00065189	0.065189
VOGT-KOYANAGI-HARADA DISEASE	0.00065189	0.065189
NIEMANN-PICK DISEASE, TYPE B	0.00065189	0.065189
MULIBREY NANISM	0.00065189	0.065189
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.00065189	0.065189
APPARENT MINERALOCORTICOID EXCESS	0.00065189	0.065189
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.00065189	0.065189
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00065189	0.065189
CHOREOACANTHOCYTOSIS	0.00065189	0.065189
ALOPECIA ANTIBODY DEFICIENCY	0.00065189	0.065189
608028 THAI SYMPHALANGISM SYNDROME	0.00065189	0.065189
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00065189	0.065189
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00065189	0.065189
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00065189	0.065189
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00065189	0.065189
NOONAN SYNDROME 11; NS11	0.00065189	0.065189
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00065189	0.065189
XP22.3 MICRODELETION SYNDROME	0.00065189	0.065189
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00065189	0.065189
IMMUNODEFICIENCY 36; IMD36	0.00065189	0.065189
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.00065189	0.065189
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00065189	0.065189
SENIOR-LOKEN SYNDROME	0.00065189	0.065189
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00065189	0.065189
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.00065189	0.065189
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.00065189	0.065189
TARSAL-CARPAL COALITION SYNDROME	0.00065189	0.065189
CASPASE 8 DEFICIENCY	0.00065189	0.065189
STIFF SKIN SYNDROME	0.00065189	0.065189
WRINKLY SKIN SYNDROME	0.00065189	0.065189
DOUBLE OUTLET RIGHT VENTRICLE	0.00065189	0.065189
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00065189	0.065189
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00065189	0.065189
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00065189	0.065189
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00065189	0.065189
HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA	0.00065189	0.065189
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00065189	0.065189
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2	0.00065189	0.065189
AURICULOOSTEODYSPLASIA	0.00065189	0.065189
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00065189	0.065189
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.00065189	0.065189
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00065189	0.065189
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00065189	0.065189
BARTTER SYNDROME	0.00065189	0.065189
OVARIAN DYSGENESIS 4; ODG4	0.00065189	0.065189
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00065189	0.065189
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00065189	0.065189
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00065189	0.065189
RUIJS-AALFS SYNDROME; RJALS	0.00065189	0.065189
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00065189	0.065189
ARTERIAL TORTUOSITY SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000524934	0.0524934
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000524934	0.0524934
HSD10 DISEASE, ATYPICAL TYPE	0.000524934	0.0524934
PERIPHERAL HYPOTHYROIDISM	0.000524934	0.0524934
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000524934	0.0524934
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000524934	0.0524934
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
BEHR SYNDROME	0.000524934	0.0524934
AUTISM	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.0524934
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000524934	0.0524934
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000524934	0.0524934
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.0524934
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000524934	0.0524934
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000524934	0.0524934
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.0524934
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000524934	0.0524934
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000524934	0.0524934
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000524934	0.0524934
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000524934	0.0524934
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000524934	0.0524934
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000524934	0.0524934
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.0524934
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.000524934	0.0524934
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000524934	0.0524934
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000524934	0.0524934
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000524934	0.0524934
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000524934	0.0524934
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000524934	0.0524934
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000524934	0.0524934
MATTHEW-WOOD SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000524934	0.0524934
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000524934	0.0524934
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.0524934
DIBASIC AMINO ACIDURIA I	0.000524934	0.0524934
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000524934	0.0524934
DERMATOLEUKODYSTROPHY	0.000524934	0.0524934
GRISCELLI SYNDROME TYPE 1	0.000524934	0.0524934
MEGALENCEPHALY	0.000524934	0.0524934
NEUROCUTANEOUS MELANOCYTOSIS	0.000524934	0.0524934
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.0524934
EPILEPSY-TELANGIECTASIA	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 19; BBS19	0.000524934	0.0524934
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.0524934
FOLATE MALABSORPTION, HEREDITARY	0.000524934	0.0524934
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000524934	0.0524934
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.0524934
RETINITIS PIGMENTOSA	0.000524934	0.0524934
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000524934	0.0524934
CLASSIC GALACTOSEMIA	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000524934	0.0524934
ELLIS-VAN CREVELD SYNDROME	0.000524934	0.0524934
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.000524934	0.0524934
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000524934	0.0524934
224250 DYSMYELINATION WITH JAUNDICE	0.000524934	0.0524934
GALACTOSE EPIMERASE DEFICIENCY	0.000524934	0.0524934
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000524934	0.0524934
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000524934	0.0524934
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000524934	0.0524934
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.000524934	0.0524934
KAPUR-TORIELLO SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000524934	0.0524934
CARNOSINEMIA	0.000524934	0.0524934
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.0524934
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000524934	0.0524934
USHER SYNDROME TYPE 1	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000524934	0.0524934
CAHMR SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000524934	0.0524934
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.0524934
ELSAHY-WATERS SYNDROME; ESWS	0.000524934	0.0524934
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000524934	0.0524934
CEPHALIN LIPIDOSIS	0.000524934	0.0524934
JOUBERT SYNDROME 1	0.000524934	0.0524934
LENNOX-GASTAUT SYNDROME	0.000524934	0.0524934
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.0524934
SCHIZENCEPHALY	0.000524934	0.0524934
47,XYY SYNDROME	0.000524934	0.0524934
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.0524934
CYSTEINE PEPTIDURIA	0.000524934	0.0524934
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.0524934
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.0524934
LAURIN-SANDROW SYNDROME	0.000524934	0.0524934
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000524934	0.0524934
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000524934	0.0524934
CITRULLINEMIA, CLASSIC	0.000524934	0.0524934
GRISCELLI SYNDROME, TYPE 1	0.000524934	0.0524934
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000524934	0.0524934
FREE SIALIC ACID STORAGE DISEASE	0.000524934	0.0524934
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
STURGE-WEBER SYNDROME	0.000524934	0.0524934
ARGININOSUCCINIC ACIDURIA	0.000524934	0.0524934
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000524934	0.0524934
FRONTONASAL DYSPLASIA 1; FND1	0.000524934	0.0524934
MENTAL RETARDATION, FRA12A TYPE	0.000524934	0.0524934
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000524934	0.0524934
DERMATOLEUKODYSTROPHY	0.000524934	0.0524934
EDINBURGH MALFORMATION SYNDROME	0.000524934	0.0524934
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000524934	0.0524934
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.000524934	0.0524934
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000524934	0.0524934
CROUZON SYNDROME	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000524934	0.0524934
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000524934	0.0524934
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.0524934
FAMILIAL PAROXYSMAL ATAXIA	0.000524934	0.0524934
PAPILLORENAL SYNDROME	0.000524934	0.0524934
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000524934	0.0524934
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
MEDNIK SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000524934	0.0524934
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000524934	0.0524934
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.0524934
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000524934	0.0524934
MEGALENCEPHALY	0.000524934	0.0524934
ACROMELIC FRONTONASAL DYSPLASIA	0.000524934	0.0524934
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000524934	0.0524934
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000524934	0.0524934
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000524934	0.0524934
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000524934	0.0524934
TEMTAMY SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.000524934	0.0524934
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000524934	0.0524934
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000524934	0.0524934
HYPOCHONDROPLASIA	0.000524934	0.0524934
COG8-CDG	0.000524934	0.0524934
HYPERCALCEMIA, INFANTILE, 1	0.000524934	0.0524934
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.0524934
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.0524934
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000524934	0.0524934
ADAMS-OLIVER SYNDROME	0.000524934	0.0524934
CINCA SYNDROME	0.000524934	0.0524934
CARNOSINASE DEFICIENCY	0.000524934	0.0524934
PRADER-WILLI SYNDROME (TYPE 2)	0.000524934	0.0524934
2Q37 MONOSOMY	0.000524934	0.0524934
HADDAD SYNDROME	0.000524934	0.0524934
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000524934	0.0524934
RING CHROMOSOME 10 SYNDROME	0.000524934	0.0524934
8P23.1 DELETION SYNDROME	0.000524934	0.0524934
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.000524934	0.0524934
WAGR 11P13 DELETION SYNDROME	0.000524934	0.0524934
POTOCKI-SHAFFER SYNDROME	0.000524934	0.0524934
22Q11 DUPLICATION SYNDROME	0.000524934	0.0524934
PERIORAL MYOCLONIA WITH ABSENCES	0.000524934	0.0524934
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.000524934	0.0524934
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.000524934	0.0524934
1P36 MICRODELETION SYNDROME	0.000524934	0.0524934
DERMOTRICHIC SYNDROME	0.000524934	0.0524934
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.000524934	0.0524934
ATR-16 SYNDROME	0.000524934	0.0524934
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.0524934
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.0524934
NEUROFERRITINOPATHY	0.000524934	0.0524934
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.0524934
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.000524934	0.0524934
SPINOCEREBELLAR ATAXIA TYPE 21	0.000524934	0.0524934
CURRY-JONES SYNDROME	0.000524934	0.0524934
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.000524934	0.0524934
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.0524934
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.0524934
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000524934	0.0524934
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000524934	0.0524934
BJÖRNSTAD SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA TYPE 2	0.000524934	0.0524934
LAMBERT SYNDROME	0.000524934	0.0524934
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000524934	0.0524934
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.0524934
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000524934	0.0524934
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.000524934	0.0524934
APERT SYNDROME	0.000524934	0.0524934
IRIDA SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000524934	0.0524934
JOUBERT SYNDROME 27	0.000524934	0.0524934
JOUBERT SYNDROME 28	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.0524934
NEURONAL CEROID LIPOFUSCINOSIS	0.000524934	0.0524934
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.000524934	0.0524934
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.0524934
SOTOS SYNDROME 3	0.000524934	0.0524934
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000524934	0.0524934
DONNAI-BARROW SYNDROME	0.000524934	0.0524934
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000524934	0.0524934
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000524934	0.0524934
WILSON DISEASE	0.000524934	0.0524934
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000524934	0.0524934
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000524934	0.0524934
CYSTATHIONINURIA	0.000524934	0.0524934
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000524934	0.0524934
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000524934	0.0524934
AGENESIS OF CEREBRAL WHITE MATTER	0.000524934	0.0524934
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000524934	0.0524934
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000524934	0.0524934
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000524934	0.0524934
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.0524934
GILLESPIE SYNDROME; GLSP	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.0524934
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.000524934	0.0524934
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000524934	0.0524934
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000524934	0.0524934
CONGENITAL HYDROCEPHALUS	0.000524934	0.0524934
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.000524934	0.0524934
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.0524934
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000524934	0.0524934
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000524934	0.0524934
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.0524934
ALPHA-METHYLACETOACETIC ACIDURIA	0.000524934	0.0524934
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000524934	0.0524934
DYSTONIA 16	0.000524934	0.0524934
CEREBROTENDINOUS XANTHOMATOSIS	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000524934	0.0524934
TELECANTHUS	0.000524934	0.0524934
PRADER-WILLI SYNDROME (TYPE 1)	0.000524934	0.0524934
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000524934	0.0524934
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.000524934	0.0524934
PELGER-HUET ANOMALY; PHA	0.000524934	0.0524934
FIBULAR HEMIMELIA	0.000524934	0.0524934
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000524934	0.0524934
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.0524934
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000524934	0.0524934
FETAL IODINE SYNDROME	0.000524934	0.0524934
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000524934	0.0524934
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000524934	0.0524934
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.0524934
JOUBERT SYNDROME 30; JBTS30	0.000524934	0.0524934
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000524934	0.0524934
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000524934	0.0524934
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.0524934
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.000524934	0.0524934
GALACTOSEMIA	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000524934	0.0524934
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000524934	0.0524934
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.0524934
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000524934	0.0524934
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000524934	0.0524934
ADULT POLYGLUCOSAN BODY DISEASE	0.000524934	0.0524934
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000524934	0.0524934
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000524934	0.0524934
RAHMAN SYNDROME	0.000524934	0.0524934
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000524934	0.0524934
MECKEL SYNDROME 13; MKS13	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000524934	0.0524934
GALACTOSE EPIMERASE DEFICIENCY	0.000524934	0.0524934
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.0524934
1Q21.1 MICRODUPLICATION SYNDROME	0.000524934	0.0524934
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000524934	0.0524934
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.0524934
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.0524934
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.000524934	0.0524934
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.0524934
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.000524934	0.0524934
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.000524934	0.0524934
PTEN HAMARTOMA TUMOR SYNDROME	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000524934	0.0524934
IMMUNODEFICIENCY 47	0.000524934	0.0524934
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000524934	0.0524934
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.000524934	0.0524934
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000524934	0.0524934
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.000524934	0.0524934
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.000524934	0.0524934
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.000524934	0.0524934
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.0524934
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 97; MRX97	0.000524934	0.0524934
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.0524934
JOUBERT SYNDROME 3; JBTS3	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 100	0.000524934	0.0524934
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000524934	0.0524934
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000524934	0.0524934
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000524934	0.0524934
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000524934	0.0524934
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000524934	0.0524934
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000524934	0.0524934
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 88	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 41	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 19	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.000524934	0.0524934
JOUBERT SYNDROME 10	0.000524934	0.0524934
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.0524934
JOUBERT SYNDROME 5	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000524934	0.0524934
RAMON SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000524934	0.0524934
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.0524934
LYSINURIC PROTEIN INTOLERANCE	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000524934	0.0524934
PORENCEPHALY	0.000524934	0.0524934
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000524934	0.0524934
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000524934	0.0524934
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.0524934
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.0524934
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000524934	0.0524934
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000524934	0.0524934
T-SUBSTANCE ANOMALY	0.000524934	0.0524934
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.0524934
CHANARIN-DORFMAN SYNDROME	0.000524934	0.0524934
OLIVER-MCFARLANE SYNDROME	0.000524934	0.0524934
JOUBERT SYNDROME 8	0.000524934	0.0524934
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000524934	0.0524934
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.0524934
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000524934	0.0524934
PROTEUS-LIKE SYNDROME	0.000524934	0.0524934
PYRIDOXINE-DEPENDENT EPILEPSY	0.000524934	0.0524934
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 77	0.000524934	0.0524934
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.000524934	0.0524934
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.0524934
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.0524934
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000524934	0.0524934
11P15.4 MICRODUPLICATION SYNDROME	0.000524934	0.0524934
JOUBERT SYNDROME 6	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 72	0.000524934	0.0524934
SPASTIC PARAPLEGIA 16, X-LINKED	0.000524934	0.0524934
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.0524934
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.000524934	0.0524934
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.0524934
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 103	0.000524934	0.0524934
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000524934	0.0524934
MACROCEPHALY/AUTISM SYNDROME	0.000524934	0.0524934
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.000524934	0.0524934
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000524934	0.0524934
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000524934	0.0524934
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.0524934
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000524934	0.0524934
SALLA DISEASE	0.000524934	0.0524934
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 6; BBS6	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 3; BBS3	0.000524934	0.0524934
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000524934	0.0524934
GLYCINE ENCEPHALOPATHY; GCE	0.000524934	0.0524934
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000524934	0.0524934
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.000524934	0.0524934
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000524934	0.0524934
FAMILIAL LAMBDOID SYNOSTOSIS	0.000524934	0.0524934
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000524934	0.0524934
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000524934	0.0524934
ZLOTOGORA-OGUR SYNDROME	0.000524934	0.0524934
TIMOTHY SYNDROME; TS	0.000524934	0.0524934
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.0524934
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000524934	0.0524934
601095 HARROD SYNDROME	0.000524934	0.0524934
WOLFRAM SYNDROME	0.000524934	0.0524934
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000524934	0.0524934
ZIMMERMANN-LABAND SYNDROME	0.000524934	0.0524934
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000524934	0.0524934
PROPIONIC ACIDEMIA	0.000524934	0.0524934
VAN DEN BOSCH SYNDROME	0.000524934	0.0524934
POTOCKI-SHAFFER SYNDROME	0.000524934	0.0524934
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000524934	0.0524934
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000524934	0.0524934
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.000524934	0.0524934
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000524934	0.0524934
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.000524934	0.0524934
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.000524934	0.0524934
GRANGE SYNDROME; GRNG	0.000524934	0.0524934
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000524934	0.0524934
COENZYME Q10 DEFICIENCY	0.000524934	0.0524934
ALDH18A1-RELATED DE BARSY SYNDROME	0.000524934	0.0524934
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.0524934
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000524934	0.0524934
WAISMAN SYNDROME; WSMN	0.000524934	0.0524934
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000524934	0.0524934
SRD5A3-CDG	0.000524934	0.0524934
STURGE-WEBER SYNDROME	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000524934	0.0524934
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000524934	0.0524934
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.0524934
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000524934	0.0524934
NIEMANN-PICK DISEASE, TYPE C2	0.000524934	0.0524934
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
HEREDITARY HYPEREKPLEXIA	0.000524934	0.0524934
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000524934	0.0524934
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000524934	0.0524934
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.000524934	0.0524934
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000524934	0.0524934
JOUBERT SYNDROME 2	0.000524934	0.0524934
KEIPERT SYNDROME; KPTS	0.000524934	0.0524934
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 105; MRX105	0.000524934	0.0524934
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000524934	0.0524934
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000524934	0.0524934
OPTIC ATROPHY 2	0.000524934	0.0524934
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000524934	0.0524934
ABETAL34V AMYLOIDOSIS	0.000524934	0.0524934
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.0524934
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000524934	0.0524934
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000524934	0.0524934
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.000524934	0.0524934
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.000524934	0.0524934
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000524934	0.0524934
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.0524934
MENTAL RETARDATION, X-LINKED 1	0.000524934	0.0524934
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000524934	0.0524934
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.000524934	0.0524934
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000524934	0.0524934
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000524934	0.0524934
ICHTHYOSIS AND MALE HYPOGONADISM	0.000524934	0.0524934
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.0524934
SUMMITT SYNDROME	0.000524934	0.0524934
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000524934	0.0524934
LISSENCEPHALY 1; LIS1	0.000524934	0.0524934
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.0524934
PENDRED SYNDROME	0.000524934	0.0524934
MONOSOMY 9Q22.3	0.000524934	0.0524934
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000524934	0.0524934
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000524934	0.0524934
CARPENTER SYNDROME	0.000524934	0.0524934
AUTISM, SUSCEPTIBILITY TO, 18	0.000524934	0.0524934
LANDAU-KLEFFNER SYNDROME	0.000524934	0.0524934
LAMBERT SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000524934	0.0524934
KIFAFA SEIZURE DISORDER	0.000524934	0.0524934
16P13.11 MICRODUPLICATION SYNDROME	0.000524934	0.0524934
KETOADIPICACIDURIA	0.000524934	0.0524934
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000524934	0.0524934
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.0524934
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.0524934
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000524934	0.0524934
IMINOGLYCINURIA	0.000524934	0.0524934
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.0524934
LINEAR NEVUS SEBACEUS SYNDROME	0.000524934	0.0524934
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.0524934
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000524934	0.0524934
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.0524934
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.000524934	0.0524934
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.0524934
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.0524934
CHYLOMICRON RETENTION DISEASE	0.000524934	0.0524934
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.000524934	0.0524934
LARON SYNDROME	0.000524934	0.0524934
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000524934	0.0524934
49,XXXYY SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.0524934
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000524934	0.0524934
MAPLE SYRUP URINE DISEASE; MSUD	0.000524934	0.0524934
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000524934	0.0524934
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000524934	0.0524934
CHILDHOOD ABSENCE EPILEPSY	0.000524934	0.0524934
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000524934	0.0524934
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.000524934	0.0524934
XP21 MICRODELETION SYNDROME	0.000524934	0.0524934
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000524934	0.0524934
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000524934	0.0524934
LYSINE MALABSORPTION SYNDROME	0.000524934	0.0524934
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000524934	0.0524934
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000524934	0.0524934
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000524934	0.0524934
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.0524934
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000524934	0.0524934
HOOFT DISEASE	0.000524934	0.0524934
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000524934	0.0524934
HISTIDINEMIA	0.000524934	0.0524934
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000524934	0.0524934
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000524934	0.0524934
NEPHRONOPHTHISIS 18; NPHP18	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000524934	0.0524934
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 2	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 4; BBS4	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 7; BBS7	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 8; BBS8	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 9; BBS9	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 13; BBS13	0.000524934	0.0524934
GLUTATHIONURIA	0.000524934	0.0524934
BARDET-BIEDL SYNDROME 14; BBS14	0.000524934	0.0524934
HOMOCARNOSINOSIS	0.000524934	0.0524934
CHROMOSOME 5Q12 DELETION SYNDROME	0.000524934	0.0524934
PENDRED SYNDROME	0.000524934	0.0524934
JOUBERT SYNDROME 21	0.000524934	0.0524934
N SYNDROME	0.000524934	0.0524934
WOODHOUSE-SAKATI SYNDROME	0.000524934	0.0524934
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.0524934
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000524934	0.0524934
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000524934	0.0524934
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.0524934
HYPERPROLINEMIA, TYPE II	0.000524934	0.0524934
MOYAMOYA DISEASE	0.000524934	0.0524934
HYPERPROLINEMIA, TYPE I	0.000524934	0.0524934
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000524934	0.0524934
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000524934	0.0524934
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.0524934
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.0524934
HYPERLYSINEMIA, TYPE I	0.000524934	0.0524934
HYPERLEUCINE-ISOLEUCINEMIA	0.000524934	0.0524934
HYDROXYPROLINEMIA	0.000524934	0.0524934
HYDROXYLYSINURIA	0.000524934	0.0524934
KAGAMI-OGATA SYNDROME	0.000524934	0.0524934
NANCE-HORAN SYNDROME	0.000524934	0.0524934
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000524934	0.0524934
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000524934	0.0524934
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000524934	0.0524934
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000524934	0.0524934
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.000524934	0.0524934
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000524934	0.0524934
PEROXISOME BIOGENESIS DISORDER 3B	0.000524934	0.0524934
PYRUVATE CARBOXYLASE DEFICIENCY	0.000524934	0.0524934
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000524934	0.0524934
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000524934	0.0524934
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000524934	0.0524934
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000524934	0.0524934
METACHROMATIC LEUKODYSTROPHY	0.000524934	0.0524934
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.0524934
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000524934	0.0524934
MAPLE SYRUP URINE DISEASE	0.000524934	0.0524934
ETHYLMALONIC ENCEPHALOPATHY	0.000524934	0.0524934
METACHROMATIC LEUKODYSTROPHY	0.000524934	0.0524934
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.000524934	0.0524934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.000524934	0.0524934
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.0524934
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000524934	0.0524934
ELLIS VAN CREVELD SYNDROME	0.000524934	0.0524934
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.0524934
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.0524934
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000524934	0.0524934
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.0524934
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.000524934	0.0524934
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000524934	0.0524934
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000524934	0.0524934
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.0524934
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000524934	0.0524934
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.000524934	0.0524934
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000524934	0.0524934
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.000524934	0.0524934
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000524934	0.0524934
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000524934	0.0524934
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000524934	0.0524934
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000524934	0.0524934
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000524934	0.0524934
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000524934	0.0524934
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000524934	0.0524934
OSTEOPENIA AND SPARSE HAIR	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000524934	0.0524934
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.000524934	0.0524934
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000524934	0.0524934
MONILETHRIX	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000524934	0.0524934
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000524934	0.0524934
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.0524934
MORQUIO SYNDROME C	0.000524934	0.0524934
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000524934	0.0524934
JOUBERT SYNDROME 15	0.000524934	0.0524934
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000524934	0.0524934
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000524934	0.0524934
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.0524934
CONGENITAL MYASTHENIC SYNDROME	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000524934	0.0524934
RHOMBENCEPHALOSYNAPSIS	0.000524934	0.0524934
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000524934	0.0524934
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000524934	0.0524934
LEIGH SYNDROME; LS	0.000524934	0.0524934
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000524934	0.0524934
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.0524934
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000524934	0.0524934
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000524934	0.0524934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000524934	0.0524934
OROFACIODIGITAL SYNDROME III	0.000524934	0.0524934
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000524934	0.0524934
OLIVER SYNDROME	0.000524934	0.0524934
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000524934	0.0524934
OCULORENOCEREBELLAR SYNDROME	0.000524934	0.0524934
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000524934	0.0524934
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.0524934
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000524934	0.0524934
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000524934	0.0524934
CHROMOSOME 13Q14 DELETION SYNDROME	0.000524934	0.0524934
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000524934	0.0524934
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000524934	0.0524934
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000524934	0.0524934
ELEJALDE DISEASE	0.000524934	0.0524934
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000524934	0.0524934
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.000524934	0.0524934
CREE MENTAL RETARDATION SYNDROME	0.000524934	0.0524934
